id	sid	tid	token	lemma	pos
eshr-6129	1	1	microsoft	microsoft	PROPN
eshr-6129	1	2	word	word	PROPN
eshr-6129	1	3	fin-6129	fin-6129	NOUN
eshr-6129	1	4	-	-	PUNCT
eshr-6129	1	5	article	article	NOUN
eshr-6129	1	6	text-22203	text-22203	NOUN
eshr-6129	1	7	-	-	PUNCT
eshr-6129	1	8	1	1	NUM
eshr-6129	1	9	-	-	PUNCT
eshr-6129	1	10	4	4	NUM
eshr-6129	1	11	-	-	PUNCT
eshr-6129	1	12	20220630	20220630	NUM
eshr-6129	1	13	-	-	SYM
eshr-6129	1	14	7	7	NUM
eshr-6129	1	15	feb	feb	NOUN
eshr-6129	1	16	2023.edited.docx	2023.edited.docx	NUM
eshr-6129	1	17	epidemiology	epidemiology	NOUN
eshr-6129	1	18	and	and	CCONJ
eshr-6129	1	19	society	society	NOUN
eshr-6129	1	20	health	health	PROPN
eshr-6129	1	21	review|	review|	PROPN
eshr-6129	1	22	eshr	eshr	PROPN
eshr-6129	1	23	vol	vol	NOUN
eshr-6129	1	24	.	.	PROPN
eshr-6129	2	1	5	5	NUM
eshr-6129	2	2	,	,	PUNCT
eshr-6129	2	3	no	no	INTJ
eshr-6129	2	4	.	.	NOUN
eshr-6129	2	5	2	2	NUM
eshr-6129	2	6	,	,	PUNCT
eshr-6129	2	7	2023	2023	NUM
eshr-6129	2	8	,	,	PUNCT
eshr-6129	2	9	pp	pp	ADJ
eshr-6129	2	10	.	.	PUNCT
eshr-6129	3	1	60	60	NUM
eshr-6129	3	2	-	-	SYM
eshr-6129	3	3	68	68	NUM
eshr-6129	3	4	issn	issn	PROPN
eshr-6129	3	5	2656	2656	NUM
eshr-6129	3	6	-	-	SYM
eshr-6129	3	7	6052	6052	NUM
eshr-6129	3	8	(	(	PUNCT
eshr-6129	3	9	online	online	NOUN
eshr-6129	3	10	)	)	PUNCT
eshr-6129	3	11	|	|	ADV
eshr-6129	3	12	2656	2656	NUM
eshr-6129	3	13	-	-	SYM
eshr-6129	3	14	1107	1107	NUM
eshr-6129	3	15	(	(	PUNCT
eshr-6129	3	16	print	print	NOUN
eshr-6129	3	17	)	)	PUNCT
eshr-6129	3	18	http://journal2.uad.ac.id/index.php/eshr/index	http://journal2.uad.ac.id/index.php/eshr/index	NOUN
eshr-6129	3	19	eshr@ikm.uad.ac.id	eshr@ikm.uad.ac.id	X
eshr-6129	3	20	10.26555	10.26555	NUM
eshr-6129	3	21	/	/	SYM
eshr-6129	3	22	eshr.v5i2.6129	eshr.v5i2.6129	PROPN
eshr-6129	3	23	60	60	NUM
eshr-6129	3	24	research	research	NOUN
eshr-6129	3	25	article	article	NOUN
eshr-6129	3	26	correlation	correlation	NOUN
eshr-6129	3	27	between	between	ADP
eshr-6129	3	28	hba1c	hba1c	PROPN
eshr-6129	3	29	and	and	CCONJ
eshr-6129	3	30	lipid	lipid	NOUN
eshr-6129	3	31	profile	profile	NOUN
eshr-6129	3	32	in	in	ADP
eshr-6129	3	33	diabetes	diabetes	NOUN
eshr-6129	3	34	:	:	PUNCT
eshr-6129	3	35	a	a	DET
eshr-6129	3	36	primary	primary	ADJ
eshr-6129	3	37	health	health	NOUN
eshr-6129	3	38	concern	concern	NOUN
eshr-6129	3	39	in	in	ADP
eshr-6129	3	40	aseer	aseer	PROPN
eshr-6129	3	41	,	,	PUNCT
eshr-6129	3	42	saudi	saudi	PROPN
eshr-6129	3	43	arabia	arabia	PROPN
eshr-6129	3	44	fatima	fatima	PROPN
eshr-6129	3	45	riaz1	riaz1	PROPN
eshr-6129	3	46	and	and	CCONJ
eshr-6129	3	47	archana	archana	PROPN
eshr-6129	3	48	nimesh2	nimesh2	PROPN
eshr-6129	3	49	*	*	PROPN
eshr-6129	3	50	1	1	NUM
eshr-6129	3	51	department	department	NOUN
eshr-6129	3	52	of	of	ADP
eshr-6129	3	53	family	family	NOUN
eshr-6129	3	54	and	and	CCONJ
eshr-6129	3	55	community	community	NOUN
eshr-6129	3	56	medicine	medicine	NOUN
eshr-6129	3	57	,	,	PUNCT
eshr-6129	3	58	college	college	NOUN
eshr-6129	3	59	of	of	ADP
eshr-6129	3	60	medicine	medicine	NOUN
eshr-6129	3	61	,	,	PUNCT
eshr-6129	3	62	king	king	PROPN
eshr-6129	3	63	khalid	khalid	PROPN
eshr-6129	3	64	university	university	PROPN
eshr-6129	3	65	,	,	PUNCT
eshr-6129	3	66	saudi	saudi	PROPN
eshr-6129	3	67	arabia	arabia	PROPN
eshr-6129	3	68	2	2	NUM
eshr-6129	3	69	department	department	NOUN
eshr-6129	3	70	of	of	ADP
eshr-6129	3	71	clinical	clinical	ADJ
eshr-6129	3	72	biochemistry	biochemistry	NOUN
eshr-6129	3	73	,	,	PUNCT
eshr-6129	3	74	college	college	NOUN
eshr-6129	3	75	of	of	ADP
eshr-6129	3	76	medicine	medicine	NOUN
eshr-6129	3	77	,	,	PUNCT
eshr-6129	3	78	king	king	PROPN
eshr-6129	3	79	khalid	khalid	PROPN
eshr-6129	3	80	university	university	PROPN
eshr-6129	3	81	,	,	PUNCT
eshr-6129	4	1	saudi	saudi	PROPN
eshr-6129	4	2	arabia	arabia	PROPN
eshr-6129	4	3	*	*	PUNCT
eshr-6129	4	4	correspondence	correspondence	NOUN
eshr-6129	4	5	:	:	PUNCT
eshr-6129	5	1	archana.akku.2010@gmail.com	archana.akku.2010@gmail.com	X
eshr-6129	5	2	.	.	PUNCT
eshr-6129	5	3	phone	phone	NOUN
eshr-6129	5	4	:	:	PUNCT
eshr-6129	6	1	+966	+966	NOUN
eshr-6129	6	2	-	-	SYM
eshr-6129	6	3	594261524	594261524	NUM
eshr-6129	6	4	received	receive	VERB
eshr-6129	6	5	04	04	NUM
eshr-6129	6	6	june	june	PROPN
eshr-6129	6	7	2022	2022	NUM
eshr-6129	6	8	;	;	PUNCT
eshr-6129	6	9	accepted	accept	VERB
eshr-6129	6	10	07	07	NUM
eshr-6129	6	11	february	february	NOUN
eshr-6129	6	12	2023	2023	NUM
eshr-6129	6	13	;	;	PUNCT
eshr-6129	6	14	published	publish	VERB
eshr-6129	6	15	30	30	NUM
eshr-6129	6	16	july	july	PROPN
eshr-6129	6	17	2023	2023	NUM
eshr-6129	6	18	abstract	abstract	ADJ
eshr-6129	6	19	background	background	NOUN
eshr-6129	6	20	:	:	PUNCT
eshr-6129	6	21	type	type	NOUN
eshr-6129	6	22	2	2	NUM
eshr-6129	6	23	diabetes	diabetes	NOUN
eshr-6129	6	24	mellitus	mellitus	NOUN
eshr-6129	6	25	(	(	PUNCT
eshr-6129	6	26	t2	t2	NOUN
eshr-6129	6	27	dm	dm	PROPN
eshr-6129	6	28	)	)	PUNCT
eshr-6129	6	29	presently	presently	ADV
eshr-6129	6	30	affects	affect	VERB
eshr-6129	6	31	537	537	NUM
eshr-6129	6	32	million	million	NUM
eshr-6129	6	33	adults	adult	NOUN
eshr-6129	6	34	globally	globally	ADV
eshr-6129	6	35	.	.	PUNCT
eshr-6129	7	1	it	it	PRON
eshr-6129	7	2	has	have	VERB
eshr-6129	7	3	a	a	DET
eshr-6129	7	4	high	high	ADJ
eshr-6129	7	5	prevalence	prevalence	NOUN
eshr-6129	7	6	in	in	ADP
eshr-6129	7	7	the	the	DET
eshr-6129	7	8	saudi	saudi	ADJ
eshr-6129	7	9	population	population	NOUN
eshr-6129	7	10	(	(	PUNCT
eshr-6129	7	11	31.6	31.6	NUM
eshr-6129	7	12	%	%	NOUN
eshr-6129	7	13	)	)	PUNCT
eshr-6129	7	14	,	,	PUNCT
eshr-6129	7	15	ranking	rank	VERB
eshr-6129	7	16	2nd	2nd	ADJ
eshr-6129	7	17	highest	high	ADJ
eshr-6129	7	18	in	in	ADP
eshr-6129	7	19	the	the	DET
eshr-6129	7	20	middle	middle	PROPN
eshr-6129	7	21	east	east	PROPN
eshr-6129	7	22	and	and	CCONJ
eshr-6129	7	23	7th	7th	ADJ
eshr-6129	7	24	worldwide	worldwide	ADV
eshr-6129	7	25	.	.	PUNCT
eshr-6129	8	1	t2	t2	NOUN
eshr-6129	8	2	dm	dm	PROPN
eshr-6129	8	3	is	be	AUX
eshr-6129	8	4	characterized	characterize	VERB
eshr-6129	8	5	by	by	ADP
eshr-6129	8	6	insulin	insulin	NOUN
eshr-6129	8	7	resistance	resistance	NOUN
eshr-6129	8	8	and	and	CCONJ
eshr-6129	8	9	hyperglycemia	hyperglycemia	NOUN
eshr-6129	8	10	,	,	PUNCT
eshr-6129	8	11	causing	cause	VERB
eshr-6129	8	12	the	the	DET
eshr-6129	8	13	glycation	glycation	NOUN
eshr-6129	8	14	of	of	ADP
eshr-6129	8	15	hemoglobin	hemoglobin	NOUN
eshr-6129	8	16	,	,	PUNCT
eshr-6129	8	17	plasma	plasma	NOUN
eshr-6129	8	18	proteins	protein	NOUN
eshr-6129	8	19	,	,	PUNCT
eshr-6129	8	20	tissue	tissue	NOUN
eshr-6129	8	21	proteins	protein	NOUN
eshr-6129	8	22	,	,	PUNCT
eshr-6129	8	23	and	and	CCONJ
eshr-6129	8	24	their	their	PRON
eshr-6129	8	25	receptors	receptor	NOUN
eshr-6129	8	26	.	.	PUNCT
eshr-6129	9	1	the	the	DET
eshr-6129	9	2	high	high	ADJ
eshr-6129	9	3	insulinemic	insulinemic	ADJ
eshr-6129	9	4	state	state	NOUN
eshr-6129	9	5	leads	lead	VERB
eshr-6129	9	6	to	to	AUX
eshr-6129	9	7	dyslipidemia	dyslipidemia	VERB
eshr-6129	9	8	.	.	PUNCT
eshr-6129	10	1	these	these	DET
eshr-6129	10	2	biochemical	biochemical	ADJ
eshr-6129	10	3	alterations	alteration	NOUN
eshr-6129	10	4	can	can	AUX
eshr-6129	10	5	cause	cause	VERB
eshr-6129	10	6	complications	complication	NOUN
eshr-6129	10	7	like	like	ADP
eshr-6129	10	8	atherosclerosis	atherosclerosis	NOUN
eshr-6129	10	9	,	,	PUNCT
eshr-6129	10	10	coronary	coronary	ADJ
eshr-6129	10	11	artery	artery	NOUN
eshr-6129	10	12	disease	disease	NOUN
eshr-6129	10	13	,	,	PUNCT
eshr-6129	10	14	angina	angina	ADJ
eshr-6129	10	15	,	,	PUNCT
eshr-6129	10	16	myocardial	myocardial	ADJ
eshr-6129	10	17	infarctions	infarction	NOUN
eshr-6129	10	18	,	,	PUNCT
eshr-6129	10	19	and	and	CCONJ
eshr-6129	10	20	hypertension	hypertension	NOUN
eshr-6129	10	21	.	.	PUNCT
eshr-6129	11	1	considering	consider	VERB
eshr-6129	11	2	the	the	DET
eshr-6129	11	3	high	high	ADJ
eshr-6129	11	4	prevalence	prevalence	NOUN
eshr-6129	11	5	of	of	ADP
eshr-6129	11	6	diabetes	diabetes	NOUN
eshr-6129	11	7	in	in	ADP
eshr-6129	11	8	the	the	DET
eshr-6129	11	9	saudi	saudi	ADJ
eshr-6129	11	10	population	population	NOUN
eshr-6129	11	11	and	and	CCONJ
eshr-6129	11	12	the	the	DET
eshr-6129	11	13	lack	lack	NOUN
eshr-6129	11	14	of	of	ADP
eshr-6129	11	15	studies	study	NOUN
eshr-6129	11	16	conducted	conduct	VERB
eshr-6129	11	17	at	at	ADP
eshr-6129	11	18	primary	primary	ADJ
eshr-6129	11	19	health	health	NOUN
eshr-6129	11	20	care	care	NOUN
eshr-6129	11	21	(	(	PUNCT
eshr-6129	11	22	phc	phc	PROPN
eshr-6129	11	23	)	)	PUNCT
eshr-6129	11	24	centers	center	NOUN
eshr-6129	11	25	in	in	ADP
eshr-6129	11	26	saudi	saudi	PROPN
eshr-6129	11	27	arabia	arabia	PROPN
eshr-6129	11	28	,	,	PUNCT
eshr-6129	11	29	this	this	DET
eshr-6129	11	30	study	study	NOUN
eshr-6129	11	31	was	be	AUX
eshr-6129	11	32	done	do	VERB
eshr-6129	11	33	to	to	PART
eshr-6129	11	34	investigate	investigate	VERB
eshr-6129	11	35	the	the	DET
eshr-6129	11	36	status	status	NOUN
eshr-6129	11	37	of	of	ADP
eshr-6129	11	38	diabetes	diabetes	NOUN
eshr-6129	11	39	control	control	NOUN
eshr-6129	11	40	in	in	ADP
eshr-6129	11	41	t2	t2	NOUN
eshr-6129	11	42	dm	dm	NUM
eshr-6129	11	43	patients	patient	NOUN
eshr-6129	11	44	and	and	CCONJ
eshr-6129	11	45	propose	propose	VERB
eshr-6129	11	46	appropriate	appropriate	ADJ
eshr-6129	11	47	measures	measure	NOUN
eshr-6129	11	48	to	to	PART
eshr-6129	11	49	prevent	prevent	VERB
eshr-6129	11	50	the	the	DET
eshr-6129	11	51	development	development	NOUN
eshr-6129	11	52	of	of	ADP
eshr-6129	11	53	future	future	ADJ
eshr-6129	11	54	complications	complication	NOUN
eshr-6129	11	55	.	.	PUNCT
eshr-6129	12	1	method	method	NOUN
eshr-6129	12	2	:	:	PUNCT
eshr-6129	12	3	this	this	DET
eshr-6129	12	4	cross	cross	ADJ
eshr-6129	12	5	-	-	ADJ
eshr-6129	12	6	sectional	sectional	ADJ
eshr-6129	12	7	study	study	NOUN
eshr-6129	12	8	recruited	recruit	VERB
eshr-6129	12	9	191	191	NUM
eshr-6129	12	10	known	know	VERB
eshr-6129	12	11	t2	t2	NOUN
eshr-6129	12	12	dm	dm	PROPN
eshr-6129	12	13	patients	patient	NOUN
eshr-6129	12	14	presenting	present	VERB
eshr-6129	12	15	at	at	ADP
eshr-6129	12	16	the	the	DET
eshr-6129	12	17	phc	phc	PROPN
eshr-6129	12	18	center	center	PROPN
eshr-6129	12	19	in	in	ADP
eshr-6129	12	20	the	the	DET
eshr-6129	12	21	al	al	PROPN
eshr-6129	12	22	qabil	qabil	PROPN
eshr-6129	12	23	locality	locality	NOUN
eshr-6129	12	24	of	of	ADP
eshr-6129	12	25	aseer	aseer	PROPN
eshr-6129	12	26	province	province	NOUN
eshr-6129	12	27	of	of	ADP
eshr-6129	12	28	saudi	saudi	PROPN
eshr-6129	12	29	arabia	arabia	PROPN
eshr-6129	12	30	.	.	PUNCT
eshr-6129	13	1	the	the	DET
eshr-6129	13	2	patient	patient	NOUN
eshr-6129	13	3	's	's	PART
eshr-6129	13	4	demographic	demographic	ADJ
eshr-6129	13	5	and	and	CCONJ
eshr-6129	13	6	glycemic	glycemic	ADJ
eshr-6129	13	7	and	and	CCONJ
eshr-6129	13	8	lipid	lipid	NOUN
eshr-6129	13	9	profile	profile	NOUN
eshr-6129	13	10	data	datum	NOUN
eshr-6129	13	11	were	be	AUX
eshr-6129	13	12	recorded	record	VERB
eshr-6129	13	13	and	and	CCONJ
eshr-6129	13	14	statistically	statistically	ADV
eshr-6129	13	15	analyzed	analyze	VERB
eshr-6129	13	16	.	.	PUNCT
eshr-6129	14	1	results	result	NOUN
eshr-6129	14	2	:	:	PUNCT
eshr-6129	14	3	t2	t2	PROPN
eshr-6129	14	4	dm	dm	PROPN
eshr-6129	14	5	was	be	AUX
eshr-6129	14	6	more	more	ADV
eshr-6129	14	7	prevalent	prevalent	ADJ
eshr-6129	14	8	in	in	ADP
eshr-6129	14	9	males	male	NOUN
eshr-6129	14	10	.	.	PUNCT
eshr-6129	15	1	t2	t2	NOUN
eshr-6129	15	2	dm	dm	PROPN
eshr-6129	15	3	patients	patient	NOUN
eshr-6129	15	4	were	be	AUX
eshr-6129	15	5	found	find	VERB
eshr-6129	15	6	to	to	PART
eshr-6129	15	7	be	be	AUX
eshr-6129	15	8	obese	obese	ADJ
eshr-6129	15	9	,	,	PUNCT
eshr-6129	15	10	and	and	CCONJ
eshr-6129	15	11	52	52	NUM
eshr-6129	15	12	%	%	NOUN
eshr-6129	15	13	had	have	AUX
eshr-6129	15	14	coexisting	coexist	VERB
eshr-6129	15	15	hypertension	hypertension	NOUN
eshr-6129	15	16	.	.	PUNCT
eshr-6129	16	1	patients	patient	NOUN
eshr-6129	16	2	had	have	AUX
eshr-6129	16	3	deranged	derange	VERB
eshr-6129	16	4	glycemic	glycemic	ADJ
eshr-6129	16	5	profiles	profile	NOUN
eshr-6129	16	6	and	and	CCONJ
eshr-6129	16	7	dyslipidemia	dyslipidemia	VERB
eshr-6129	16	8	despite	despite	SCONJ
eshr-6129	16	9	taking	take	VERB
eshr-6129	16	10	hypoglycemic	hypoglycemic	ADJ
eshr-6129	16	11	agents	agent	NOUN
eshr-6129	16	12	.	.	PUNCT
eshr-6129	17	1	hyperglycemia	hyperglycemia	NOUN
eshr-6129	17	2	and	and	CCONJ
eshr-6129	17	3	dyslipidemia	dyslipidemia	NOUN
eshr-6129	17	4	were	be	AUX
eshr-6129	17	5	significantly	significantly	ADV
eshr-6129	17	6	higher	high	ADJ
eshr-6129	17	7	in	in	ADP
eshr-6129	17	8	people	people	NOUN
eshr-6129	17	9	with	with	ADP
eshr-6129	17	10	diabetes	diabetes	NOUN
eshr-6129	17	11	having	have	VERB
eshr-6129	17	12	hba1c	hba1c	PROPN
eshr-6129	17	13	>	>	X
eshr-6129	17	14	7	7	X
eshr-6129	17	15	.	.	PUNCT
eshr-6129	18	1	hba1c	hba1c	PROPN
eshr-6129	18	2	is	be	AUX
eshr-6129	18	3	correlated	correlate	VERB
eshr-6129	18	4	with	with	ADP
eshr-6129	18	5	dyslipidemia	dyslipidemia	NOUN
eshr-6129	18	6	,	,	PUNCT
eshr-6129	18	7	and	and	CCONJ
eshr-6129	18	8	dyslipidemia	dyslipidemia	NOUN
eshr-6129	18	9	is	be	AUX
eshr-6129	18	10	linked	link	VERB
eshr-6129	18	11	considerably	considerably	ADV
eshr-6129	18	12	with	with	ADP
eshr-6129	18	13	obesity	obesity	NOUN
eshr-6129	18	14	.	.	PUNCT
eshr-6129	19	1	conclusion	conclusion	NOUN
eshr-6129	19	2	:	:	PUNCT
eshr-6129	19	3	t2	t2	NOUN
eshr-6129	19	4	dm	dm	PROPN
eshr-6129	19	5	patients	patient	NOUN
eshr-6129	19	6	must	must	AUX
eshr-6129	19	7	be	be	AUX
eshr-6129	19	8	regularly	regularly	ADV
eshr-6129	19	9	followed	follow	VERB
eshr-6129	19	10	up	up	ADP
eshr-6129	19	11	to	to	PART
eshr-6129	19	12	ensure	ensure	VERB
eshr-6129	19	13	drug	drug	NOUN
eshr-6129	19	14	compliance	compliance	NOUN
eshr-6129	19	15	,	,	PUNCT
eshr-6129	19	16	explained	explain	VERB
eshr-6129	19	17	about	about	ADP
eshr-6129	19	18	foreseen	foreseen	ADJ
eshr-6129	19	19	medical	medical	ADJ
eshr-6129	19	20	complications	complication	NOUN
eshr-6129	19	21	,	,	PUNCT
eshr-6129	19	22	and	and	CCONJ
eshr-6129	19	23	motivated	motivate	VERB
eshr-6129	19	24	to	to	PART
eshr-6129	19	25	adopt	adopt	VERB
eshr-6129	19	26	lifestyle	lifestyle	NOUN
eshr-6129	19	27	modification	modification	NOUN
eshr-6129	19	28	measures	measure	NOUN
eshr-6129	19	29	to	to	PART
eshr-6129	19	30	control	control	VERB
eshr-6129	19	31	their	their	PRON
eshr-6129	19	32	weight	weight	NOUN
eshr-6129	19	33	,	,	PUNCT
eshr-6129	19	34	bp	bp	PROPN
eshr-6129	19	35	,	,	PUNCT
eshr-6129	19	36	and	and	CCONJ
eshr-6129	19	37	blood	blood	NOUN
eshr-6129	19	38	glucose	glucose	NOUN
eshr-6129	19	39	.	.	PUNCT
eshr-6129	20	1	keywords	keyword	NOUN
eshr-6129	20	2	:	:	PUNCT
eshr-6129	20	3	correlation	correlation	NOUN
eshr-6129	20	4	;	;	PUNCT
eshr-6129	20	5	hba1c	hba1c	PROPN
eshr-6129	20	6	;	;	PUNCT
eshr-6129	20	7	lipid	lipid	NOUN
eshr-6129	20	8	profile	profile	NOUN
eshr-6129	20	9	;	;	PUNCT
eshr-6129	20	10	type	type	NOUN
eshr-6129	20	11	2	2	NUM
eshr-6129	20	12	diabetes	diabetes	NOUN
eshr-6129	20	13	mellitus	mellitus	NOUN
eshr-6129	20	14	;	;	PUNCT
eshr-6129	20	15	saudi	saudi	PROPN
eshr-6129	20	16	arabia	arabia	PROPN
eshr-6129	20	17	riaz	riaz	PROPN
eshr-6129	20	18	(	(	PUNCT
eshr-6129	20	19	correlation	correlation	NOUN
eshr-6129	20	20	between	between	ADP
eshr-6129	20	21	hba1c	hba1c	PROPN
eshr-6129	20	22	and	and	CCONJ
eshr-6129	20	23	lipid	lipid	NOUN
eshr-6129	20	24	profile	profile	NOUN
eshr-6129	20	25	in	in	ADP
eshr-6129	20	26	diabetes	diabetes	NOUN
eshr-6129	20	27	:	:	PUNCT
eshr-6129	20	28	a	a	DET
eshr-6129	20	29	health	health	NOUN
eshr-6129	20	30	concern	concern	NOUN
eshr-6129	20	31	in	in	ADP
eshr-6129	20	32	aseer	aseer	PROPN
eshr-6129	20	33	,	,	PUNCT
eshr-6129	20	34	saudi	saudi	PROPN
eshr-6129	20	35	arabia	arabia	PROPN
eshr-6129	20	36	)	)	PUNCT
eshr-6129	20	37	vol	vol	NOUN
eshr-6129	20	38	.	.	PROPN
eshr-6129	21	1	5	5	NUM
eshr-6129	21	2	,	,	PUNCT
eshr-6129	21	3	no	no	INTJ
eshr-6129	21	4	.	.	NOUN
eshr-6129	21	5	2	2	NUM
eshr-6129	21	6	,	,	PUNCT
eshr-6129	21	7	2023	2023	NUM
eshr-6129	21	8	,	,	PUNCT
eshr-6129	21	9	pp	pp	ADJ
eshr-6129	21	10	.	.	PUNCT
eshr-6129	22	1	60	60	NUM
eshr-6129	22	2	-	-	SYM
eshr-6129	22	3	68	68	NUM
eshr-6129	22	4	61	61	NUM
eshr-6129	22	5	10.26555	10.26555	NUM
eshr-6129	22	6	/	/	SYM
eshr-6129	22	7	eshr.v5i2.6129	eshr.v5i2.6129	NOUN
eshr-6129	22	8	introduction	introduction	NOUN
eshr-6129	22	9	type	type	NOUN
eshr-6129	22	10	2	2	NUM
eshr-6129	22	11	diabetes	diabetes	NOUN
eshr-6129	22	12	mellitus	mellitus	NOUN
eshr-6129	22	13	(	(	PUNCT
eshr-6129	22	14	t2	t2	NOUN
eshr-6129	22	15	dm	dm	PROPN
eshr-6129	22	16	)	)	PUNCT
eshr-6129	22	17	is	be	AUX
eshr-6129	22	18	one	one	NUM
eshr-6129	22	19	of	of	ADP
eshr-6129	22	20	the	the	DET
eshr-6129	22	21	most	most	ADV
eshr-6129	22	22	commonly	commonly	ADV
eshr-6129	22	23	encountered	encounter	VERB
eshr-6129	22	24	metabolic	metabolic	NOUN
eshr-6129	22	25	disorders	disorder	NOUN
eshr-6129	22	26	in	in	ADP
eshr-6129	22	27	clinical	clinical	ADJ
eshr-6129	22	28	practice	practice	NOUN
eshr-6129	22	29	and	and	CCONJ
eshr-6129	22	30	communities	community	NOUN
eshr-6129	22	31	worldwide	worldwide	ADV
eshr-6129	22	32	.	.	PUNCT
eshr-6129	23	1	the	the	DET
eshr-6129	23	2	prevalence	prevalence	NOUN
eshr-6129	23	3	of	of	ADP
eshr-6129	23	4	this	this	DET
eshr-6129	23	5	chronic	chronic	ADJ
eshr-6129	23	6	disorder	disorder	NOUN
eshr-6129	23	7	is	be	AUX
eshr-6129	23	8	increasing	increase	VERB
eshr-6129	23	9	at	at	ADP
eshr-6129	23	10	an	an	DET
eshr-6129	23	11	alarming	alarming	ADJ
eshr-6129	23	12	rate	rate	NOUN
eshr-6129	23	13	globally	globally	ADV
eshr-6129	23	14	.	.	PUNCT
eshr-6129	24	1	presently	presently	ADV
eshr-6129	24	2	537	537	NUM
eshr-6129	24	3	million	million	NUM
eshr-6129	24	4	adults	adult	NOUN
eshr-6129	24	5	are	be	AUX
eshr-6129	24	6	living	live	VERB
eshr-6129	24	7	with	with	ADP
eshr-6129	24	8	diabetes	diabetes	NOUN
eshr-6129	24	9	worldwide	worldwide	ADV
eshr-6129	24	10	,	,	PUNCT
eshr-6129	24	11	accounting	account	VERB
eshr-6129	24	12	for	for	ADP
eshr-6129	24	13	about	about	ADV
eshr-6129	24	14	one	one	NUM
eshr-6129	24	15	diabetic	diabetic	ADJ
eshr-6129	24	16	person	person	NOUN
eshr-6129	24	17	in	in	ADP
eshr-6129	24	18	every	every	DET
eshr-6129	24	19	ten	ten	NUM
eshr-6129	24	20	persons	person	NOUN
eshr-6129	24	21	(	(	PUNCT
eshr-6129	24	22	according	accord	VERB
eshr-6129	24	23	to	to	ADP
eshr-6129	24	24	the	the	DET
eshr-6129	24	25	year	year	NOUN
eshr-6129	24	26	2021	2021	NUM
eshr-6129	24	27	data	datum	NOUN
eshr-6129	24	28	)	)	PUNCT
eshr-6129	24	29	,	,	PUNCT
eshr-6129	24	30	and	and	CCONJ
eshr-6129	24	31	this	this	DET
eshr-6129	24	32	number	number	NOUN
eshr-6129	24	33	is	be	AUX
eshr-6129	24	34	predicted	predict	VERB
eshr-6129	24	35	to	to	PART
eshr-6129	24	36	rise	rise	VERB
eshr-6129	24	37	to	to	ADP
eshr-6129	24	38	643	643	NUM
eshr-6129	24	39	million	million	NUM
eshr-6129	24	40	by	by	ADP
eshr-6129	24	41	2030	2030	NUM
eshr-6129	24	42	and	and	CCONJ
eshr-6129	24	43	783	783	NUM
eshr-6129	24	44	million	million	NUM
eshr-6129	24	45	by	by	ADP
eshr-6129	24	46	2045.1	2045.1	NUM
eshr-6129	24	47	the	the	DET
eshr-6129	24	48	prevalence	prevalence	NOUN
eshr-6129	24	49	of	of	ADP
eshr-6129	24	50	diabetes	diabetes	NOUN
eshr-6129	24	51	in	in	ADP
eshr-6129	24	52	saudi	saudi	ADJ
eshr-6129	24	53	population2	population2	NOUN
eshr-6129	24	54	is	be	AUX
eshr-6129	24	55	31.6	31.6	NUM
eshr-6129	24	56	%	%	NOUN
eshr-6129	24	57	which	which	PRON
eshr-6129	24	58	is	be	AUX
eshr-6129	24	59	relatively	relatively	ADV
eshr-6129	24	60	high	high	ADJ
eshr-6129	24	61	and	and	CCONJ
eshr-6129	24	62	saudi	saudi	PROPN
eshr-6129	24	63	arabia	arabia	PROPN
eshr-6129	24	64	is	be	AUX
eshr-6129	24	65	ranked	rank	VERB
eshr-6129	24	66	as	as	ADP
eshr-6129	24	67	the	the	DET
eshr-6129	24	68	2nd	2nd	ADJ
eshr-6129	24	69	highest	high	ADJ
eshr-6129	24	70	country	country	NOUN
eshr-6129	24	71	in	in	ADP
eshr-6129	24	72	the	the	DET
eshr-6129	24	73	middle	middle	PROPN
eshr-6129	24	74	east	east	PROPN
eshr-6129	24	75	zone	zone	NOUN
eshr-6129	24	76	and	and	CCONJ
eshr-6129	24	77	seventh	seventh	ADJ
eshr-6129	24	78	in	in	ADP
eshr-6129	24	79	the	the	DET
eshr-6129	24	80	world	world	NOUN
eshr-6129	24	81	regarding	regard	VERB
eshr-6129	24	82	the	the	DET
eshr-6129	24	83	prevalence	prevalence	NOUN
eshr-6129	24	84	of	of	ADP
eshr-6129	24	85	diabetes	diabetes	NOUN
eshr-6129	24	86	mellitus.3	mellitus.3	PROPN
eshr-6129	24	87	type	type	NOUN
eshr-6129	24	88	2	2	NUM
eshr-6129	24	89	diabetes	diabetes	NOUN
eshr-6129	24	90	mellitus	mellitus	NOUN
eshr-6129	24	91	is	be	AUX
eshr-6129	24	92	characterized	characterize	VERB
eshr-6129	24	93	by	by	ADP
eshr-6129	24	94	insulin	insulin	NOUN
eshr-6129	24	95	resistance	resistance	NOUN
eshr-6129	24	96	leading	lead	VERB
eshr-6129	24	97	to	to	ADP
eshr-6129	24	98	hyperglycemia	hyperglycemia	NOUN
eshr-6129	24	99	which	which	PRON
eshr-6129	24	100	consequently	consequently	ADV
eshr-6129	24	101	leads	lead	VERB
eshr-6129	24	102	to	to	ADP
eshr-6129	24	103	further	further	ADJ
eshr-6129	24	104	biochemical	biochemical	ADJ
eshr-6129	24	105	derangements	derangement	NOUN
eshr-6129	24	106	in	in	ADP
eshr-6129	24	107	the	the	DET
eshr-6129	24	108	body	body	NOUN
eshr-6129	24	109	leading	lead	VERB
eshr-6129	24	110	to	to	ADP
eshr-6129	24	111	the	the	DET
eshr-6129	24	112	development	development	NOUN
eshr-6129	24	113	of	of	ADP
eshr-6129	24	114	a	a	DET
eshr-6129	24	115	vast	vast	ADJ
eshr-6129	24	116	array	array	NOUN
eshr-6129	24	117	of	of	ADP
eshr-6129	24	118	clinical	clinical	ADJ
eshr-6129	24	119	complications	complication	NOUN
eshr-6129	24	120	in	in	ADP
eshr-6129	24	121	due	due	ADJ
eshr-6129	24	122	course	course	NOUN
eshr-6129	24	123	of	of	ADP
eshr-6129	24	124	time	time	NOUN
eshr-6129	24	125	.	.	PUNCT
eshr-6129	25	1	insulin	insulin	NOUN
eshr-6129	25	2	resistance	resistance	NOUN
eshr-6129	25	3	leads	lead	VERB
eshr-6129	25	4	to	to	ADP
eshr-6129	25	5	a	a	DET
eshr-6129	25	6	hyperinsulinemia	hyperinsulinemia	NOUN
eshr-6129	25	7	state	state	NOUN
eshr-6129	25	8	in	in	ADP
eshr-6129	25	9	the	the	DET
eshr-6129	25	10	body	body	NOUN
eshr-6129	25	11	in	in	ADP
eshr-6129	25	12	an	an	DET
eshr-6129	25	13	attempt	attempt	NOUN
eshr-6129	25	14	to	to	PART
eshr-6129	25	15	bring	bring	VERB
eshr-6129	25	16	down	down	ADP
eshr-6129	25	17	the	the	DET
eshr-6129	25	18	blood	blood	NOUN
eshr-6129	25	19	glucose	glucose	NOUN
eshr-6129	25	20	levels	level	NOUN
eshr-6129	25	21	by	by	ADP
eshr-6129	25	22	trying	try	VERB
eshr-6129	25	23	to	to	PART
eshr-6129	25	24	facilitate	facilitate	VERB
eshr-6129	25	25	the	the	DET
eshr-6129	25	26	entry	entry	NOUN
eshr-6129	25	27	of	of	ADP
eshr-6129	25	28	plasma	plasma	NOUN
eshr-6129	25	29	glucose	glucose	NOUN
eshr-6129	25	30	into	into	ADP
eshr-6129	25	31	the	the	DET
eshr-6129	25	32	tissue	tissue	NOUN
eshr-6129	25	33	cells	cell	NOUN
eshr-6129	25	34	.	.	PUNCT
eshr-6129	26	1	this	this	DET
eshr-6129	26	2	high	high	ADJ
eshr-6129	26	3	insulin	insulin	NOUN
eshr-6129	26	4	level	level	NOUN
eshr-6129	26	5	leads	lead	VERB
eshr-6129	26	6	to	to	PART
eshr-6129	26	7	dyslipidemia	dyslipidemia	VERB
eshr-6129	26	8	in	in	ADP
eshr-6129	26	9	the	the	DET
eshr-6129	26	10	body	body	NOUN
eshr-6129	26	11	,	,	PUNCT
eshr-6129	26	12	thereby	thereby	ADV
eshr-6129	26	13	increasing	increase	VERB
eshr-6129	26	14	the	the	DET
eshr-6129	26	15	propensity	propensity	NOUN
eshr-6129	26	16	to	to	PART
eshr-6129	26	17	develop	develop	VERB
eshr-6129	26	18	cardiovascular	cardiovascular	ADJ
eshr-6129	26	19	complications	complication	NOUN
eshr-6129	26	20	.	.	PUNCT
eshr-6129	27	1	besides	besides	SCONJ
eshr-6129	27	2	this	this	PRON
eshr-6129	27	3	,	,	PUNCT
eshr-6129	27	4	hyperglycemia	hyperglycemia	NOUN
eshr-6129	27	5	leads	lead	VERB
eshr-6129	27	6	to	to	ADP
eshr-6129	27	7	the	the	DET
eshr-6129	27	8	glycation	glycation	NOUN
eshr-6129	27	9	of	of	ADP
eshr-6129	27	10	hemoglobin	hemoglobin	NOUN
eshr-6129	27	11	,	,	PUNCT
eshr-6129	27	12	plasma	plasma	NOUN
eshr-6129	27	13	proteins	protein	NOUN
eshr-6129	27	14	,	,	PUNCT
eshr-6129	27	15	tissue	tissue	NOUN
eshr-6129	27	16	proteins	protein	NOUN
eshr-6129	27	17	,	,	PUNCT
eshr-6129	27	18	and	and	CCONJ
eshr-6129	27	19	their	their	PRON
eshr-6129	27	20	receptors	receptor	NOUN
eshr-6129	27	21	.	.	PUNCT
eshr-6129	28	1	these	these	DET
eshr-6129	28	2	biochemical	biochemical	ADJ
eshr-6129	28	3	alterations	alteration	NOUN
eshr-6129	28	4	over	over	ADP
eshr-6129	28	5	a	a	DET
eshr-6129	28	6	chronic	chronic	ADJ
eshr-6129	28	7	period	period	NOUN
eshr-6129	28	8	have	have	AUX
eshr-6129	28	9	been	be	AUX
eshr-6129	28	10	known	know	VERB
eshr-6129	28	11	to	to	PART
eshr-6129	28	12	cause	cause	VERB
eshr-6129	28	13	several	several	ADJ
eshr-6129	28	14	complications	complication	NOUN
eshr-6129	28	15	,	,	PUNCT
eshr-6129	28	16	especially	especially	ADV
eshr-6129	28	17	atherosclerosis	atherosclerosis	NOUN
eshr-6129	28	18	,	,	PUNCT
eshr-6129	28	19	coronary	coronary	ADJ
eshr-6129	28	20	artery	artery	NOUN
eshr-6129	28	21	disease	disease	NOUN
eshr-6129	28	22	,	,	PUNCT
eshr-6129	28	23	angina	angina	ADJ
eshr-6129	28	24	,	,	PUNCT
eshr-6129	28	25	myocardial	myocardial	ADJ
eshr-6129	28	26	infarctions	infarction	NOUN
eshr-6129	28	27	,	,	PUNCT
eshr-6129	28	28	hypertension	hypertension	NOUN
eshr-6129	28	29	,	,	PUNCT
eshr-6129	28	30	stroke	stroke	NOUN
eshr-6129	28	31	,	,	PUNCT
eshr-6129	28	32	obesity	obesity	NOUN
eshr-6129	28	33	,	,	PUNCT
eshr-6129	28	34	retinopathy	retinopathy	ADJ
eshr-6129	28	35	,	,	PUNCT
eshr-6129	28	36	neuropathies	neuropathy	NOUN
eshr-6129	28	37	,	,	PUNCT
eshr-6129	28	38	nephropathy	nephropathy	NOUN
eshr-6129	28	39	,	,	PUNCT
eshr-6129	28	40	and	and	CCONJ
eshr-6129	28	41	xanthelasmas.4	xanthelasmas.4	PROPN
eshr-6129	28	42	moreover	moreover	ADV
eshr-6129	28	43	,	,	PUNCT
eshr-6129	28	44	it	it	PRON
eshr-6129	28	45	is	be	AUX
eshr-6129	28	46	not	not	PART
eshr-6129	28	47	uncommon	uncommon	ADJ
eshr-6129	28	48	to	to	PART
eshr-6129	28	49	see	see	VERB
eshr-6129	28	50	patients	patient	NOUN
eshr-6129	28	51	presenting	present	VERB
eshr-6129	28	52	to	to	ADP
eshr-6129	28	53	the	the	DET
eshr-6129	28	54	medical	medical	ADJ
eshr-6129	28	55	emergency	emergency	PROPN
eshr-6129	28	56	department	department	PROPN
eshr-6129	28	57	having	have	VERB
eshr-6129	28	58	diabetic	diabetic	ADJ
eshr-6129	28	59	ketoacidosis	ketoacidosis	NOUN
eshr-6129	28	60	or	or	CCONJ
eshr-6129	28	61	hyperosmolar	hyperosmolar	ADJ
eshr-6129	28	62	coma	coma	NOUN
eshr-6129	28	63	due	due	ADP
eshr-6129	28	64	to	to	ADP
eshr-6129	28	65	poorly	poorly	ADV
eshr-6129	28	66	controlled	control	VERB
eshr-6129	28	67	diabetes	diabetes	NOUN
eshr-6129	28	68	mellitus	mellitus	NOUN
eshr-6129	28	69	.	.	PUNCT
eshr-6129	29	1	thus	thus	ADV
eshr-6129	29	2	,	,	PUNCT
eshr-6129	29	3	it	it	PRON
eshr-6129	29	4	becomes	become	VERB
eshr-6129	29	5	essential	essential	ADJ
eshr-6129	29	6	that	that	SCONJ
eshr-6129	29	7	a	a	DET
eshr-6129	29	8	patient	patient	NOUN
eshr-6129	29	9	,	,	PUNCT
eshr-6129	29	10	once	once	ADV
eshr-6129	29	11	diagnosed	diagnose	VERB
eshr-6129	29	12	with	with	ADP
eshr-6129	29	13	diabetes	diabetes	NOUN
eshr-6129	29	14	,	,	PUNCT
eshr-6129	29	15	is	be	AUX
eshr-6129	29	16	strictly	strictly	ADV
eshr-6129	29	17	followed	follow	VERB
eshr-6129	29	18	up	up	ADP
eshr-6129	29	19	clinically	clinically	ADV
eshr-6129	29	20	to	to	PART
eshr-6129	29	21	prevent	prevent	VERB
eshr-6129	29	22	the	the	DET
eshr-6129	29	23	development	development	NOUN
eshr-6129	29	24	of	of	ADP
eshr-6129	29	25	these	these	DET
eshr-6129	29	26	medical	medical	ADJ
eshr-6129	29	27	sequelae	sequelae	NOUN
eshr-6129	29	28	that	that	PRON
eshr-6129	29	29	leads	lead	VERB
eshr-6129	29	30	to	to	ADP
eshr-6129	29	31	depreciation	depreciation	NOUN
eshr-6129	29	32	in	in	ADP
eshr-6129	29	33	their	their	PRON
eshr-6129	29	34	quality	quality	NOUN
eshr-6129	29	35	of	of	ADP
eshr-6129	29	36	life	life	NOUN
eshr-6129	29	37	.	.	PUNCT
eshr-6129	30	1	this	this	DET
eshr-6129	30	2	study	study	NOUN
eshr-6129	30	3	has	have	AUX
eshr-6129	30	4	been	be	AUX
eshr-6129	30	5	carried	carry	VERB
eshr-6129	30	6	out	out	ADP
eshr-6129	30	7	in	in	ADP
eshr-6129	30	8	the	the	DET
eshr-6129	30	9	primary	primary	ADJ
eshr-6129	30	10	health	health	NOUN
eshr-6129	30	11	care	care	NOUN
eshr-6129	30	12	(	(	PUNCT
eshr-6129	30	13	phc	phc	PROPN
eshr-6129	30	14	)	)	PUNCT
eshr-6129	30	15	center	center	NOUN
eshr-6129	30	16	of	of	ADP
eshr-6129	30	17	the	the	DET
eshr-6129	30	18	aseer	aseer	PROPN
eshr-6129	30	19	region	region	NOUN
eshr-6129	30	20	on	on	ADP
eshr-6129	30	21	known	know	VERB
eshr-6129	30	22	cases	case	NOUN
eshr-6129	30	23	of	of	ADP
eshr-6129	30	24	type	type	NOUN
eshr-6129	30	25	2	2	NUM
eshr-6129	30	26	diabetes	diabetes	NOUN
eshr-6129	30	27	mellitus	mellitus	NOUN
eshr-6129	30	28	patients	patient	NOUN
eshr-6129	30	29	because	because	SCONJ
eshr-6129	30	30	primary	primary	ADJ
eshr-6129	30	31	health	health	NOUN
eshr-6129	30	32	care	care	NOUN
eshr-6129	30	33	serves	serve	VERB
eshr-6129	30	34	as	as	ADP
eshr-6129	30	35	the	the	DET
eshr-6129	30	36	first	first	ADJ
eshr-6129	30	37	interface	interface	NOUN
eshr-6129	30	38	of	of	ADP
eshr-6129	30	39	interaction	interaction	NOUN
eshr-6129	30	40	with	with	ADP
eshr-6129	30	41	patients	patient	NOUN
eshr-6129	30	42	to	to	PART
eshr-6129	30	43	provide	provide	VERB
eshr-6129	30	44	healthcare	healthcare	NOUN
eshr-6129	30	45	to	to	ADP
eshr-6129	30	46	the	the	DET
eshr-6129	30	47	community	community	NOUN
eshr-6129	30	48	.	.	PUNCT
eshr-6129	31	1	due	due	ADP
eshr-6129	31	2	to	to	ADP
eshr-6129	31	3	the	the	DET
eshr-6129	31	4	increasing	increase	VERB
eshr-6129	31	5	prevalence	prevalence	NOUN
eshr-6129	31	6	of	of	ADP
eshr-6129	31	7	diabetes	diabetes	NOUN
eshr-6129	31	8	among	among	ADP
eshr-6129	31	9	the	the	DET
eshr-6129	31	10	saudi	saudi	ADJ
eshr-6129	31	11	population	population	NOUN
eshr-6129	31	12	and	and	CCONJ
eshr-6129	31	13	the	the	DET
eshr-6129	31	14	lack	lack	NOUN
eshr-6129	31	15	of	of	ADP
eshr-6129	31	16	studies	study	NOUN
eshr-6129	31	17	conducted	conduct	VERB
eshr-6129	31	18	at	at	ADP
eshr-6129	31	19	the	the	DET
eshr-6129	31	20	primary	primary	ADJ
eshr-6129	31	21	healthcare	healthcare	NOUN
eshr-6129	31	22	level	level	NOUN
eshr-6129	31	23	in	in	ADP
eshr-6129	31	24	saudi	saudi	PROPN
eshr-6129	31	25	arabia	arabia	PROPN
eshr-6129	31	26	,	,	PUNCT
eshr-6129	31	27	this	this	DET
eshr-6129	31	28	study	study	NOUN
eshr-6129	31	29	was	be	AUX
eshr-6129	31	30	conducted	conduct	VERB
eshr-6129	31	31	to	to	PART
eshr-6129	31	32	investigate	investigate	VERB
eshr-6129	31	33	the	the	DET
eshr-6129	31	34	status	status	NOUN
eshr-6129	31	35	of	of	ADP
eshr-6129	31	36	diabetes	diabetes	NOUN
eshr-6129	31	37	control	control	NOUN
eshr-6129	31	38	in	in	ADP
eshr-6129	31	39	t2	t2	NOUN
eshr-6129	31	40	dm	dm	NUM
eshr-6129	31	41	patients	patient	NOUN
eshr-6129	31	42	and	and	CCONJ
eshr-6129	31	43	if	if	SCONJ
eshr-6129	31	44	they	they	PRON
eshr-6129	31	45	had	have	VERB
eshr-6129	31	46	dyslipidemia	dyslipidemia	NOUN
eshr-6129	31	47	or	or	CCONJ
eshr-6129	31	48	not	not	PART
eshr-6129	31	49	and	and	CCONJ
eshr-6129	31	50	to	to	PART
eshr-6129	31	51	propose	propose	VERB
eshr-6129	31	52	appropriate	appropriate	ADJ
eshr-6129	31	53	measures	measure	NOUN
eshr-6129	31	54	to	to	PART
eshr-6129	31	55	be	be	AUX
eshr-6129	31	56	adopted	adopt	VERB
eshr-6129	31	57	at	at	ADP
eshr-6129	31	58	primary	primary	ADJ
eshr-6129	31	59	health	health	NOUN
eshr-6129	31	60	care	care	NOUN
eshr-6129	31	61	level	level	NOUN
eshr-6129	31	62	that	that	PRON
eshr-6129	31	63	could	could	AUX
eshr-6129	31	64	help	help	VERB
eshr-6129	31	65	serve	serve	VERB
eshr-6129	31	66	the	the	DET
eshr-6129	31	67	community	community	NOUN
eshr-6129	31	68	in	in	ADP
eshr-6129	31	69	a	a	DET
eshr-6129	31	70	better	well	ADJ
eshr-6129	31	71	way	way	NOUN
eshr-6129	31	72	to	to	PART
eshr-6129	31	73	battle	battle	VERB
eshr-6129	31	74	this	this	DET
eshr-6129	31	75	disease	disease	NOUN
eshr-6129	31	76	that	that	PRON
eshr-6129	31	77	silently	silently	ADV
eshr-6129	31	78	affects	affect	VERB
eshr-6129	31	79	almost	almost	ADV
eshr-6129	31	80	all	all	PRON
eshr-6129	31	81	tissue	tissue	NOUN
eshr-6129	31	82	of	of	ADP
eshr-6129	31	83	the	the	DET
eshr-6129	31	84	body	body	NOUN
eshr-6129	31	85	.	.	PUNCT
eshr-6129	32	1	method	method	VERB
eshr-6129	32	2	this	this	DET
eshr-6129	32	3	cross	cross	ADJ
eshr-6129	32	4	-	-	ADJ
eshr-6129	32	5	sectional	sectional	ADJ
eshr-6129	32	6	study	study	NOUN
eshr-6129	32	7	was	be	AUX
eshr-6129	32	8	carried	carry	VERB
eshr-6129	32	9	out	out	ADP
eshr-6129	32	10	after	after	ADP
eshr-6129	32	11	taking	take	VERB
eshr-6129	32	12	ethical	ethical	ADJ
eshr-6129	32	13	permission	permission	NOUN
eshr-6129	32	14	from	from	ADP
eshr-6129	32	15	our	our	PRON
eshr-6129	32	16	organization	organization	NOUN
eshr-6129	32	17	's	's	PART
eshr-6129	32	18	scientific	scientific	ADJ
eshr-6129	32	19	committee	committee	NOUN
eshr-6129	32	20	of	of	ADP
eshr-6129	32	21	research	research	NOUN
eshr-6129	32	22	.	.	PUNCT
eshr-6129	33	1	informed	informed	ADJ
eshr-6129	33	2	consent	consent	NOUN
eshr-6129	33	3	was	be	AUX
eshr-6129	33	4	taken	take	VERB
eshr-6129	33	5	from	from	ADP
eshr-6129	33	6	the	the	DET
eshr-6129	33	7	patients	patient	NOUN
eshr-6129	33	8	to	to	PART
eshr-6129	33	9	recruit	recruit	VERB
eshr-6129	33	10	them	they	PRON
eshr-6129	33	11	for	for	ADP
eshr-6129	33	12	the	the	DET
eshr-6129	33	13	study	study	NOUN
eshr-6129	33	14	.	.	PUNCT
eshr-6129	34	1	the	the	DET
eshr-6129	34	2	known	know	VERB
eshr-6129	34	3	cases	case	NOUN
eshr-6129	34	4	of	of	ADP
eshr-6129	34	5	type	type	NOUN
eshr-6129	34	6	2	2	NUM
eshr-6129	34	7	diabetes	diabetes	NOUN
eshr-6129	34	8	mellitus	mellitus	NOUN
eshr-6129	34	9	who	who	PRON
eshr-6129	34	10	presented	present	VERB
eshr-6129	34	11	to	to	ADP
eshr-6129	34	12	the	the	DET
eshr-6129	34	13	primary	primary	ADJ
eshr-6129	34	14	health	health	NOUN
eshr-6129	34	15	care	care	NOUN
eshr-6129	34	16	center	center	PROPN
eshr-6129	34	17	(	(	PUNCT
eshr-6129	34	18	situated	situate	VERB
eshr-6129	34	19	at	at	ADP
eshr-6129	34	20	al	al	PROPN
eshr-6129	34	21	-	-	PROPN
eshr-6129	34	22	qabil	qabil	ADJ
eshr-6129	34	23	locality	locality	NOUN
eshr-6129	34	24	of	of	ADP
eshr-6129	34	25	the	the	DET
eshr-6129	34	26	aseer	aseer	PROPN
eshr-6129	34	27	province	province	NOUN
eshr-6129	34	28	of	of	ADP
eshr-6129	34	29	saudi	saudi	PROPN
eshr-6129	34	30	arabia	arabia	PROPN
eshr-6129	34	31	)	)	PUNCT
eshr-6129	34	32	for	for	ADP
eshr-6129	34	33	their	their	PRON
eshr-6129	34	34	follow	follow	NOUN
eshr-6129	34	35	-	-	PUNCT
eshr-6129	34	36	up	up	NOUN
eshr-6129	34	37	were	be	AUX
eshr-6129	34	38	the	the	DET
eshr-6129	34	39	subjects	subject	NOUN
eshr-6129	34	40	of	of	ADP
eshr-6129	34	41	this	this	DET
eshr-6129	34	42	study	study	NOUN
eshr-6129	34	43	.	.	PUNCT
eshr-6129	35	1	only	only	ADV
eshr-6129	35	2	patients	patient	NOUN
eshr-6129	35	3	with	with	ADP
eshr-6129	35	4	type	type	NOUN
eshr-6129	35	5	2	2	NUM
eshr-6129	35	6	diabetes	diabetes	NOUN
eshr-6129	35	7	mellitus	mellitus	NOUN
eshr-6129	35	8	with	with	ADP
eshr-6129	35	9	at	at	ADV
eshr-6129	35	10	least	least	ADV
eshr-6129	35	11	one	one	NUM
eshr-6129	35	12	year	year	NOUN
eshr-6129	35	13	of	of	ADP
eshr-6129	35	14	duration	duration	NOUN
eshr-6129	35	15	were	be	AUX
eshr-6129	35	16	included	include	VERB
eshr-6129	35	17	in	in	ADP
eshr-6129	35	18	the	the	DET
eshr-6129	35	19	study	study	NOUN
eshr-6129	35	20	.	.	PUNCT
eshr-6129	36	1	the	the	DET
eshr-6129	36	2	study	study	NOUN
eshr-6129	36	3	was	be	AUX
eshr-6129	36	4	conducted	conduct	VERB
eshr-6129	36	5	for	for	ADP
eshr-6129	36	6	ten	ten	NUM
eshr-6129	36	7	months	month	NOUN
eshr-6129	36	8	,	,	PUNCT
eshr-6129	36	9	from	from	ADP
eshr-6129	36	10	april	april	PROPN
eshr-6129	36	11	2019	2019	NUM
eshr-6129	36	12	to	to	ADP
eshr-6129	36	13	january	january	PROPN
eshr-6129	36	14	2020	2020	NUM
eshr-6129	36	15	,	,	PUNCT
eshr-6129	36	16	and	and	CCONJ
eshr-6129	36	17	191	191	NUM
eshr-6129	36	18	t2	t2	NOUN
eshr-6129	36	19	dm	dm	PROPN
eshr-6129	36	20	patients	patient	NOUN
eshr-6129	36	21	were	be	AUX
eshr-6129	36	22	recruited	recruit	VERB
eshr-6129	36	23	in	in	ADP
eshr-6129	36	24	the	the	DET
eshr-6129	36	25	riaz	riaz	PROPN
eshr-6129	36	26	(	(	PUNCT
eshr-6129	36	27	correlation	correlation	NOUN
eshr-6129	36	28	between	between	ADP
eshr-6129	36	29	hba1c	hba1c	PROPN
eshr-6129	36	30	and	and	CCONJ
eshr-6129	36	31	lipid	lipid	NOUN
eshr-6129	36	32	profile	profile	NOUN
eshr-6129	36	33	in	in	ADP
eshr-6129	36	34	diabetes	diabetes	NOUN
eshr-6129	36	35	:	:	PUNCT
eshr-6129	36	36	a	a	DET
eshr-6129	36	37	health	health	NOUN
eshr-6129	36	38	concern	concern	NOUN
eshr-6129	36	39	in	in	ADP
eshr-6129	36	40	aseer	aseer	PROPN
eshr-6129	36	41	,	,	PUNCT
eshr-6129	36	42	saudi	saudi	PROPN
eshr-6129	36	43	arabia	arabia	PROPN
eshr-6129	36	44	)	)	PUNCT
eshr-6129	36	45	vol	vol	NOUN
eshr-6129	36	46	.	.	PROPN
eshr-6129	37	1	5	5	NUM
eshr-6129	37	2	,	,	PUNCT
eshr-6129	37	3	no	no	INTJ
eshr-6129	37	4	.	.	NOUN
eshr-6129	37	5	2	2	NUM
eshr-6129	37	6	,	,	PUNCT
eshr-6129	37	7	2023	2023	NUM
eshr-6129	37	8	,	,	PUNCT
eshr-6129	37	9	pp	pp	ADJ
eshr-6129	37	10	.	.	PUNCT
eshr-6129	38	1	60	60	NUM
eshr-6129	38	2	-	-	SYM
eshr-6129	38	3	68	68	NUM
eshr-6129	38	4	62	62	NUM
eshr-6129	38	5	10.26555	10.26555	NUM
eshr-6129	38	6	/	/	SYM
eshr-6129	38	7	eshr.v5i2.6129	eshr.v5i2.6129	PROPN
eshr-6129	38	8	study	study	NOUN
eshr-6129	38	9	group	group	NOUN
eshr-6129	38	10	.	.	PUNCT
eshr-6129	39	1	diabetic	diabetic	ADJ
eshr-6129	39	2	patients	patient	NOUN
eshr-6129	39	3	who	who	PRON
eshr-6129	39	4	were	be	AUX
eshr-6129	39	5	taking	take	VERB
eshr-6129	39	6	drugs	drug	NOUN
eshr-6129	39	7	causing	cause	VERB
eshr-6129	39	8	hypolipidemia	hypolipidemia	NOUN
eshr-6129	39	9	were	be	AUX
eshr-6129	39	10	excluded	exclude	VERB
eshr-6129	39	11	from	from	ADP
eshr-6129	39	12	the	the	DET
eshr-6129	39	13	study	study	NOUN
eshr-6129	39	14	.	.	PUNCT
eshr-6129	40	1	patients	patient	NOUN
eshr-6129	40	2	having	have	VERB
eshr-6129	40	3	a	a	DET
eshr-6129	40	4	history	history	NOUN
eshr-6129	40	5	of	of	ADP
eshr-6129	40	6	any	any	DET
eshr-6129	40	7	other	other	ADJ
eshr-6129	40	8	metabolic	metabolic	NOUN
eshr-6129	40	9	disorder	disorder	NOUN
eshr-6129	40	10	were	be	AUX
eshr-6129	40	11	excluded	exclude	VERB
eshr-6129	40	12	from	from	ADP
eshr-6129	40	13	the	the	DET
eshr-6129	40	14	study	study	NOUN
eshr-6129	40	15	to	to	PART
eshr-6129	40	16	avoid	avoid	VERB
eshr-6129	40	17	getting	get	VERB
eshr-6129	40	18	confounding	confound	VERB
eshr-6129	40	19	results	result	NOUN
eshr-6129	40	20	.	.	PUNCT
eshr-6129	41	1	type	type	NOUN
eshr-6129	41	2	1	1	NUM
eshr-6129	41	3	diabetes	diabetes	NOUN
eshr-6129	41	4	patients	patient	NOUN
eshr-6129	41	5	and	and	CCONJ
eshr-6129	41	6	newly	newly	ADV
eshr-6129	41	7	diagnosed	diagnose	VERB
eshr-6129	41	8	type	type	NOUN
eshr-6129	41	9	2	2	NUM
eshr-6129	41	10	diabetics	diabetic	NOUN
eshr-6129	41	11	were	be	AUX
eshr-6129	41	12	also	also	ADV
eshr-6129	41	13	excluded	exclude	VERB
eshr-6129	41	14	from	from	ADP
eshr-6129	41	15	the	the	DET
eshr-6129	41	16	study	study	NOUN
eshr-6129	41	17	.	.	PUNCT
eshr-6129	42	1	the	the	DET
eshr-6129	42	2	patients	patient	NOUN
eshr-6129	42	3	'	'	PART
eshr-6129	42	4	demographic	demographic	ADJ
eshr-6129	42	5	data	datum	NOUN
eshr-6129	42	6	were	be	AUX
eshr-6129	42	7	recorded	record	VERB
eshr-6129	42	8	and	and	CCONJ
eshr-6129	42	9	then	then	ADV
eshr-6129	42	10	asked	ask	VERB
eshr-6129	42	11	to	to	PART
eshr-6129	42	12	undergo	undergo	VERB
eshr-6129	42	13	biochemistry	biochemistry	NOUN
eshr-6129	42	14	lab	lab	NOUN
eshr-6129	42	15	investigations	investigation	NOUN
eshr-6129	42	16	to	to	PART
eshr-6129	42	17	check	check	VERB
eshr-6129	42	18	their	their	PRON
eshr-6129	42	19	glycemic	glycemic	ADJ
eshr-6129	42	20	and	and	CCONJ
eshr-6129	42	21	lipid	lipid	NOUN
eshr-6129	42	22	profile	profile	NOUN
eshr-6129	42	23	status	status	NOUN
eshr-6129	42	24	.	.	PUNCT
eshr-6129	43	1	the	the	DET
eshr-6129	43	2	socio	socio	NOUN
eshr-6129	43	3	-	-	PUNCT
eshr-6129	43	4	demographic	demographic	ADJ
eshr-6129	43	5	data	datum	NOUN
eshr-6129	43	6	included	include	VERB
eshr-6129	43	7	age	age	NOUN
eshr-6129	43	8	,	,	PUNCT
eshr-6129	43	9	gender	gender	NOUN
eshr-6129	43	10	,	,	PUNCT
eshr-6129	43	11	body	body	NOUN
eshr-6129	43	12	mass	mass	NOUN
eshr-6129	43	13	index	index	NOUN
eshr-6129	43	14	(	(	PUNCT
eshr-6129	43	15	bmi	bmi	PROPN
eshr-6129	43	16	)	)	PUNCT
eshr-6129	43	17	,	,	PUNCT
eshr-6129	43	18	blood	blood	NOUN
eshr-6129	43	19	pressure	pressure	NOUN
eshr-6129	43	20	(	(	PUNCT
eshr-6129	43	21	bp	bp	PROPN
eshr-6129	43	22	)	)	PUNCT
eshr-6129	43	23	,	,	PUNCT
eshr-6129	43	24	and	and	CCONJ
eshr-6129	43	25	nationality	nationality	NOUN
eshr-6129	43	26	.	.	PUNCT
eshr-6129	44	1	the	the	DET
eshr-6129	44	2	glycemic	glycemic	ADJ
eshr-6129	44	3	profile	profile	NOUN
eshr-6129	44	4	of	of	ADP
eshr-6129	44	5	the	the	DET
eshr-6129	44	6	patients	patient	NOUN
eshr-6129	44	7	was	be	AUX
eshr-6129	44	8	checked	check	VERB
eshr-6129	44	9	by	by	ADP
eshr-6129	44	10	measuring	measure	VERB
eshr-6129	44	11	fasting	fast	VERB
eshr-6129	44	12	blood	blood	NOUN
eshr-6129	44	13	glucose	glucose	NOUN
eshr-6129	44	14	(	(	PUNCT
eshr-6129	44	15	fbs	fbs	PROPN
eshr-6129	44	16	)	)	PUNCT
eshr-6129	44	17	,	,	PUNCT
eshr-6129	44	18	random	random	ADJ
eshr-6129	44	19	blood	blood	NOUN
eshr-6129	44	20	glucose	glucose	NOUN
eshr-6129	44	21	(	(	PUNCT
eshr-6129	44	22	rbs	rbs	PROPN
eshr-6129	44	23	)	)	PUNCT
eshr-6129	44	24	,	,	PUNCT
eshr-6129	44	25	and	and	CCONJ
eshr-6129	44	26	glycated	glycate	VERB
eshr-6129	44	27	hemoglobin	hemoglobin	NOUN
eshr-6129	44	28	(	(	PUNCT
eshr-6129	44	29	hba1c	hba1c	NOUN
eshr-6129	44	30	)	)	PUNCT
eshr-6129	44	31	levels	level	NOUN
eshr-6129	44	32	.	.	PUNCT
eshr-6129	45	1	the	the	DET
eshr-6129	45	2	lipid	lipid	NOUN
eshr-6129	45	3	profile	profile	NOUN
eshr-6129	45	4	assessment	assessment	NOUN
eshr-6129	45	5	was	be	AUX
eshr-6129	45	6	done	do	VERB
eshr-6129	45	7	by	by	ADP
eshr-6129	45	8	measuring	measure	VERB
eshr-6129	45	9	serum	serum	NOUN
eshr-6129	45	10	total	total	ADJ
eshr-6129	45	11	cholesterol	cholesterol	NOUN
eshr-6129	45	12	(	(	PUNCT
eshr-6129	45	13	tc	tc	NOUN
eshr-6129	45	14	)	)	PUNCT
eshr-6129	45	15	,	,	PUNCT
eshr-6129	45	16	ldl	ldl	NOUN
eshr-6129	45	17	cholesterol	cholesterol	NOUN
eshr-6129	45	18	(	(	PUNCT
eshr-6129	45	19	ldl	ldl	NOUN
eshr-6129	45	20	)	)	PUNCT
eshr-6129	45	21	,	,	PUNCT
eshr-6129	45	22	triglycerides	triglyceride	NOUN
eshr-6129	45	23	,	,	PUNCT
eshr-6129	45	24	hdl	hdl	PROPN
eshr-6129	45	25	cholesterol	cholesterol	PROPN
eshr-6129	45	26	(	(	PUNCT
eshr-6129	45	27	hdl	hdl	PROPN
eshr-6129	45	28	)	)	PUNCT
eshr-6129	45	29	,	,	PUNCT
eshr-6129	45	30	and	and	CCONJ
eshr-6129	45	31	vldl	vldl	NOUN
eshr-6129	45	32	levels	level	NOUN
eshr-6129	45	33	.	.	PUNCT
eshr-6129	46	1	vldl	vldl	NOUN
eshr-6129	46	2	levels	level	NOUN
eshr-6129	46	3	were	be	AUX
eshr-6129	46	4	determined	determine	VERB
eshr-6129	46	5	using	use	VERB
eshr-6129	46	6	freidwald	freidwald	PROPN
eshr-6129	46	7	’s	’s	PART
eshr-6129	46	8	formula	formula	NOUN
eshr-6129	46	9	(	(	PUNCT
eshr-6129	46	10	vldl	vldl	NOUN
eshr-6129	46	11	=	=	SYM
eshr-6129	46	12	tg/5	tg/5	PROPN
eshr-6129	46	13	)	)	PUNCT
eshr-6129	46	14	.	.	PUNCT
eshr-6129	47	1	the	the	DET
eshr-6129	47	2	hba1c	hba1c	PROPN
eshr-6129	47	3	data	datum	NOUN
eshr-6129	47	4	was	be	AUX
eshr-6129	47	5	used	use	VERB
eshr-6129	47	6	to	to	PART
eshr-6129	47	7	further	far	ADV
eshr-6129	47	8	categorize	categorize	VERB
eshr-6129	47	9	the	the	DET
eshr-6129	47	10	diabetes	diabetes	NOUN
eshr-6129	47	11	patients	patient	NOUN
eshr-6129	47	12	into	into	ADP
eshr-6129	47	13	well	well	ADV
eshr-6129	47	14	-	-	PUNCT
eshr-6129	47	15	controlled	control	VERB
eshr-6129	47	16	diabetes	diabetes	NOUN
eshr-6129	47	17	(	(	PUNCT
eshr-6129	47	18	hba1c	hba1c	X
eshr-6129	47	19	≤	≤	NUM
eshr-6129	47	20	7	7	NUM
eshr-6129	47	21	)	)	PUNCT
eshr-6129	47	22	and	and	CCONJ
eshr-6129	47	23	inadequately	inadequately	ADV
eshr-6129	47	24	controlled	control	VERB
eshr-6129	47	25	diabetes	diabetes	NOUN
eshr-6129	47	26	groups	group	NOUN
eshr-6129	47	27	(	(	PUNCT
eshr-6129	47	28	hba1c	hba1c	X
eshr-6129	47	29	≥	≥	NOUN
eshr-6129	47	30	7	7	NUM
eshr-6129	47	31	)	)	PUNCT
eshr-6129	47	32	for	for	ADP
eshr-6129	47	33	further	further	ADJ
eshr-6129	47	34	comparison	comparison	NOUN
eshr-6129	47	35	of	of	ADP
eshr-6129	47	36	glycemic	glycemic	ADJ
eshr-6129	47	37	and	and	CCONJ
eshr-6129	47	38	lipid	lipid	NOUN
eshr-6129	47	39	profiles	profile	NOUN
eshr-6129	47	40	.	.	PUNCT
eshr-6129	48	1	the	the	DET
eshr-6129	48	2	data	datum	NOUN
eshr-6129	48	3	so	so	ADV
eshr-6129	48	4	obtained	obtain	VERB
eshr-6129	48	5	from	from	ADP
eshr-6129	48	6	the	the	DET
eshr-6129	48	7	patients	patient	NOUN
eshr-6129	48	8	were	be	AUX
eshr-6129	48	9	compiled	compile	VERB
eshr-6129	48	10	and	and	CCONJ
eshr-6129	48	11	statistically	statistically	ADV
eshr-6129	48	12	analyzed	analyze	VERB
eshr-6129	48	13	.	.	PUNCT
eshr-6129	49	1	statistical	statistical	ADJ
eshr-6129	49	2	analysis	analysis	NOUN
eshr-6129	49	3	the	the	DET
eshr-6129	49	4	data	datum	NOUN
eshr-6129	49	5	related	relate	VERB
eshr-6129	49	6	to	to	ADP
eshr-6129	49	7	age	age	NOUN
eshr-6129	49	8	,	,	PUNCT
eshr-6129	49	9	bmi	bmi	PROPN
eshr-6129	49	10	,	,	PUNCT
eshr-6129	49	11	fbs	fbs	PROPN
eshr-6129	49	12	,	,	PUNCT
eshr-6129	49	13	rbs	rbs	PROPN
eshr-6129	49	14	,	,	PUNCT
eshr-6129	49	15	hba1c	hba1c	PROPN
eshr-6129	49	16	,	,	PUNCT
eshr-6129	49	17	total	total	ADJ
eshr-6129	49	18	cholesterol	cholesterol	NOUN
eshr-6129	49	19	,	,	PUNCT
eshr-6129	49	20	ldl	ldl	NOUN
eshr-6129	49	21	cholesterol	cholesterol	NOUN
eshr-6129	49	22	,	,	PUNCT
eshr-6129	49	23	triglycerides	triglyceride	NOUN
eshr-6129	49	24	,	,	PUNCT
eshr-6129	49	25	hdl	hdl	PROPN
eshr-6129	49	26	cholesterol	cholesterol	PROPN
eshr-6129	49	27	,	,	PUNCT
eshr-6129	49	28	and	and	CCONJ
eshr-6129	49	29	vldl	vldl	NOUN
eshr-6129	49	30	was	be	AUX
eshr-6129	49	31	parametric	parametric	ADJ
eshr-6129	49	32	and	and	CCONJ
eshr-6129	49	33	has	have	AUX
eshr-6129	49	34	been	be	AUX
eshr-6129	49	35	expressed	express	VERB
eshr-6129	49	36	as	as	ADP
eshr-6129	49	37	mean	mean	NOUN
eshr-6129	49	38	±	±	NUM
eshr-6129	49	39	standard	standard	ADJ
eshr-6129	49	40	deviation	deviation	NOUN
eshr-6129	49	41	.	.	PUNCT
eshr-6129	50	1	the	the	DET
eshr-6129	50	2	glycemic	glycemic	ADJ
eshr-6129	50	3	and	and	CCONJ
eshr-6129	50	4	lipid	lipid	NOUN
eshr-6129	50	5	profile	profile	PROPN
eshr-6129	50	6	comparison	comparison	NOUN
eshr-6129	50	7	amongst	amongst	ADP
eshr-6129	50	8	the	the	DET
eshr-6129	50	9	two	two	NUM
eshr-6129	50	10	groups	group	NOUN
eshr-6129	50	11	(	(	PUNCT
eshr-6129	50	12	wellcontrolled	wellcontrolle	VERB
eshr-6129	50	13	diabetes	diabetes	NOUN
eshr-6129	50	14	group	group	NOUN
eshr-6129	50	15	and	and	CCONJ
eshr-6129	50	16	inadequately	inadequately	ADV
eshr-6129	50	17	controlled	control	VERB
eshr-6129	50	18	diabetes	diabetes	NOUN
eshr-6129	50	19	group	group	NOUN
eshr-6129	50	20	)	)	PUNCT
eshr-6129	50	21	has	have	AUX
eshr-6129	50	22	been	be	AUX
eshr-6129	50	23	made	make	VERB
eshr-6129	50	24	using	use	VERB
eshr-6129	50	25	an	an	DET
eshr-6129	50	26	independent	independent	ADJ
eshr-6129	50	27	student	student	NOUN
eshr-6129	50	28	t	t	NOUN
eshr-6129	50	29	-	-	PUNCT
eshr-6129	50	30	test	test	NOUN
eshr-6129	50	31	.	.	PUNCT
eshr-6129	51	1	linear	linear	ADJ
eshr-6129	51	2	regression	regression	NOUN
eshr-6129	51	3	analysis	analysis	NOUN
eshr-6129	51	4	was	be	AUX
eshr-6129	51	5	used	use	VERB
eshr-6129	51	6	to	to	PART
eshr-6129	51	7	check	check	VERB
eshr-6129	51	8	the	the	DET
eshr-6129	51	9	correlations	correlation	NOUN
eshr-6129	51	10	between	between	ADP
eshr-6129	51	11	the	the	DET
eshr-6129	51	12	biochemical	biochemical	ADJ
eshr-6129	51	13	parameters	parameter	NOUN
eshr-6129	51	14	in	in	ADP
eshr-6129	51	15	diabetes	diabetes	NOUN
eshr-6129	51	16	patients	patient	NOUN
eshr-6129	51	17	.	.	PUNCT
eshr-6129	52	1	p	p	NOUN
eshr-6129	52	2	value	value	NOUN
eshr-6129	52	3	<	<	X
eshr-6129	52	4	0.05	0.05	NUM
eshr-6129	52	5	has	have	AUX
eshr-6129	52	6	been	be	AUX
eshr-6129	52	7	considered	consider	VERB
eshr-6129	52	8	significant	significant	ADJ
eshr-6129	52	9	.	.	PUNCT
eshr-6129	53	1	the	the	DET
eshr-6129	53	2	statistical	statistical	ADJ
eshr-6129	53	3	analysis	analysis	NOUN
eshr-6129	53	4	was	be	AUX
eshr-6129	53	5	done	do	VERB
eshr-6129	53	6	using	use	VERB
eshr-6129	53	7	spss	spss	PROPN
eshr-6129	53	8	software	software	NOUN
eshr-6129	53	9	(	(	PUNCT
eshr-6129	53	10	version	version	NOUN
eshr-6129	53	11	20	20	NUM
eshr-6129	53	12	)	)	PUNCT
eshr-6129	53	13	.	.	PUNCT
eshr-6129	54	1	results	result	VERB
eshr-6129	54	2	the	the	DET
eshr-6129	54	3	demographic	demographic	ADJ
eshr-6129	54	4	data	datum	NOUN
eshr-6129	54	5	and	and	CCONJ
eshr-6129	54	6	glycemic	glycemic	ADJ
eshr-6129	54	7	and	and	CCONJ
eshr-6129	54	8	lipid	lipid	NOUN
eshr-6129	54	9	profiles	profile	NOUN
eshr-6129	54	10	of	of	ADP
eshr-6129	54	11	diabetes	diabetes	NOUN
eshr-6129	54	12	patients	patient	NOUN
eshr-6129	54	13	have	have	AUX
eshr-6129	54	14	been	be	AUX
eshr-6129	54	15	shown	show	VERB
eshr-6129	54	16	in	in	ADP
eshr-6129	54	17	table	table	NOUN
eshr-6129	54	18	1	1	NUM
eshr-6129	54	19	.	.	PUNCT
eshr-6129	55	1	in	in	ADP
eshr-6129	55	2	this	this	DET
eshr-6129	55	3	study	study	NOUN
eshr-6129	55	4	,	,	PUNCT
eshr-6129	55	5	it	it	PRON
eshr-6129	55	6	was	be	AUX
eshr-6129	55	7	found	find	VERB
eshr-6129	55	8	that	that	SCONJ
eshr-6129	55	9	the	the	DET
eshr-6129	55	10	prevalence	prevalence	NOUN
eshr-6129	55	11	of	of	ADP
eshr-6129	55	12	type	type	NOUN
eshr-6129	55	13	2	2	NUM
eshr-6129	55	14	diabetes	diabetes	NOUN
eshr-6129	55	15	mellitus	mellitus	NOUN
eshr-6129	55	16	was	be	AUX
eshr-6129	55	17	relatively	relatively	ADV
eshr-6129	55	18	higher	high	ADJ
eshr-6129	55	19	in	in	ADP
eshr-6129	55	20	males	male	NOUN
eshr-6129	55	21	in	in	ADP
eshr-6129	55	22	comparison	comparison	NOUN
eshr-6129	55	23	to	to	ADP
eshr-6129	55	24	females	female	NOUN
eshr-6129	55	25	.	.	PUNCT
eshr-6129	56	1	the	the	DET
eshr-6129	56	2	mean	mean	ADJ
eshr-6129	56	3	age	age	NOUN
eshr-6129	56	4	of	of	ADP
eshr-6129	56	5	the	the	DET
eshr-6129	56	6	study	study	NOUN
eshr-6129	56	7	subjects	subject	NOUN
eshr-6129	56	8	was	be	AUX
eshr-6129	56	9	54.9	54.9	NUM
eshr-6129	56	10	years	year	NOUN
eshr-6129	56	11	.	.	PUNCT
eshr-6129	57	1	the	the	DET
eshr-6129	57	2	mean	mean	ADJ
eshr-6129	57	3	bmi	bmi	NOUN
eshr-6129	57	4	of	of	ADP
eshr-6129	57	5	these	these	DET
eshr-6129	57	6	patients	patient	NOUN
eshr-6129	57	7	was	be	AUX
eshr-6129	57	8	30.3	30.3	NUM
eshr-6129	57	9	falling	fall	VERB
eshr-6129	57	10	in	in	ADP
eshr-6129	57	11	class	class	NOUN
eshr-6129	57	12	1	1	NUM
eshr-6129	57	13	obese	obese	ADJ
eshr-6129	57	14	category	category	NOUN
eshr-6129	57	15	.	.	PUNCT
eshr-6129	58	1	out	out	ADP
eshr-6129	58	2	of	of	ADP
eshr-6129	58	3	191	191	NUM
eshr-6129	58	4	diabetes	diabetes	NOUN
eshr-6129	58	5	patients	patient	NOUN
eshr-6129	58	6	,	,	PUNCT
eshr-6129	58	7	100	100	NUM
eshr-6129	58	8	(	(	PUNCT
eshr-6129	58	9	52	52	NUM
eshr-6129	58	10	%	%	NOUN
eshr-6129	58	11	)	)	PUNCT
eshr-6129	58	12	also	also	ADV
eshr-6129	58	13	had	have	VERB
eshr-6129	58	14	hypertension	hypertension	NOUN
eshr-6129	58	15	.	.	PUNCT
eshr-6129	59	1	the	the	DET
eshr-6129	59	2	nationality	nationality	NOUN
eshr-6129	59	3	of	of	ADP
eshr-6129	59	4	these	these	DET
eshr-6129	59	5	patients	patient	NOUN
eshr-6129	59	6	was	be	AUX
eshr-6129	59	7	saudi	saudi	ADJ
eshr-6129	59	8	.	.	PUNCT
eshr-6129	60	1	the	the	DET
eshr-6129	60	2	diabetic	diabetic	ADJ
eshr-6129	60	3	patients	patient	NOUN
eshr-6129	60	4	showed	show	VERB
eshr-6129	60	5	a	a	DET
eshr-6129	60	6	hyperglycemic	hyperglycemic	ADJ
eshr-6129	60	7	and	and	CCONJ
eshr-6129	60	8	dyslipidemia	dyslipidemia	VERB
eshr-6129	60	9	blood	blood	NOUN
eshr-6129	60	10	picture	picture	NOUN
eshr-6129	60	11	(	(	PUNCT
eshr-6129	60	12	n=191	n=191	NOUN
eshr-6129	60	13	,	,	PUNCT
eshr-6129	60	14	table	table	NOUN
eshr-6129	60	15	1	1	NUM
eshr-6129	60	16	)	)	PUNCT
eshr-6129	60	17	.	.	PUNCT
eshr-6129	61	1	table	table	NOUN
eshr-6129	61	2	2	2	NUM
eshr-6129	61	3	compares	compare	VERB
eshr-6129	61	4	glycemic	glycemic	ADJ
eshr-6129	61	5	and	and	CCONJ
eshr-6129	61	6	lipid	lipid	NOUN
eshr-6129	61	7	profiles	profile	NOUN
eshr-6129	61	8	amongst	amongst	ADP
eshr-6129	61	9	patients	patient	NOUN
eshr-6129	61	10	with	with	ADP
eshr-6129	61	11	adequately	adequately	ADV
eshr-6129	61	12	controlled	control	VERB
eshr-6129	61	13	diabetes	diabetes	NOUN
eshr-6129	61	14	and	and	CCONJ
eshr-6129	61	15	inadequately	inadequately	ADV
eshr-6129	61	16	controlled	control	VERB
eshr-6129	61	17	diabetes	diabetes	NOUN
eshr-6129	61	18	.	.	PUNCT
eshr-6129	62	1	it	it	PRON
eshr-6129	62	2	was	be	AUX
eshr-6129	62	3	found	find	VERB
eshr-6129	62	4	that	that	SCONJ
eshr-6129	62	5	the	the	DET
eshr-6129	62	6	patients	patient	NOUN
eshr-6129	62	7	whose	whose	DET
eshr-6129	62	8	hba1c	hba1c	PROPN
eshr-6129	62	9	was	be	AUX
eshr-6129	62	10	>	>	X
eshr-6129	62	11	7	7	NUM
eshr-6129	62	12	had	have	VERB
eshr-6129	62	13	significantly	significantly	ADV
eshr-6129	62	14	higher	high	ADJ
eshr-6129	62	15	fbs	fbs	PROPN
eshr-6129	62	16	,	,	PUNCT
eshr-6129	62	17	rbs	rbs	PROPN
eshr-6129	62	18	,	,	PUNCT
eshr-6129	62	19	hba1c	hba1c	PROPN
eshr-6129	62	20	,	,	PUNCT
eshr-6129	62	21	total	total	ADJ
eshr-6129	62	22	cholesterol	cholesterol	NOUN
eshr-6129	62	23	,	,	PUNCT
eshr-6129	62	24	ldl	ldl	NOUN
eshr-6129	62	25	cholesterol	cholesterol	NOUN
eshr-6129	62	26	,	,	PUNCT
eshr-6129	62	27	triglycerides	triglyceride	NOUN
eshr-6129	62	28	,	,	PUNCT
eshr-6129	62	29	and	and	CCONJ
eshr-6129	62	30	vldl	vldl	NOUN
eshr-6129	62	31	cholesterol	cholesterol	NOUN
eshr-6129	62	32	level	level	NOUN
eshr-6129	62	33	compared	compare	VERB
eshr-6129	62	34	to	to	ADP
eshr-6129	62	35	diabetes	diabetes	NOUN
eshr-6129	62	36	patients	patient	NOUN
eshr-6129	62	37	with	with	ADP
eshr-6129	62	38	hba1c	hba1c	PROPN
eshr-6129	62	39	≤	≤	ADV
eshr-6129	62	40	7	7	NUM
eshr-6129	62	41	.	.	PUNCT
eshr-6129	63	1	in	in	ADP
eshr-6129	63	2	linear	linear	PROPN
eshr-6129	63	3	regression	regression	NOUN
eshr-6129	63	4	analysis	analysis	NOUN
eshr-6129	63	5	(	(	PUNCT
eshr-6129	63	6	table	table	NOUN
eshr-6129	63	7	3	3	NUM
eshr-6129	63	8	,	,	PUNCT
eshr-6129	63	9	figure	figure	NOUN
eshr-6129	63	10	1	1	NUM
eshr-6129	63	11	)	)	PUNCT
eshr-6129	63	12	,	,	PUNCT
eshr-6129	63	13	the	the	DET
eshr-6129	63	14	hba1c	hba1c	PROPN
eshr-6129	63	15	groups	group	NOUN
eshr-6129	63	16	of	of	ADP
eshr-6129	63	17	the	the	DET
eshr-6129	63	18	diabetes	diabetes	NOUN
eshr-6129	63	19	patients	patient	NOUN
eshr-6129	63	20	showed	show	VERB
eshr-6129	63	21	a	a	DET
eshr-6129	63	22	significant	significant	ADJ
eshr-6129	63	23	positive	positive	ADJ
eshr-6129	63	24	correlation	correlation	NOUN
eshr-6129	63	25	with	with	ADP
eshr-6129	63	26	total	total	ADJ
eshr-6129	63	27	cholesterol	cholesterol	NOUN
eshr-6129	63	28	and	and	CCONJ
eshr-6129	63	29	ldl	ldl	NOUN
eshr-6129	63	30	levels	level	NOUN
eshr-6129	63	31	.	.	PUNCT
eshr-6129	64	1	linear	linear	ADJ
eshr-6129	64	2	regression	regression	NOUN
eshr-6129	64	3	analysis	analysis	NOUN
eshr-6129	64	4	(	(	PUNCT
eshr-6129	64	5	table	table	NOUN
eshr-6129	64	6	3	3	NUM
eshr-6129	64	7	,	,	PUNCT
eshr-6129	64	8	figure	figure	NOUN
eshr-6129	64	9	2	2	NUM
eshr-6129	64	10	)	)	PUNCT
eshr-6129	64	11	also	also	ADV
eshr-6129	64	12	revealed	reveal	VERB
eshr-6129	64	13	that	that	SCONJ
eshr-6129	64	14	total	total	ADJ
eshr-6129	64	15	cholesterol	cholesterol	NOUN
eshr-6129	64	16	and	and	CCONJ
eshr-6129	64	17	triglyceride	triglyceride	ADJ
eshr-6129	64	18	levels	level	NOUN
eshr-6129	64	19	of	of	ADP
eshr-6129	64	20	diabetic	diabetic	ADJ
eshr-6129	64	21	patients	patient	NOUN
eshr-6129	64	22	showed	show	VERB
eshr-6129	64	23	a	a	DET
eshr-6129	64	24	significant	significant	ADJ
eshr-6129	64	25	positive	positive	ADJ
eshr-6129	64	26	correlation	correlation	NOUN
eshr-6129	64	27	with	with	ADP
eshr-6129	64	28	bmi	bmi	PROPN
eshr-6129	64	29	.	.	PUNCT
eshr-6129	65	1	riaz	riaz	PROPN
eshr-6129	65	2	(	(	PUNCT
eshr-6129	65	3	correlation	correlation	NOUN
eshr-6129	65	4	between	between	ADP
eshr-6129	65	5	hba1c	hba1c	PROPN
eshr-6129	65	6	and	and	CCONJ
eshr-6129	65	7	lipid	lipid	NOUN
eshr-6129	65	8	profile	profile	NOUN
eshr-6129	65	9	in	in	ADP
eshr-6129	65	10	diabetes	diabetes	NOUN
eshr-6129	65	11	:	:	PUNCT
eshr-6129	65	12	a	a	DET
eshr-6129	65	13	health	health	NOUN
eshr-6129	65	14	concern	concern	NOUN
eshr-6129	65	15	in	in	ADP
eshr-6129	65	16	aseer	aseer	PROPN
eshr-6129	65	17	,	,	PUNCT
eshr-6129	65	18	saudi	saudi	PROPN
eshr-6129	65	19	arabia	arabia	PROPN
eshr-6129	65	20	)	)	PUNCT
eshr-6129	65	21	vol	vol	NOUN
eshr-6129	65	22	.	.	PROPN
eshr-6129	65	23	5	5	NUM
eshr-6129	65	24	,	,	PUNCT
eshr-6129	65	25	no	no	INTJ
eshr-6129	65	26	.	.	NOUN
eshr-6129	65	27	2	2	NUM
eshr-6129	65	28	,	,	PUNCT
eshr-6129	65	29	2023	2023	NUM
eshr-6129	65	30	,	,	PUNCT
eshr-6129	65	31	pp	pp	ADJ
eshr-6129	65	32	.	.	PUNCT
eshr-6129	66	1	60	60	NUM
eshr-6129	66	2	-	-	SYM
eshr-6129	66	3	68	68	NUM
eshr-6129	66	4	63	63	NUM
eshr-6129	66	5	10.26555	10.26555	NUM
eshr-6129	66	6	/	/	SYM
eshr-6129	66	7	eshr.v5i2.6129	eshr.v5i2.6129	NOUN
eshr-6129	66	8	table	table	NOUN
eshr-6129	66	9	1	1	NUM
eshr-6129	66	10	.	.	PUNCT
eshr-6129	66	11	demographic	demographic	ADJ
eshr-6129	66	12	data	datum	NOUN
eshr-6129	66	13	,	,	PUNCT
eshr-6129	66	14	glycemic	glycemic	ADJ
eshr-6129	66	15	and	and	CCONJ
eshr-6129	66	16	lipid	lipid	NOUN
eshr-6129	66	17	profile	profile	NOUN
eshr-6129	66	18	of	of	ADP
eshr-6129	66	19	diabetes	diabetes	NOUN
eshr-6129	66	20	patients	patient	NOUN
eshr-6129	66	21	(	(	PUNCT
eshr-6129	66	22	n=191	n=191	NOUN
eshr-6129	66	23	)	)	PUNCT
eshr-6129	66	24	demographic	demographic	ADJ
eshr-6129	66	25	and	and	CCONJ
eshr-6129	66	26	biochemical	biochemical	ADJ
eshr-6129	66	27	variables	variable	NOUN
eshr-6129	66	28	data	datum	NOUN
eshr-6129	66	29	gender	gender	NOUN
eshr-6129	66	30	male	male	NOUN
eshr-6129	66	31	111(58	111(58	NUM
eshr-6129	66	32	%	%	NOUN
eshr-6129	66	33	)	)	PUNCT
eshr-6129	66	34	female	female	NOUN
eshr-6129	66	35	80	80	NUM
eshr-6129	66	36	(	(	PUNCT
eshr-6129	66	37	42	42	NUM
eshr-6129	66	38	%	%	NOUN
eshr-6129	66	39	)	)	PUNCT
eshr-6129	66	40	nationality	nationality	NOUN
eshr-6129	66	41	saudi	saudi	ADJ
eshr-6129	66	42	191	191	NUM
eshr-6129	66	43	(	(	PUNCT
eshr-6129	66	44	100	100	NUM
eshr-6129	66	45	%	%	NOUN
eshr-6129	66	46	)	)	PUNCT
eshr-6129	66	47	age	age	NOUN
eshr-6129	66	48	(	(	PUNCT
eshr-6129	66	49	years	year	NOUN
eshr-6129	66	50	)	)	PUNCT
eshr-6129	66	51	(	(	PUNCT
eshr-6129	66	52	mean	mean	VERB
eshr-6129	66	53	±	±	NUM
eshr-6129	66	54	sd	sd	NOUN
eshr-6129	66	55	)	)	PUNCT
eshr-6129	66	56	54.9	54.9	NUM
eshr-6129	66	57	±	±	NUM
eshr-6129	66	58	12.7	12.7	NUM
eshr-6129	66	59	bmi	bmi	NOUN
eshr-6129	66	60	(	(	PUNCT
eshr-6129	66	61	mean	mean	NOUN
eshr-6129	66	62	±	±	NUM
eshr-6129	66	63	sd	sd	NOUN
eshr-6129	66	64	)	)	PUNCT
eshr-6129	66	65	30.3	30.3	NUM
eshr-6129	66	66	±	±	NUM
eshr-6129	66	67	5.6	5.6	NUM
eshr-6129	66	68	blood	blood	NOUN
eshr-6129	66	69	pressure	pressure	NOUN
eshr-6129	66	70	hypertensive	hypertensive	NOUN
eshr-6129	66	71	(	(	PUNCT
eshr-6129	66	72	bp	bp	PROPN
eshr-6129	66	73	≥140/90mmhg	≥140/90mmhg	PROPN
eshr-6129	66	74	)	)	PUNCT
eshr-6129	66	75	100	100	NUM
eshr-6129	66	76	(	(	PUNCT
eshr-6129	66	77	52	52	NUM
eshr-6129	66	78	%	%	NOUN
eshr-6129	66	79	)	)	PUNCT
eshr-6129	66	80	normotensive	normotensive	NOUN
eshr-6129	66	81	(	(	PUNCT
eshr-6129	66	82	bp	bp	PROPN
eshr-6129	66	83	<	<	X
eshr-6129	66	84	130/85	130/85	NUM
eshr-6129	66	85	)	)	PUNCT
eshr-6129	66	86	91	91	NUM
eshr-6129	66	87	(	(	PUNCT
eshr-6129	66	88	48	48	NUM
eshr-6129	66	89	%	%	NOUN
eshr-6129	66	90	)	)	PUNCT
eshr-6129	66	91	glycemic	glycemic	ADJ
eshr-6129	66	92	and	and	CCONJ
eshr-6129	66	93	lipid	lipid	NOUN
eshr-6129	66	94	profile	profile	NOUN
eshr-6129	66	95	parameters	parameter	NOUN
eshr-6129	66	96	mean	mean	VERB
eshr-6129	66	97	±	±	NOUN
eshr-6129	66	98	sd	sd	ADP
eshr-6129	66	99	fasting	fast	VERB
eshr-6129	66	100	blood	blood	NOUN
eshr-6129	66	101	sugar	sugar	NOUN
eshr-6129	66	102	(	(	PUNCT
eshr-6129	66	103	fbs)(mg	fbs)(mg	PROPN
eshr-6129	66	104	/	/	SYM
eshr-6129	66	105	dl	dl	NOUN
eshr-6129	66	106	)	)	PUNCT
eshr-6129	66	107	201.3	201.3	NUM
eshr-6129	66	108	±	±	NUM
eshr-6129	66	109	69.8	69.8	NUM
eshr-6129	66	110	random	random	ADJ
eshr-6129	66	111	blood	blood	NOUN
eshr-6129	66	112	sugar	sugar	NOUN
eshr-6129	66	113	(	(	PUNCT
eshr-6129	66	114	rbs)(mg	rbs)(mg	PROPN
eshr-6129	66	115	/	/	SYM
eshr-6129	66	116	dl	dl	NOUN
eshr-6129	66	117	)	)	PUNCT
eshr-6129	66	118	313.9	313.9	NUM
eshr-6129	66	119	±	±	NUM
eshr-6129	66	120	84.6	84.6	NUM
eshr-6129	66	121	hba1c	hba1c	PROPN
eshr-6129	66	122	(	(	PUNCT
eshr-6129	66	123	%	%	INTJ
eshr-6129	66	124	)	)	PUNCT
eshr-6129	66	125	10.3	10.3	NUM
eshr-6129	66	126	±	±	NUM
eshr-6129	66	127	2.9	2.9	NUM
eshr-6129	66	128	total	total	NOUN
eshr-6129	66	129	cholesterol	cholesterol	NOUN
eshr-6129	66	130	(	(	PUNCT
eshr-6129	66	131	mg	mg	PROPN
eshr-6129	66	132	/	/	SYM
eshr-6129	66	133	dl	dl	NOUN
eshr-6129	66	134	)	)	PUNCT
eshr-6129	66	135	210.4	210.4	NUM
eshr-6129	66	136	±	±	NUM
eshr-6129	66	137	51.4	51.4	NUM
eshr-6129	66	138	ldl	ldl	NOUN
eshr-6129	66	139	(	(	PUNCT
eshr-6129	66	140	mg	mg	PROPN
eshr-6129	66	141	/	/	SYM
eshr-6129	66	142	dl	dl	PROPN
eshr-6129	66	143	)	)	PUNCT
eshr-6129	66	144	121.7	121.7	NUM
eshr-6129	66	145	±	±	NUM
eshr-6129	66	146	42.0	42.0	NUM
eshr-6129	66	147	hdl	hdl	X
eshr-6129	66	148	(	(	PUNCT
eshr-6129	66	149	mg	mg	PROPN
eshr-6129	66	150	/	/	SYM
eshr-6129	66	151	dl	dl	NOUN
eshr-6129	66	152	)	)	PUNCT
eshr-6129	66	153	33.9	33.9	NUM
eshr-6129	66	154	±	±	NUM
eshr-6129	66	155	6.3	6.3	NUM
eshr-6129	66	156	triglycerides	triglyceride	NOUN
eshr-6129	66	157	(	(	PUNCT
eshr-6129	66	158	mg	mg	PROPN
eshr-6129	66	159	/	/	SYM
eshr-6129	66	160	dl	dl	PROPN
eshr-6129	66	161	)	)	PUNCT
eshr-6129	66	162	201.7	201.7	NUM
eshr-6129	66	163	±	±	NUM
eshr-6129	66	164	120.3	120.3	NUM
eshr-6129	66	165	vldl	vldl	NOUN
eshr-6129	66	166	(	(	PUNCT
eshr-6129	66	167	mg	mg	PROPN
eshr-6129	66	168	/	/	SYM
eshr-6129	66	169	dl	dl	NOUN
eshr-6129	66	170	)	)	PUNCT
eshr-6129	66	171	40.3	40.3	NUM
eshr-6129	66	172	±	±	NUM
eshr-6129	66	173	24.1	24.1	NUM
eshr-6129	66	174	table	table	NOUN
eshr-6129	66	175	2	2	NUM
eshr-6129	66	176	.	.	PUNCT
eshr-6129	66	177	comparison	comparison	NOUN
eshr-6129	66	178	of	of	ADP
eshr-6129	66	179	glycemic	glycemic	ADJ
eshr-6129	66	180	and	and	CCONJ
eshr-6129	66	181	lipid	lipid	NOUN
eshr-6129	66	182	profile	profile	NOUN
eshr-6129	66	183	amongst	amongst	ADP
eshr-6129	66	184	patients	patient	NOUN
eshr-6129	66	185	with	with	ADP
eshr-6129	66	186	adequately	adequately	ADV
eshr-6129	66	187	controlled	control	VERB
eshr-6129	66	188	diabetes	diabetes	NOUN
eshr-6129	66	189	and	and	CCONJ
eshr-6129	66	190	inadequately	inadequately	ADV
eshr-6129	66	191	controlled	control	VERB
eshr-6129	66	192	diabetes	diabetes	NOUN
eshr-6129	66	193	.	.	PUNCT
eshr-6129	67	1	variables	variable	NOUN
eshr-6129	67	2	patients	patient	NOUN
eshr-6129	67	3	with	with	ADP
eshr-6129	67	4	adequately	adequately	ADV
eshr-6129	67	5	controlled	control	VERB
eshr-6129	67	6	diabetes	diabetes	NOUN
eshr-6129	67	7	patients	patient	NOUN
eshr-6129	67	8	with	with	ADP
eshr-6129	67	9	inadequately	inadequately	ADV
eshr-6129	67	10	controlled	control	VERB
eshr-6129	67	11	diabetes	diabetes	NOUN
eshr-6129	67	12	p	p	NOUN
eshr-6129	67	13	-	-	PUNCT
eshr-6129	67	14	value	value	NOUN
eshr-6129	67	15	(	(	PUNCT
eshr-6129	67	16	hba1c	hba1c	NOUN
eshr-6129	67	17	≤	≤	NUM
eshr-6129	67	18	7	7	NUM
eshr-6129	67	19	)	)	PUNCT
eshr-6129	67	20	(	(	PUNCT
eshr-6129	67	21	hba1c	hba1c	X
eshr-6129	67	22	>	>	X
eshr-6129	67	23	7	7	NUM
eshr-6129	67	24	)	)	PUNCT
eshr-6129	67	25	(	(	PUNCT
eshr-6129	67	26	n=40	n=40	ADJ
eshr-6129	67	27	)	)	PUNCT
eshr-6129	67	28	(	(	PUNCT
eshr-6129	67	29	n=151	n=151	NOUN
eshr-6129	67	30	)	)	PUNCT
eshr-6129	67	31	mean	mean	VERB
eshr-6129	67	32	±	±	NUM
eshr-6129	67	33	sd	sd	ADP
eshr-6129	67	34	mean	mean	NOUN
eshr-6129	67	35	±	±	PROPN
eshr-6129	67	36	sd	sd	ADP
eshr-6129	67	37	fasting	fast	VERB
eshr-6129	67	38	blood	blood	NOUN
eshr-6129	67	39	sugar	sugar	NOUN
eshr-6129	67	40	(	(	PUNCT
eshr-6129	67	41	fbs	fbs	PROPN
eshr-6129	67	42	)	)	PUNCT
eshr-6129	67	43	(	(	PUNCT
eshr-6129	67	44	mg	mg	PROPN
eshr-6129	67	45	/	/	SYM
eshr-6129	67	46	dl	dl	NOUN
eshr-6129	67	47	)	)	PUNCT
eshr-6129	67	48	137.3	137.3	NUM
eshr-6129	67	49	±	±	NUM
eshr-6129	67	50	29.1	29.1	NUM
eshr-6129	67	51	218.3	218.3	NUM
eshr-6129	67	52	±	±	NOUN
eshr-6129	68	1	67.6	67.6	NUM
eshr-6129	68	2	0.000	0.000	NUM
eshr-6129	68	3	*	*	PUNCT
eshr-6129	68	4	random	random	ADJ
eshr-6129	68	5	blood	blood	NOUN
eshr-6129	68	6	sugar	sugar	NOUN
eshr-6129	68	7	(	(	PUNCT
eshr-6129	68	8	rbs	rbs	PROPN
eshr-6129	68	9	)	)	PUNCT
eshr-6129	68	10	(	(	PUNCT
eshr-6129	68	11	mg	mg	PROPN
eshr-6129	68	12	/	/	SYM
eshr-6129	68	13	dl	dl	NOUN
eshr-6129	68	14	)	)	PUNCT
eshr-6129	68	15	223.0	223.0	NUM
eshr-6129	68	16	±	±	NUM
eshr-6129	68	17	36.9	36.9	NUM
eshr-6129	68	18	337.9	337.9	NUM
eshr-6129	68	19	±	±	NUM
eshr-6129	68	20	76.9	76.9	NUM
eshr-6129	68	21	0.000	0.000	NUM
eshr-6129	68	22	*	*	PUNCT
eshr-6129	69	1	hba1c	hba1c	PROPN
eshr-6129	69	2	(	(	PUNCT
eshr-6129	69	3	%	%	NOUN
eshr-6129	69	4	)	)	PUNCT
eshr-6129	69	5	6.5	6.5	NUM
eshr-6129	69	6	±	±	NOUN
eshr-6129	69	7	0.7	0.7	NUM
eshr-6129	69	8	11.3	11.3	NUM
eshr-6129	69	9	±	±	NUM
eshr-6129	69	10	2.4	2.4	NUM
eshr-6129	69	11	0.000	0.000	NUM
eshr-6129	69	12	*	*	PUNCT
eshr-6129	69	13	total	total	ADJ
eshr-6129	69	14	cholesterol	cholesterol	NOUN
eshr-6129	69	15	(	(	PUNCT
eshr-6129	69	16	tc	tc	NOUN
eshr-6129	69	17	)	)	PUNCT
eshr-6129	69	18	(	(	PUNCT
eshr-6129	69	19	mg	mg	PROPN
eshr-6129	69	20	/	/	SYM
eshr-6129	69	21	dl	dl	PROPN
eshr-6129	69	22	)	)	PUNCT
eshr-6129	69	23	184.4	184.4	NUM
eshr-6129	69	24	±	±	NUM
eshr-6129	69	25	40.7	40.7	NUM
eshr-6129	69	26	217.3	217.3	NUM
eshr-6129	69	27	±	±	NUM
eshr-6129	69	28	51.9	51.9	NUM
eshr-6129	69	29	0.000	0.000	NUM
eshr-6129	69	30	*	*	PUNCT
eshr-6129	69	31	ldl	ldl	NOUN
eshr-6129	69	32	(	(	PUNCT
eshr-6129	69	33	mg	mg	PROPN
eshr-6129	69	34	/	/	SYM
eshr-6129	69	35	dl	dl	NOUN
eshr-6129	69	36	)	)	PUNCT
eshr-6129	69	37	106.8	106.8	NUM
eshr-6129	69	38	±	±	NUM
eshr-6129	69	39	15.8	15.8	NUM
eshr-6129	69	40	125.6	125.6	NUM
eshr-6129	69	41	±	±	NUM
eshr-6129	69	42	45.8	45.8	NUM
eshr-6129	69	43	0.000	0.000	NUM
eshr-6129	69	44	*	*	PUNCT
eshr-6129	69	45	hdl	hdl	X
eshr-6129	69	46	(	(	PUNCT
eshr-6129	69	47	mg	mg	PROPN
eshr-6129	69	48	/	/	SYM
eshr-6129	69	49	dl	dl	PROPN
eshr-6129	69	50	)	)	PUNCT
eshr-6129	69	51	33.2	33.2	NUM
eshr-6129	69	52	±	±	NUM
eshr-6129	69	53	2.1	2.1	NUM
eshr-6129	69	54	34.1	34.1	NUM
eshr-6129	69	55	±	±	NUM
eshr-6129	69	56	6.8	6.8	NUM
eshr-6129	69	57	0.39	0.39	NUM
eshr-6129	69	58	triglyceride	triglyceride	INTJ
eshr-6129	69	59	(	(	PUNCT
eshr-6129	69	60	mg	mg	PROPN
eshr-6129	69	61	/	/	SYM
eshr-6129	69	62	dl	dl	PROPN
eshr-6129	69	63	)	)	PUNCT
eshr-6129	69	64	132.8	132.8	NUM
eshr-6129	69	65	±	±	NUM
eshr-6129	69	66	85.4	85.4	NUM
eshr-6129	69	67	216.8	216.8	NUM
eshr-6129	69	68	±	±	NUM
eshr-6129	69	69	121.9	121.9	NUM
eshr-6129	69	70	0.001	0.001	NUM
eshr-6129	69	71	*	*	PUNCT
eshr-6129	69	72	vldl	vldl	NOUN
eshr-6129	69	73	(	(	PUNCT
eshr-6129	69	74	mg	mg	PROPN
eshr-6129	69	75	/	/	SYM
eshr-6129	69	76	dl	dl	NOUN
eshr-6129	69	77	)	)	PUNCT
eshr-6129	69	78	26.6	26.6	NUM
eshr-6129	69	79	(	(	PUNCT
eshr-6129	69	80	17.1	17.1	NUM
eshr-6129	69	81	)	)	PUNCT
eshr-6129	69	82	43.4	43.4	NUM
eshr-6129	69	83	(	(	PUNCT
eshr-6129	69	84	24.4	24.4	NUM
eshr-6129	69	85	)	)	PUNCT
eshr-6129	69	86	0.001	0.001	NUM
eshr-6129	69	87	*	*	PUNCT
eshr-6129	69	88	*	*	PUNCT
eshr-6129	69	89	p	p	NOUN
eshr-6129	69	90	value	value	NOUN
eshr-6129	69	91	<	<	X
eshr-6129	69	92	0.05	0.05	NUM
eshr-6129	69	93	is	be	AUX
eshr-6129	69	94	considered	consider	VERB
eshr-6129	69	95	significant	significant	ADJ
eshr-6129	69	96	riaz	riaz	PROPN
eshr-6129	69	97	(	(	PUNCT
eshr-6129	69	98	correlation	correlation	NOUN
eshr-6129	69	99	between	between	ADP
eshr-6129	69	100	hba1c	hba1c	PROPN
eshr-6129	69	101	and	and	CCONJ
eshr-6129	69	102	lipid	lipid	NOUN
eshr-6129	69	103	profile	profile	NOUN
eshr-6129	69	104	in	in	ADP
eshr-6129	69	105	diabetes	diabetes	NOUN
eshr-6129	69	106	:	:	PUNCT
eshr-6129	69	107	a	a	DET
eshr-6129	69	108	health	health	NOUN
eshr-6129	69	109	concern	concern	NOUN
eshr-6129	69	110	in	in	ADP
eshr-6129	69	111	aseer	aseer	PROPN
eshr-6129	69	112	,	,	PUNCT
eshr-6129	69	113	saudi	saudi	PROPN
eshr-6129	69	114	arabia	arabia	PROPN
eshr-6129	69	115	)	)	PUNCT
eshr-6129	69	116	vol	vol	NOUN
eshr-6129	69	117	.	.	PROPN
eshr-6129	70	1	5	5	NUM
eshr-6129	70	2	,	,	PUNCT
eshr-6129	70	3	no	no	INTJ
eshr-6129	70	4	.	.	NOUN
eshr-6129	70	5	2	2	NUM
eshr-6129	70	6	,	,	PUNCT
eshr-6129	70	7	2023	2023	NUM
eshr-6129	70	8	,	,	PUNCT
eshr-6129	70	9	pp	pp	ADJ
eshr-6129	70	10	.	.	PUNCT
eshr-6129	71	1	60	60	NUM
eshr-6129	71	2	-	-	SYM
eshr-6129	71	3	68	68	NUM
eshr-6129	71	4	64	64	NUM
eshr-6129	71	5	10.26555	10.26555	NUM
eshr-6129	71	6	/	/	SYM
eshr-6129	71	7	eshr.v5i2.6129	eshr.v5i2.6129	NOUN
eshr-6129	71	8	table	table	NOUN
eshr-6129	71	9	3	3	NUM
eshr-6129	71	10	.	.	PUNCT
eshr-6129	72	1	linear	linear	PROPN
eshr-6129	72	2	regression	regression	NOUN
eshr-6129	72	3	analysis	analysis	NOUN
eshr-6129	72	4	to	to	PART
eshr-6129	72	5	check	check	VERB
eshr-6129	72	6	the	the	DET
eshr-6129	72	7	correlation	correlation	NOUN
eshr-6129	72	8	between	between	ADP
eshr-6129	72	9	the	the	DET
eshr-6129	72	10	biochemical	biochemical	ADJ
eshr-6129	72	11	parameters	parameter	NOUN
eshr-6129	72	12	in	in	ADP
eshr-6129	72	13	diabetes	diabetes	NOUN
eshr-6129	72	14	patients	patient	NOUN
eshr-6129	72	15	variables	variable	VERB
eshr-6129	72	16	correlation	correlation	NOUN
eshr-6129	72	17	coefficient	coefficient	NOUN
eshr-6129	72	18	(	(	PUNCT
eshr-6129	72	19	beta	beta	NOUN
eshr-6129	72	20	)	)	PUNCT
eshr-6129	72	21	p	p	NOUN
eshr-6129	72	22	-	-	PUNCT
eshr-6129	72	23	value	value	NOUN
eshr-6129	72	24	hba1c	hba1c	PROPN
eshr-6129	72	25	and	and	CCONJ
eshr-6129	72	26	tc	tc	ADP
eshr-6129	72	27	0.3	0.3	NUM
eshr-6129	72	28	0.001	0.001	NUM
eshr-6129	72	29	*	*	NOUN
eshr-6129	72	30	hba1c	hba1c	NOUN
eshr-6129	72	31	and	and	CCONJ
eshr-6129	72	32	ldl	ldl	VERB
eshr-6129	72	33	0.3	0.3	NUM
eshr-6129	72	34	0.000	0.000	NUM
eshr-6129	72	35	*	*	PUNCT
eshr-6129	73	1	hba1c	hba1c	NOUN
eshr-6129	73	2	and	and	CCONJ
eshr-6129	73	3	triglyceride	triglyceride	ADP
eshr-6129	73	4	0.2	0.2	NUM
eshr-6129	73	5	0.053	0.053	NUM
eshr-6129	73	6	hba1c	hba1c	PROPN
eshr-6129	73	7	and	and	CCONJ
eshr-6129	73	8	hdl	hdl	PROPN
eshr-6129	73	9	0.1	0.1	NUM
eshr-6129	73	10	0.533	0.533	NUM
eshr-6129	73	11	hba1c	hba1c	PROPN
eshr-6129	73	12	and	and	CCONJ
eshr-6129	73	13	vldl	vldl	PROPN
eshr-6129	73	14	0.2	0.2	NUM
eshr-6129	73	15	0.053	0.053	NUM
eshr-6129	73	16	total	total	ADJ
eshr-6129	73	17	cholesterol	cholesterol	NOUN
eshr-6129	73	18	and	and	CCONJ
eshr-6129	73	19	bmi	bmi	VERB
eshr-6129	73	20	0.2	0.2	NUM
eshr-6129	73	21	0.037	0.037	NUM
eshr-6129	73	22	*	*	PUNCT
eshr-6129	73	23	triglyceride	triglyceride	ADJ
eshr-6129	73	24	and	and	CCONJ
eshr-6129	73	25	bmi	bmi	VERB
eshr-6129	73	26	0.4	0.4	NUM
eshr-6129	73	27	0.001	0.001	NUM
eshr-6129	73	28	*	*	PUNCT
eshr-6129	74	1	*	*	PUNCT
eshr-6129	74	2	p	p	NOUN
eshr-6129	74	3	value	value	NOUN
eshr-6129	74	4	<	<	X
eshr-6129	74	5	0.05	0.05	NUM
eshr-6129	74	6	is	be	AUX
eshr-6129	74	7	considered	consider	VERB
eshr-6129	74	8	significant	significant	ADJ
eshr-6129	74	9	(	(	PUNCT
eshr-6129	74	10	a	a	NOUN
eshr-6129	74	11	)	)	PUNCT
eshr-6129	74	12	(	(	PUNCT
eshr-6129	74	13	b	b	X
eshr-6129	74	14	)	)	PUNCT
eshr-6129	74	15	figure	figure	NOUN
eshr-6129	74	16	1	1	NUM
eshr-6129	74	17	.	.	PUNCT
eshr-6129	74	18	correlation	correlation	NOUN
eshr-6129	74	19	of	of	ADP
eshr-6129	74	20	hba1c	hba1c	PROPN
eshr-6129	74	21	with	with	ADP
eshr-6129	74	22	total	total	ADJ
eshr-6129	74	23	cholesterol	cholesterol	NOUN
eshr-6129	74	24	(	(	PUNCT
eshr-6129	74	25	a	a	NOUN
eshr-6129	74	26	)	)	PUNCT
eshr-6129	74	27	and	and	CCONJ
eshr-6129	74	28	hba1c	hba1c	NOUN
eshr-6129	74	29	with	with	ADP
eshr-6129	74	30	ldl	ldl	PROPN
eshr-6129	74	31	(	(	PUNCT
eshr-6129	74	32	b	b	NOUN
eshr-6129	74	33	)	)	PUNCT
eshr-6129	74	34	discussion	discussion	NOUN
eshr-6129	74	35	this	this	DET
eshr-6129	74	36	study	study	NOUN
eshr-6129	74	37	shows	show	VERB
eshr-6129	74	38	that	that	PRON
eshr-6129	74	39	type	type	NOUN
eshr-6129	74	40	2	2	NUM
eshr-6129	74	41	diabetes	diabetes	NOUN
eshr-6129	74	42	mellitus	mellitus	NOUN
eshr-6129	74	43	was	be	AUX
eshr-6129	74	44	more	more	ADV
eshr-6129	74	45	prevalent	prevalent	ADJ
eshr-6129	74	46	in	in	ADP
eshr-6129	74	47	males	male	NOUN
eshr-6129	74	48	,	,	PUNCT
eshr-6129	74	49	and	and	CCONJ
eshr-6129	74	50	the	the	DET
eshr-6129	74	51	average	average	ADJ
eshr-6129	74	52	age	age	NOUN
eshr-6129	74	53	of	of	ADP
eshr-6129	74	54	the	the	DET
eshr-6129	74	55	patients	patient	NOUN
eshr-6129	74	56	was	be	AUX
eshr-6129	74	57	54.9	54.9	NUM
eshr-6129	74	58	years	year	NOUN
eshr-6129	74	59	.	.	PUNCT
eshr-6129	75	1	these	these	DET
eshr-6129	75	2	patients	patient	NOUN
eshr-6129	75	3	were	be	AUX
eshr-6129	75	4	found	find	VERB
eshr-6129	75	5	to	to	PART
eshr-6129	75	6	be	be	AUX
eshr-6129	75	7	falling	fall	VERB
eshr-6129	75	8	in	in	ADP
eshr-6129	75	9	the	the	DET
eshr-6129	75	10	obesity	obesity	NOUN
eshr-6129	75	11	class	class	NOUN
eshr-6129	75	12	1	1	NUM
eshr-6129	75	13	category	category	NOUN
eshr-6129	75	14	.	.	PUNCT
eshr-6129	76	1	these	these	DET
eshr-6129	76	2	patients	patient	NOUN
eshr-6129	76	3	were	be	AUX
eshr-6129	76	4	of	of	ADP
eshr-6129	76	5	saudi	saudi	ADJ
eshr-6129	76	6	nationality	nationality	NOUN
eshr-6129	76	7	.	.	PUNCT
eshr-6129	77	1	saudi	saudi	ADJ
eshr-6129	77	2	arabian	arabian	ADJ
eshr-6129	77	3	diet	diet	PROPN
eshr-6129	77	4	predominantly	predominantly	ADV
eshr-6129	77	5	contains	contain	VERB
eshr-6129	77	6	food	food	NOUN
eshr-6129	77	7	items	item	NOUN
eshr-6129	77	8	of	of	ADP
eshr-6129	77	9	non	non	ADJ
eshr-6129	77	10	-	-	ADJ
eshr-6129	77	11	vegetarian	vegetarian	ADJ
eshr-6129	77	12	origin	origin	NOUN
eshr-6129	77	13	.	.	PUNCT
eshr-6129	78	1	the	the	DET
eshr-6129	78	2	non	non	ADJ
eshr-6129	78	3	-	-	ADJ
eshr-6129	78	4	vegetarian	vegetarian	ADJ
eshr-6129	78	5	diets	diet	NOUN
eshr-6129	78	6	are	be	AUX
eshr-6129	78	7	considered	consider	VERB
eshr-6129	78	8	high	high	ADJ
eshr-6129	78	9	in	in	ADP
eshr-6129	78	10	cholesterol	cholesterol	NOUN
eshr-6129	78	11	and	and	CCONJ
eshr-6129	78	12	triacylglycerol	triacylglycerol	NOUN
eshr-6129	78	13	content	content	NOUN
eshr-6129	78	14	,	,	PUNCT
eshr-6129	78	15	which	which	PRON
eshr-6129	78	16	might	might	AUX
eshr-6129	78	17	have	have	AUX
eshr-6129	78	18	been	be	AUX
eshr-6129	78	19	a	a	DET
eshr-6129	78	20	contributing	contribute	VERB
eshr-6129	78	21	factor	factor	NOUN
eshr-6129	78	22	to	to	ADP
eshr-6129	78	23	obesity	obesity	NOUN
eshr-6129	78	24	.	.	PUNCT
eshr-6129	79	1	a	a	DET
eshr-6129	79	2	study	study	NOUN
eshr-6129	79	3	by	by	ADP
eshr-6129	79	4	wang	wang	PROPN
eshr-6129	79	5	et	et	PROPN
eshr-6129	79	6	al	al	PROPN
eshr-6129	79	7	.	.	PROPN
eshr-6129	79	8	has	have	AUX
eshr-6129	79	9	shown	show	VERB
eshr-6129	79	10	that	that	SCONJ
eshr-6129	79	11	meat	meat	NOUN
eshr-6129	79	12	consumption	consumption	NOUN
eshr-6129	79	13	is	be	AUX
eshr-6129	79	14	associated	associate	VERB
eshr-6129	79	15	with	with	ADP
eshr-6129	79	16	increased	increase	VERB
eshr-6129	79	17	bmi	bmi	NOUN
eshr-6129	79	18	and	and	CCONJ
eshr-6129	79	19	obesity.5	obesity.5	PRON
eshr-6129	79	20	the	the	DET
eshr-6129	79	21	study	study	NOUN
eshr-6129	79	22	also	also	ADV
eshr-6129	79	23	found	find	VERB
eshr-6129	79	24	that	that	SCONJ
eshr-6129	79	25	52	52	NUM
eshr-6129	79	26	%	%	NOUN
eshr-6129	79	27	of	of	ADP
eshr-6129	79	28	diabetes	diabetes	NOUN
eshr-6129	79	29	patients	patient	NOUN
eshr-6129	79	30	also	also	ADV
eshr-6129	79	31	had	have	VERB
eshr-6129	79	32	hypertension	hypertension	NOUN
eshr-6129	79	33	.	.	PUNCT
eshr-6129	80	1	the	the	DET
eshr-6129	80	2	glycemic	glycemic	ADJ
eshr-6129	80	3	profile	profile	NOUN
eshr-6129	80	4	of	of	ADP
eshr-6129	80	5	the	the	DET
eshr-6129	80	6	study	study	NOUN
eshr-6129	80	7	subjects	subject	NOUN
eshr-6129	80	8	(	(	PUNCT
eshr-6129	80	9	n	n	NOUN
eshr-6129	80	10	=	=	SYM
eshr-6129	80	11	191	191	NUM
eshr-6129	80	12	)	)	PUNCT
eshr-6129	80	13	showed	show	VERB
eshr-6129	80	14	the	the	DET
eshr-6129	80	15	mean	mean	NOUN
eshr-6129	80	16	with	with	ADP
eshr-6129	80	17	a	a	DET
eshr-6129	80	18	standard	standard	ADJ
eshr-6129	80	19	deviation	deviation	NOUN
eshr-6129	80	20	of	of	ADP
eshr-6129	80	21	fasting	fast	VERB
eshr-6129	80	22	blood	blood	NOUN
eshr-6129	80	23	glucose	glucose	NOUN
eshr-6129	80	24	(	(	PUNCT
eshr-6129	80	25	201.3	201.3	NUM
eshr-6129	80	26	±	±	NUM
eshr-6129	80	27	69.8	69.8	NUM
eshr-6129	80	28	)	)	PUNCT
eshr-6129	80	29	,	,	PUNCT
eshr-6129	80	30	random	random	ADJ
eshr-6129	80	31	blood	blood	NOUN
eshr-6129	80	32	glucose	glucose	NOUN
eshr-6129	80	33	(	(	PUNCT
eshr-6129	80	34	313.9	313.9	NUM
eshr-6129	80	35	±	±	NUM
eshr-6129	80	36	84.6	84.6	NUM
eshr-6129	80	37	,	,	PUNCT
eshr-6129	80	38	and	and	CCONJ
eshr-6129	80	39	hba1c	hba1c	PROPN
eshr-6129	80	40	(	(	PUNCT
eshr-6129	80	41	10.3	10.3	NUM
eshr-6129	80	42	riaz	riaz	PROPN
eshr-6129	80	43	(	(	PUNCT
eshr-6129	80	44	correlation	correlation	NOUN
eshr-6129	80	45	between	between	ADP
eshr-6129	80	46	hba1c	hba1c	PROPN
eshr-6129	80	47	and	and	CCONJ
eshr-6129	80	48	lipid	lipid	NOUN
eshr-6129	80	49	profile	profile	NOUN
eshr-6129	80	50	in	in	ADP
eshr-6129	80	51	diabetes	diabetes	NOUN
eshr-6129	80	52	:	:	PUNCT
eshr-6129	80	53	a	a	DET
eshr-6129	80	54	health	health	NOUN
eshr-6129	80	55	concern	concern	NOUN
eshr-6129	80	56	in	in	ADP
eshr-6129	80	57	aseer	aseer	PROPN
eshr-6129	80	58	,	,	PUNCT
eshr-6129	80	59	saudi	saudi	PROPN
eshr-6129	80	60	arabia	arabia	PROPN
eshr-6129	80	61	)	)	PUNCT
eshr-6129	80	62	vol	vol	NOUN
eshr-6129	80	63	.	.	PROPN
eshr-6129	81	1	5	5	NUM
eshr-6129	81	2	,	,	PUNCT
eshr-6129	81	3	no	no	INTJ
eshr-6129	81	4	.	.	NOUN
eshr-6129	81	5	2	2	NUM
eshr-6129	81	6	,	,	PUNCT
eshr-6129	81	7	2023	2023	NUM
eshr-6129	81	8	,	,	PUNCT
eshr-6129	81	9	pp	pp	ADJ
eshr-6129	81	10	.	.	PUNCT
eshr-6129	82	1	60	60	NUM
eshr-6129	82	2	-	-	SYM
eshr-6129	82	3	68	68	NUM
eshr-6129	82	4	65	65	NUM
eshr-6129	82	5	10.26555	10.26555	NUM
eshr-6129	82	6	/	/	SYM
eshr-6129	82	7	eshr.v5i2.6129	eshr.v5i2.6129	PROPN
eshr-6129	82	8	±	±	NUM
eshr-6129	82	9	2.9	2.9	NUM
eshr-6129	82	10	)	)	PUNCT
eshr-6129	82	11	were	be	AUX
eshr-6129	82	12	all	all	ADV
eshr-6129	82	13	out	out	ADP
eshr-6129	82	14	of	of	ADP
eshr-6129	82	15	the	the	DET
eshr-6129	82	16	normal	normal	ADJ
eshr-6129	82	17	reference	reference	NOUN
eshr-6129	82	18	range	range	NOUN
eshr-6129	82	19	indicating	indicate	VERB
eshr-6129	82	20	that	that	SCONJ
eshr-6129	82	21	these	these	DET
eshr-6129	82	22	patients	patient	NOUN
eshr-6129	82	23	'	'	PART
eshr-6129	82	24	despite	despite	SCONJ
eshr-6129	82	25	of	of	ADP
eshr-6129	82	26	taking	take	VERB
eshr-6129	82	27	oral	oral	ADJ
eshr-6129	82	28	hypoglycemic	hypoglycemic	ADJ
eshr-6129	82	29	drugs	drug	NOUN
eshr-6129	82	30	and	and	CCONJ
eshr-6129	82	31	insulin	insulin	NOUN
eshr-6129	82	32	were	be	AUX
eshr-6129	82	33	not	not	PART
eshr-6129	82	34	able	able	ADJ
eshr-6129	82	35	to	to	PART
eshr-6129	82	36	maintain	maintain	VERB
eshr-6129	82	37	an	an	DET
eshr-6129	82	38	average	average	ADJ
eshr-6129	82	39	glycemic	glycemic	ADJ
eshr-6129	82	40	profile	profile	NOUN
eshr-6129	82	41	.	.	PUNCT
eshr-6129	83	1	the	the	DET
eshr-6129	83	2	lipid	lipid	NOUN
eshr-6129	83	3	profile	profile	NOUN
eshr-6129	83	4	analysis	analysis	NOUN
eshr-6129	83	5	also	also	ADV
eshr-6129	83	6	revealed	reveal	VERB
eshr-6129	83	7	that	that	SCONJ
eshr-6129	83	8	these	these	DET
eshr-6129	83	9	patients	patient	NOUN
eshr-6129	83	10	had	have	VERB
eshr-6129	83	11	dyslipidemia	dyslipidemia	NOUN
eshr-6129	83	12	.	.	PUNCT
eshr-6129	84	1	their	their	PRON
eshr-6129	84	2	mean	mean	NOUN
eshr-6129	84	3	with	with	ADP
eshr-6129	84	4	a	a	DET
eshr-6129	84	5	standard	standard	ADJ
eshr-6129	84	6	deviation	deviation	NOUN
eshr-6129	84	7	of	of	ADP
eshr-6129	84	8	total	total	ADJ
eshr-6129	84	9	cholesterol	cholesterol	NOUN
eshr-6129	84	10	(	(	PUNCT
eshr-6129	84	11	210.4	210.4	NUM
eshr-6129	84	12	±	±	NUM
eshr-6129	84	13	51.4	51.4	NUM
eshr-6129	84	14	)	)	PUNCT
eshr-6129	84	15	,	,	PUNCT
eshr-6129	84	16	ldl	ldl	NOUN
eshr-6129	84	17	cholesterol	cholesterol	NOUN
eshr-6129	84	18	(	(	PUNCT
eshr-6129	84	19	121.7	121.7	NUM
eshr-6129	84	20	±	±	NUM
eshr-6129	84	21	42.0	42.0	NUM
eshr-6129	84	22	)	)	PUNCT
eshr-6129	84	23	,	,	PUNCT
eshr-6129	84	24	triglycerides	triglyceride	NOUN
eshr-6129	84	25	(	(	PUNCT
eshr-6129	84	26	201.7	201.7	NUM
eshr-6129	84	27	±	±	NUM
eshr-6129	84	28	120.3	120.3	NUM
eshr-6129	84	29	)	)	PUNCT
eshr-6129	84	30	,	,	PUNCT
eshr-6129	84	31	hdl	hdl	PROPN
eshr-6129	84	32	cholesterol	cholesterol	PROPN
eshr-6129	84	33	(	(	PUNCT
eshr-6129	84	34	33.9	33.9	NUM
eshr-6129	84	35	±	±	NUM
eshr-6129	84	36	6.3	6.3	NUM
eshr-6129	84	37	)	)	PUNCT
eshr-6129	84	38	,	,	PUNCT
eshr-6129	84	39	and	and	CCONJ
eshr-6129	84	40	vldl	vldl	NOUN
eshr-6129	84	41	(	(	PUNCT
eshr-6129	84	42	40.3	40.3	NUM
eshr-6129	84	43	±	±	NUM
eshr-6129	84	44	24.1	24.1	NUM
eshr-6129	84	45	)	)	PUNCT
eshr-6129	84	46	were	be	AUX
eshr-6129	84	47	found	find	VERB
eshr-6129	84	48	to	to	PART
eshr-6129	84	49	be	be	AUX
eshr-6129	84	50	out	out	ADP
eshr-6129	84	51	of	of	ADP
eshr-6129	84	52	normal	normal	ADJ
eshr-6129	84	53	reference	reference	NOUN
eshr-6129	84	54	range	range	NOUN
eshr-6129	84	55	.	.	PUNCT
eshr-6129	85	1	according	accord	VERB
eshr-6129	85	2	to	to	ADP
eshr-6129	85	3	the	the	DET
eshr-6129	85	4	ncep	ncep	PROPN
eshr-6129	85	5	atp	atp	PROPN
eshr-6129	85	6	iii	iii	PROPN
eshr-6129	85	7	criteria	criteria	PROPN
eshr-6129	85	8	,	,	PUNCT
eshr-6129	85	9	the	the	DET
eshr-6129	85	10	total	total	ADJ
eshr-6129	85	11	cholesterol	cholesterol	NOUN
eshr-6129	85	12	level	level	NOUN
eshr-6129	85	13	in	in	ADP
eshr-6129	85	14	the	the	DET
eshr-6129	85	15	range	range	NOUN
eshr-6129	85	16	of	of	ADP
eshr-6129	85	17	200	200	NUM
eshr-6129	85	18	-	-	SYM
eshr-6129	85	19	239	239	NUM
eshr-6129	85	20	is	be	AUX
eshr-6129	85	21	considered	consider	VERB
eshr-6129	85	22	to	to	PART
eshr-6129	85	23	be	be	AUX
eshr-6129	85	24	borderline	borderline	NOUN
eshr-6129	85	25	high	high	ADJ
eshr-6129	85	26	,	,	PUNCT
eshr-6129	85	27	ldl	ldl	VERB
eshr-6129	85	28	cholesterol	cholesterol	NOUN
eshr-6129	85	29	in	in	ADP
eshr-6129	85	30	the	the	DET
eshr-6129	85	31	range	range	NOUN
eshr-6129	85	32	of	of	ADP
eshr-6129	85	33	100	100	NUM
eshr-6129	85	34	-	-	SYM
eshr-6129	85	35	129	129	NUM
eshr-6129	85	36	is	be	AUX
eshr-6129	85	37	considered	consider	VERB
eshr-6129	85	38	above	above	ADP
eshr-6129	85	39	the	the	DET
eshr-6129	85	40	optimal	optimal	ADJ
eshr-6129	85	41	range	range	NOUN
eshr-6129	85	42	,	,	PUNCT
eshr-6129	85	43	hdl	hdl	PROPN
eshr-6129	85	44	cholesterol	cholesterol	PROPN
eshr-6129	85	45	<	<	X
eshr-6129	85	46	40	40	NUM
eshr-6129	85	47	is	be	AUX
eshr-6129	85	48	considered	consider	VERB
eshr-6129	85	49	to	to	PART
eshr-6129	85	50	be	be	AUX
eshr-6129	85	51	low	low	ADJ
eshr-6129	85	52	and	and	CCONJ
eshr-6129	85	53	fasting	fast	VERB
eshr-6129	85	54	triglyceride	triglyceride	ADP
eshr-6129	85	55	level	level	NOUN
eshr-6129	85	56	>	>	X
eshr-6129	85	57	150	150	NUM
eshr-6129	85	58	mg	mg	NUM
eshr-6129	85	59	/	/	SYM
eshr-6129	85	60	dl	dl	PROPN
eshr-6129	85	61	is	be	AUX
eshr-6129	85	62	considered	consider	VERB
eshr-6129	85	63	to	to	PART
eshr-6129	85	64	be	be	AUX
eshr-6129	85	65	high	high	ADJ
eshr-6129	85	66	.	.	PUNCT
eshr-6129	86	1	this	this	DET
eshr-6129	86	2	study	study	NOUN
eshr-6129	86	3	confirmed	confirm	VERB
eshr-6129	86	4	through	through	ADP
eshr-6129	86	5	linear	linear	ADJ
eshr-6129	86	6	regression	regression	NOUN
eshr-6129	86	7	analysis	analysis	NOUN
eshr-6129	86	8	that	that	SCONJ
eshr-6129	86	9	hba1c	hba1c	PROPN
eshr-6129	86	10	,	,	PUNCT
eshr-6129	86	11	a	a	DET
eshr-6129	86	12	glycemic	glycemic	ADJ
eshr-6129	86	13	profile	profile	NOUN
eshr-6129	86	14	indicator	indicator	NOUN
eshr-6129	86	15	,	,	PUNCT
eshr-6129	86	16	significantly	significantly	ADV
eshr-6129	86	17	correlated	correlate	VERB
eshr-6129	86	18	with	with	ADP
eshr-6129	86	19	total	total	ADJ
eshr-6129	86	20	serum	serum	NOUN
eshr-6129	86	21	cholesterol	cholesterol	NOUN
eshr-6129	86	22	and	and	CCONJ
eshr-6129	86	23	ldl	ldl	NOUN
eshr-6129	86	24	cholesterol	cholesterol	NOUN
eshr-6129	86	25	,	,	PUNCT
eshr-6129	86	26	indicating	indicate	VERB
eshr-6129	86	27	that	that	SCONJ
eshr-6129	86	28	hyperglycemia	hyperglycemia	NOUN
eshr-6129	86	29	leads	lead	VERB
eshr-6129	86	30	to	to	PART
eshr-6129	86	31	dyslipidemia	dyslipidemia	VERB
eshr-6129	86	32	in	in	ADP
eshr-6129	86	33	diabetic	diabetic	ADJ
eshr-6129	86	34	patients	patient	NOUN
eshr-6129	86	35	.	.	PUNCT
eshr-6129	87	1	(	(	PUNCT
eshr-6129	87	2	a	a	X
eshr-6129	87	3	)	)	PUNCT
eshr-6129	87	4	(	(	PUNCT
eshr-6129	87	5	b	b	X
eshr-6129	87	6	)	)	PUNCT
eshr-6129	87	7	figure	figure	NOUN
eshr-6129	87	8	2	2	NUM
eshr-6129	87	9	.	.	PUNCT
eshr-6129	87	10	correlation	correlation	NOUN
eshr-6129	87	11	of	of	ADP
eshr-6129	87	12	total	total	ADJ
eshr-6129	87	13	cholesterol	cholesterol	NOUN
eshr-6129	87	14	with	with	ADP
eshr-6129	87	15	bmi	bmi	NOUN
eshr-6129	87	16	(	(	PUNCT
eshr-6129	87	17	a	a	NOUN
eshr-6129	87	18	)	)	PUNCT
eshr-6129	87	19	and	and	CCONJ
eshr-6129	87	20	triglycerides	triglyceride	NOUN
eshr-6129	87	21	with	with	ADP
eshr-6129	87	22	bmi	bmi	NOUN
eshr-6129	87	23	(	(	PUNCT
eshr-6129	87	24	b	b	X
eshr-6129	87	25	)	)	PUNCT
eshr-6129	87	26	the	the	DET
eshr-6129	87	27	linear	linear	ADJ
eshr-6129	87	28	regression	regression	NOUN
eshr-6129	87	29	also	also	ADV
eshr-6129	87	30	confirmed	confirm	VERB
eshr-6129	87	31	that	that	SCONJ
eshr-6129	87	32	serum	serum	NOUN
eshr-6129	87	33	total	total	ADJ
eshr-6129	87	34	cholesterol	cholesterol	NOUN
eshr-6129	87	35	and	and	CCONJ
eshr-6129	87	36	triglyceride	triglyceride	ADJ
eshr-6129	87	37	levels	level	NOUN
eshr-6129	87	38	were	be	AUX
eshr-6129	87	39	significantly	significantly	ADV
eshr-6129	87	40	correlated	correlate	VERB
eshr-6129	87	41	with	with	ADP
eshr-6129	87	42	bmi	bmi	NOUN
eshr-6129	87	43	,	,	PUNCT
eshr-6129	87	44	indicating	indicate	VERB
eshr-6129	87	45	that	that	SCONJ
eshr-6129	87	46	dyslipidemia	dyslipidemia	NOUN
eshr-6129	87	47	leads	lead	VERB
eshr-6129	87	48	to	to	ADP
eshr-6129	87	49	increased	increase	VERB
eshr-6129	87	50	bmi	bmi	NOUN
eshr-6129	87	51	.	.	PUNCT
eshr-6129	88	1	the	the	DET
eshr-6129	88	2	mean	mean	ADJ
eshr-6129	88	3	bmi	bmi	NOUN
eshr-6129	88	4	of	of	ADP
eshr-6129	88	5	the	the	DET
eshr-6129	88	6	diabetic	diabetic	ADJ
eshr-6129	88	7	subjects	subject	NOUN
eshr-6129	88	8	enrolled	enrol	VERB
eshr-6129	88	9	in	in	ADP
eshr-6129	88	10	this	this	DET
eshr-6129	88	11	study	study	NOUN
eshr-6129	88	12	was	be	AUX
eshr-6129	88	13	found	find	VERB
eshr-6129	88	14	to	to	PART
eshr-6129	88	15	be	be	AUX
eshr-6129	88	16	in	in	ADP
eshr-6129	88	17	the	the	DET
eshr-6129	88	18	obesity	obesity	NOUN
eshr-6129	88	19	category	category	NOUN
eshr-6129	88	20	,	,	PUNCT
eshr-6129	88	21	implying	imply	VERB
eshr-6129	88	22	that	that	PRON
eshr-6129	88	23	dyslipidemia	dyslipidemia	NOUN
eshr-6129	88	24	could	could	AUX
eshr-6129	88	25	have	have	AUX
eshr-6129	88	26	led	lead	VERB
eshr-6129	88	27	to	to	ADP
eshr-6129	88	28	obesity	obesity	NOUN
eshr-6129	88	29	.	.	PUNCT
eshr-6129	89	1	a	a	DET
eshr-6129	89	2	study	study	NOUN
eshr-6129	89	3	in	in	ADP
eshr-6129	89	4	the	the	DET
eshr-6129	89	5	literature	literature	NOUN
eshr-6129	89	6	has	have	AUX
eshr-6129	89	7	shown	show	VERB
eshr-6129	89	8	that	that	SCONJ
eshr-6129	89	9	approximately	approximately	ADV
eshr-6129	89	10	60	60	NUM
eshr-6129	89	11	-	-	SYM
eshr-6129	89	12	70	70	NUM
eshr-6129	89	13	%	%	NOUN
eshr-6129	89	14	of	of	ADP
eshr-6129	89	15	patients	patient	NOUN
eshr-6129	89	16	who	who	PRON
eshr-6129	89	17	are	be	AUX
eshr-6129	89	18	obese	obese	ADJ
eshr-6129	89	19	are	be	AUX
eshr-6129	89	20	dyslipidemia.6	dyslipidemia.6	PROPN
eshr-6129	89	21	dyslipidemia	dyslipidemia	NOUN
eshr-6129	89	22	and	and	CCONJ
eshr-6129	89	23	obesity7	obesity7	NOUN
eshr-6129	89	24	are	be	AUX
eshr-6129	89	25	associated	associate	VERB
eshr-6129	89	26	with	with	ADP
eshr-6129	89	27	increased	increase	VERB
eshr-6129	89	28	risk	risk	NOUN
eshr-6129	89	29	for	for	ADP
eshr-6129	89	30	cardiovascular	cardiovascular	ADJ
eshr-6129	89	31	complications	complication	NOUN
eshr-6129	89	32	.	.	PUNCT
eshr-6129	90	1	besides	besides	SCONJ
eshr-6129	90	2	this	this	PRON
eshr-6129	90	3	,	,	PUNCT
eshr-6129	90	4	the	the	DET
eshr-6129	90	5	presence	presence	NOUN
eshr-6129	90	6	of	of	ADP
eshr-6129	90	7	hypertension	hypertension	NOUN
eshr-6129	90	8	is	be	AUX
eshr-6129	90	9	also	also	ADV
eshr-6129	90	10	considered	consider	VERB
eshr-6129	90	11	to	to	PART
eshr-6129	90	12	be	be	AUX
eshr-6129	90	13	a	a	DET
eshr-6129	90	14	risk	risk	NOUN
eshr-6129	90	15	factor	factor	NOUN
eshr-6129	90	16	for	for	ADP
eshr-6129	90	17	the	the	DET
eshr-6129	90	18	development	development	NOUN
eshr-6129	90	19	of	of	ADP
eshr-6129	90	20	cardiovascular	cardiovascular	ADJ
eshr-6129	90	21	disease.8	disease.8	PROPN
eshr-6129	90	22	the	the	DET
eshr-6129	90	23	adequately	adequately	ADV
eshr-6129	90	24	controlled	control	VERB
eshr-6129	90	25	diabetic	diabetic	ADJ
eshr-6129	90	26	group	group	NOUN
eshr-6129	90	27	and	and	CCONJ
eshr-6129	90	28	inadequately	inadequately	ADV
eshr-6129	90	29	controlled	control	VERB
eshr-6129	90	30	diabetic	diabetic	ADJ
eshr-6129	90	31	group	group	NOUN
eshr-6129	90	32	,	,	PUNCT
eshr-6129	90	33	when	when	SCONJ
eshr-6129	90	34	compared	compare	VERB
eshr-6129	90	35	for	for	ADP
eshr-6129	90	36	their	their	PRON
eshr-6129	90	37	glycemic	glycemic	ADJ
eshr-6129	90	38	and	and	CCONJ
eshr-6129	90	39	dyslipidemia	dyslipidemia	NOUN
eshr-6129	90	40	profile	profile	NOUN
eshr-6129	90	41	,	,	PUNCT
eshr-6129	90	42	showed	show	VERB
eshr-6129	90	43	a	a	DET
eshr-6129	90	44	significantly	significantly	ADV
eshr-6129	90	45	deranged	derange	VERB
eshr-6129	90	46	glycemic	glycemic	ADJ
eshr-6129	90	47	and	and	CCONJ
eshr-6129	90	48	dyslipidemia	dyslipidemia	NOUN
eshr-6129	90	49	picture	picture	NOUN
eshr-6129	90	50	in	in	ADP
eshr-6129	90	51	the	the	DET
eshr-6129	90	52	poorly	poorly	ADV
eshr-6129	90	53	controlled	control	VERB
eshr-6129	90	54	diabetic	diabetic	ADJ
eshr-6129	90	55	group	group	NOUN
eshr-6129	90	56	(	(	PUNCT
eshr-6129	90	57	table	table	NOUN
eshr-6129	90	58	2	2	NUM
eshr-6129	90	59	)	)	PUNCT
eshr-6129	90	60	.	.	PUNCT
eshr-6129	91	1	this	this	PRON
eshr-6129	91	2	implies	imply	VERB
eshr-6129	91	3	that	that	SCONJ
eshr-6129	91	4	if	if	SCONJ
eshr-6129	91	5	tight	tight	ADJ
eshr-6129	91	6	glycemic	glycemic	ADJ
eshr-6129	91	7	control	control	NOUN
eshr-6129	91	8	is	be	AUX
eshr-6129	91	9	not	not	PART
eshr-6129	91	10	maintained	maintain	VERB
eshr-6129	91	11	in	in	ADP
eshr-6129	91	12	diabetes	diabetes	NOUN
eshr-6129	91	13	patients	patient	NOUN
eshr-6129	91	14	,	,	PUNCT
eshr-6129	91	15	then	then	ADV
eshr-6129	91	16	the	the	DET
eshr-6129	91	17	pathophysiology	pathophysiology	NOUN
eshr-6129	91	18	of	of	ADP
eshr-6129	91	19	diabetes	diabetes	NOUN
eshr-6129	91	20	progresses	progress	VERB
eshr-6129	91	21	in	in	ADP
eshr-6129	91	22	an	an	DET
eshr-6129	91	23	uncontrolled	uncontrolled	ADJ
eshr-6129	91	24	manner	manner	NOUN
eshr-6129	91	25	leading	lead	VERB
eshr-6129	91	26	to	to	ADP
eshr-6129	91	27	the	the	DET
eshr-6129	91	28	worsening	worsening	NOUN
eshr-6129	91	29	of	of	ADP
eshr-6129	91	30	the	the	DET
eshr-6129	91	31	lipid	lipid	NOUN
eshr-6129	91	32	profile	profile	NOUN
eshr-6129	91	33	.	.	PUNCT
eshr-6129	92	1	riaz	riaz	PROPN
eshr-6129	92	2	(	(	PUNCT
eshr-6129	92	3	correlation	correlation	NOUN
eshr-6129	92	4	between	between	ADP
eshr-6129	92	5	hba1c	hba1c	PROPN
eshr-6129	92	6	and	and	CCONJ
eshr-6129	92	7	lipid	lipid	NOUN
eshr-6129	92	8	profile	profile	NOUN
eshr-6129	92	9	in	in	ADP
eshr-6129	92	10	diabetes	diabetes	NOUN
eshr-6129	92	11	:	:	PUNCT
eshr-6129	92	12	a	a	DET
eshr-6129	92	13	health	health	NOUN
eshr-6129	92	14	concern	concern	NOUN
eshr-6129	92	15	in	in	ADP
eshr-6129	92	16	aseer	aseer	PROPN
eshr-6129	92	17	,	,	PUNCT
eshr-6129	92	18	saudi	saudi	PROPN
eshr-6129	92	19	arabia	arabia	PROPN
eshr-6129	92	20	)	)	PUNCT
eshr-6129	92	21	vol	vol	NOUN
eshr-6129	92	22	.	.	PROPN
eshr-6129	92	23	5	5	NUM
eshr-6129	92	24	,	,	PUNCT
eshr-6129	92	25	no	no	INTJ
eshr-6129	92	26	.	.	NOUN
eshr-6129	92	27	2	2	NUM
eshr-6129	92	28	,	,	PUNCT
eshr-6129	92	29	2023	2023	NUM
eshr-6129	92	30	,	,	PUNCT
eshr-6129	92	31	pp	pp	ADJ
eshr-6129	92	32	.	.	PUNCT
eshr-6129	93	1	60	60	NUM
eshr-6129	93	2	-	-	SYM
eshr-6129	93	3	68	68	NUM
eshr-6129	93	4	66	66	NUM
eshr-6129	93	5	10.26555	10.26555	NUM
eshr-6129	93	6	/	/	SYM
eshr-6129	93	7	eshr.v5i2.6129	eshr.v5i2.6129	PROPN
eshr-6129	93	8	dyslipidemia	dyslipidemia	NOUN
eshr-6129	93	9	increases	increase	VERB
eshr-6129	93	10	the	the	DET
eshr-6129	93	11	risk	risk	NOUN
eshr-6129	93	12	for	for	ADP
eshr-6129	93	13	cardiovascular	cardiovascular	ADJ
eshr-6129	93	14	complications	complication	NOUN
eshr-6129	93	15	mainly	mainly	ADV
eshr-6129	93	16	because	because	SCONJ
eshr-6129	93	17	dyslipidemia	dyslipidemia	NOUN
eshr-6129	93	18	promotes	promote	VERB
eshr-6129	93	19	atherosclerosis	atherosclerosis	NOUN
eshr-6129	93	20	.	.	PUNCT
eshr-6129	94	1	9,10	9,10	NUM
eshr-6129	94	2	high	high	ADJ
eshr-6129	94	3	levels	level	NOUN
eshr-6129	94	4	of	of	ADP
eshr-6129	94	5	low	low	ADJ
eshr-6129	94	6	-	-	PUNCT
eshr-6129	94	7	density	density	NOUN
eshr-6129	94	8	lipoprotein	lipoprotein	NOUN
eshr-6129	94	9	(	(	PUNCT
eshr-6129	94	10	ldl)11	ldl)11	X
eshr-6129	94	11	and	and	CCONJ
eshr-6129	94	12	low	low	ADJ
eshr-6129	94	13	levels	level	NOUN
eshr-6129	94	14	of	of	ADP
eshr-6129	94	15	high	high	ADJ
eshr-6129	94	16	-	-	PUNCT
eshr-6129	94	17	density	density	NOUN
eshr-6129	94	18	lipoprotein	lipoprotein	NOUN
eshr-6129	94	19	(	(	PUNCT
eshr-6129	94	20	hdl)12	hdl)12	PROPN
eshr-6129	94	21	are	be	AUX
eshr-6129	94	22	associated	associate	VERB
eshr-6129	94	23	with	with	ADP
eshr-6129	94	24	myocardial	myocardial	ADJ
eshr-6129	94	25	infarction	infarction	NOUN
eshr-6129	94	26	(	(	PUNCT
eshr-6129	94	27	mi	mi	NOUN
eshr-6129	94	28	)	)	PUNCT
eshr-6129	94	29	and	and	CCONJ
eshr-6129	94	30	stroke.13,14	stroke.13,14	ADV
eshr-6129	94	31	a	a	DET
eshr-6129	94	32	study	study	NOUN
eshr-6129	94	33	by	by	ADP
eshr-6129	94	34	tasneem	tasneem	PROPN
eshr-6129	94	35	et	et	PROPN
eshr-6129	95	1	al	al	PROPN
eshr-6129	95	2	.	.	PROPN
eshr-6129	95	3	also	also	ADV
eshr-6129	95	4	found	find	VERB
eshr-6129	95	5	that	that	SCONJ
eshr-6129	95	6	hba1c	hba1c	PROPN
eshr-6129	95	7	can	can	AUX
eshr-6129	95	8	be	be	AUX
eshr-6129	95	9	used	use	VERB
eshr-6129	95	10	as	as	ADP
eshr-6129	95	11	a	a	DET
eshr-6129	95	12	marker	marker	NOUN
eshr-6129	95	13	for	for	ADP
eshr-6129	95	14	dyslipidemia	dyslipidemia	NOUN
eshr-6129	95	15	and	and	CCONJ
eshr-6129	95	16	to	to	PART
eshr-6129	95	17	screen	screen	VERB
eshr-6129	95	18	patients	patient	NOUN
eshr-6129	95	19	with	with	ADP
eshr-6129	95	20	a	a	DET
eshr-6129	95	21	high	high	ADJ
eshr-6129	95	22	risk	risk	NOUN
eshr-6129	95	23	for	for	ADP
eshr-6129	95	24	cardiovascular	cardiovascular	ADJ
eshr-6129	95	25	complications.15	complications.15	NOUN
eshr-6129	95	26	a	a	DET
eshr-6129	95	27	study	study	NOUN
eshr-6129	95	28	by	by	ADP
eshr-6129	95	29	anderson	anderson	PROPN
eshr-6129	95	30	et	et	PROPN
eshr-6129	95	31	al	al	PROPN
eshr-6129	95	32	.	.	PROPN
eshr-6129	95	33	also	also	ADV
eshr-6129	95	34	showed	show	VERB
eshr-6129	95	35	that	that	SCONJ
eshr-6129	95	36	dyslipidemia	dyslipidemia	NOUN
eshr-6129	95	37	is	be	AUX
eshr-6129	95	38	a	a	DET
eshr-6129	95	39	strong	strong	ADJ
eshr-6129	95	40	predictor	predictor	NOUN
eshr-6129	95	41	of	of	ADP
eshr-6129	95	42	cardiovascular	cardiovascular	ADJ
eshr-6129	95	43	disease.16	disease.16	PROPN
eshr-6129	95	44	dyslipidemia	dyslipidemia	NOUN
eshr-6129	95	45	causes	cause	VERB
eshr-6129	95	46	endothelial	endothelial	ADJ
eshr-6129	95	47	damage17	damage17	NOUN
eshr-6129	95	48	and	and	CCONJ
eshr-6129	95	49	subsequent	subsequent	ADJ
eshr-6129	95	50	loss	loss	NOUN
eshr-6129	95	51	of	of	ADP
eshr-6129	95	52	physiological	physiological	ADJ
eshr-6129	95	53	vasomotor	vasomotor	NOUN
eshr-6129	95	54	activity	activity	NOUN
eshr-6129	95	55	that	that	PRON
eshr-6129	95	56	may	may	AUX
eshr-6129	95	57	manifest	manifest	VERB
eshr-6129	95	58	as	as	ADP
eshr-6129	95	59	increased	increase	VERB
eshr-6129	95	60	blood	blood	NOUN
eshr-6129	95	61	pressure	pressure	NOUN
eshr-6129	95	62	(	(	PUNCT
eshr-6129	95	63	bp).18,19	bp).18,19	NOUN
eshr-6129	95	64	many	many	ADJ
eshr-6129	95	65	studies	study	NOUN
eshr-6129	95	66	have	have	AUX
eshr-6129	95	67	recommended	recommend	VERB
eshr-6129	95	68	treating	treat	VERB
eshr-6129	95	69	dyslipidemia	dyslipidemia	NOUN
eshr-6129	95	70	to	to	PART
eshr-6129	95	71	decrease	decrease	VERB
eshr-6129	95	72	the	the	DET
eshr-6129	95	73	risk	risk	NOUN
eshr-6129	95	74	of	of	ADP
eshr-6129	95	75	cardiovascular	cardiovascular	ADJ
eshr-6129	95	76	diseases	disease	NOUN
eshr-6129	95	77	.	.	PUNCT
eshr-6129	96	1	20,21	20,21	NUM
eshr-6129	96	2	besides	besides	SCONJ
eshr-6129	96	3	cardiovascular	cardiovascular	ADJ
eshr-6129	96	4	complications	complication	NOUN
eshr-6129	96	5	,	,	PUNCT
eshr-6129	96	6	hyperglycemia	hyperglycemia	NOUN
eshr-6129	96	7	and	and	CCONJ
eshr-6129	96	8	dyslipidemia	dyslipidemia	NOUN
eshr-6129	96	9	in	in	ADP
eshr-6129	96	10	diabetes	diabetes	NOUN
eshr-6129	96	11	are	be	AUX
eshr-6129	96	12	also	also	ADV
eshr-6129	96	13	found	find	VERB
eshr-6129	96	14	to	to	PART
eshr-6129	96	15	be	be	AUX
eshr-6129	96	16	associated	associate	VERB
eshr-6129	96	17	with	with	ADP
eshr-6129	96	18	other	other	ADJ
eshr-6129	96	19	complications	complication	NOUN
eshr-6129	96	20	such	such	ADJ
eshr-6129	96	21	as	as	ADP
eshr-6129	96	22	diabetic	diabetic	ADJ
eshr-6129	96	23	retinopathy	retinopathy	NOUN
eshr-6129	96	24	,	,	PUNCT
eshr-6129	96	25	cataract	cataract	NOUN
eshr-6129	96	26	,	,	PUNCT
eshr-6129	96	27	diabetic	diabetic	ADJ
eshr-6129	96	28	nephropathy	nephropathy	NOUN
eshr-6129	96	29	,	,	PUNCT
eshr-6129	96	30	diabetic	diabetic	ADJ
eshr-6129	96	31	foot	foot	NOUN
eshr-6129	96	32	,	,	PUNCT
eshr-6129	96	33	urinary	urinary	ADJ
eshr-6129	96	34	tract	tract	NOUN
eshr-6129	96	35	infections	infection	NOUN
eshr-6129	96	36	,	,	PUNCT
eshr-6129	96	37	skin	skin	NOUN
eshr-6129	96	38	infections	infection	NOUN
eshr-6129	96	39	,	,	PUNCT
eshr-6129	96	40	and	and	CCONJ
eshr-6129	96	41	xanthomas	xanthomas	PROPN
eshr-6129	96	42	.	.	PUNCT
eshr-6129	97	1	thus	thus	ADV
eshr-6129	97	2	,	,	PUNCT
eshr-6129	97	3	it	it	PRON
eshr-6129	97	4	is	be	AUX
eshr-6129	97	5	of	of	ADP
eshr-6129	97	6	great	great	ADJ
eshr-6129	97	7	concern	concern	NOUN
eshr-6129	97	8	to	to	PART
eshr-6129	97	9	control	control	VERB
eshr-6129	97	10	diabetes	diabetes	NOUN
eshr-6129	97	11	by	by	ADP
eshr-6129	97	12	administering	administer	VERB
eshr-6129	97	13	oral	oral	ADJ
eshr-6129	97	14	hypoglycemic	hypoglycemic	ADJ
eshr-6129	97	15	drugs	drug	NOUN
eshr-6129	97	16	,	,	PUNCT
eshr-6129	97	17	insulin	insulin	NOUN
eshr-6129	97	18	,	,	PUNCT
eshr-6129	97	19	and	and	CCONJ
eshr-6129	97	20	lifestyle	lifestyle	NOUN
eshr-6129	97	21	modification	modification	NOUN
eshr-6129	97	22	and	and	CCONJ
eshr-6129	97	23	maintaining	maintain	VERB
eshr-6129	97	24	a	a	DET
eshr-6129	97	25	regular	regular	ADJ
eshr-6129	97	26	follow	follow	NOUN
eshr-6129	97	27	-	-	PUNCT
eshr-6129	97	28	up	up	NOUN
eshr-6129	97	29	of	of	ADP
eshr-6129	97	30	diabetic	diabetic	ADJ
eshr-6129	97	31	patients.22	patients.22	NOUN
eshr-6129	97	32	it	it	PRON
eshr-6129	97	33	is	be	AUX
eshr-6129	97	34	our	our	PRON
eshr-6129	97	35	observation	observation	NOUN
eshr-6129	97	36	that	that	SCONJ
eshr-6129	97	37	diabetes	diabetes	NOUN
eshr-6129	97	38	patients	patient	NOUN
eshr-6129	97	39	are	be	AUX
eshr-6129	97	40	not	not	PART
eshr-6129	97	41	very	very	ADV
eshr-6129	97	42	compliant	compliant	ADJ
eshr-6129	97	43	in	in	ADP
eshr-6129	97	44	taking	take	VERB
eshr-6129	97	45	pharmacological	pharmacological	ADJ
eshr-6129	97	46	treatment	treatment	NOUN
eshr-6129	97	47	regularly	regularly	ADV
eshr-6129	97	48	,	,	PUNCT
eshr-6129	97	49	which	which	PRON
eshr-6129	97	50	might	might	AUX
eshr-6129	97	51	be	be	AUX
eshr-6129	97	52	a	a	DET
eshr-6129	97	53	probable	probable	ADJ
eshr-6129	97	54	reason	reason	NOUN
eshr-6129	97	55	in	in	ADP
eshr-6129	97	56	our	our	PRON
eshr-6129	97	57	study	study	NOUN
eshr-6129	97	58	that	that	SCONJ
eshr-6129	97	59	151	151	NUM
eshr-6129	97	60	out	out	ADP
eshr-6129	97	61	of	of	ADP
eshr-6129	97	62	191	191	NUM
eshr-6129	97	63	diabetes	diabetes	NOUN
eshr-6129	97	64	patients	patient	NOUN
eshr-6129	97	65	(	(	PUNCT
eshr-6129	97	66	79	79	NUM
eshr-6129	97	67	%	%	NOUN
eshr-6129	97	68	)	)	PUNCT
eshr-6129	97	69	had	have	AUX
eshr-6129	97	70	inadequately	inadequately	ADV
eshr-6129	97	71	controlled	control	VERB
eshr-6129	97	72	diabetes	diabetes	NOUN
eshr-6129	97	73	.	.	PUNCT
eshr-6129	98	1	diabetic	diabetic	ADJ
eshr-6129	98	2	patients	patient	NOUN
eshr-6129	98	3	must	must	AUX
eshr-6129	98	4	be	be	AUX
eshr-6129	98	5	thoroughly	thoroughly	ADV
eshr-6129	98	6	counseled	counsel	VERB
eshr-6129	98	7	regarding	regard	VERB
eshr-6129	98	8	the	the	DET
eshr-6129	98	9	importance	importance	NOUN
eshr-6129	98	10	of	of	ADP
eshr-6129	98	11	taking	take	VERB
eshr-6129	98	12	drugs	drug	NOUN
eshr-6129	98	13	regularly	regularly	ADV
eshr-6129	98	14	in	in	ADP
eshr-6129	98	15	appropriate	appropriate	ADJ
eshr-6129	98	16	doses	dose	NOUN
eshr-6129	98	17	.	.	PUNCT
eshr-6129	99	1	though	though	SCONJ
eshr-6129	99	2	drugs	drug	NOUN
eshr-6129	99	3	play	play	VERB
eshr-6129	99	4	an	an	DET
eshr-6129	99	5	indispensable	indispensable	ADJ
eshr-6129	99	6	role	role	NOUN
eshr-6129	99	7	in	in	ADP
eshr-6129	99	8	controlling	control	VERB
eshr-6129	99	9	the	the	DET
eshr-6129	99	10	blood	blood	NOUN
eshr-6129	99	11	sugar	sugar	NOUN
eshr-6129	99	12	level	level	NOUN
eshr-6129	99	13	,	,	PUNCT
eshr-6129	99	14	the	the	DET
eshr-6129	99	15	role	role	NOUN
eshr-6129	99	16	of	of	ADP
eshr-6129	99	17	lifestyle	lifestyle	NOUN
eshr-6129	99	18	modification	modification	NOUN
eshr-6129	99	19	should	should	AUX
eshr-6129	99	20	not	not	PART
eshr-6129	99	21	be	be	AUX
eshr-6129	99	22	overlooked	overlook	VERB
eshr-6129	99	23	in	in	ADP
eshr-6129	99	24	type	type	NOUN
eshr-6129	99	25	2	2	NUM
eshr-6129	99	26	diabetes	diabetes	NOUN
eshr-6129	99	27	mellitus.23	mellitus.23	ADV
eshr-6129	99	28	since	since	SCONJ
eshr-6129	99	29	type	type	NOUN
eshr-6129	99	30	2	2	NUM
eshr-6129	99	31	diabetes	diabetes	NOUN
eshr-6129	99	32	mellitus	mellitus	NOUN
eshr-6129	99	33	is	be	AUX
eshr-6129	99	34	characterized	characterize	VERB
eshr-6129	99	35	by	by	ADP
eshr-6129	99	36	insulin	insulin	NOUN
eshr-6129	99	37	resistance	resistance	NOUN
eshr-6129	99	38	,	,	PUNCT
eshr-6129	99	39	these	these	DET
eshr-6129	99	40	patients	patient	NOUN
eshr-6129	99	41	must	must	AUX
eshr-6129	99	42	be	be	AUX
eshr-6129	99	43	counseled	counsel	VERB
eshr-6129	99	44	and	and	CCONJ
eshr-6129	99	45	encouraged	encourage	VERB
eshr-6129	99	46	by	by	ADP
eshr-6129	99	47	healthcare	healthcare	NOUN
eshr-6129	99	48	practitioners	practitioner	NOUN
eshr-6129	99	49	to	to	PART
eshr-6129	99	50	adopt	adopt	VERB
eshr-6129	99	51	measures	measure	NOUN
eshr-6129	99	52	related	relate	VERB
eshr-6129	99	53	to	to	ADP
eshr-6129	99	54	lifestyle	lifestyle	NOUN
eshr-6129	99	55	modification	modification	NOUN
eshr-6129	99	56	,	,	PUNCT
eshr-6129	99	57	such	such	ADJ
eshr-6129	99	58	as	as	ADP
eshr-6129	99	59	engaging	engage	VERB
eshr-6129	99	60	in	in	ADP
eshr-6129	99	61	daily	daily	ADJ
eshr-6129	99	62	physical	physical	ADJ
eshr-6129	99	63	exercise	exercise	NOUN
eshr-6129	99	64	to	to	PART
eshr-6129	99	65	upregulate	upregulate	VERB
eshr-6129	99	66	the	the	DET
eshr-6129	99	67	peripheral	peripheral	ADJ
eshr-6129	99	68	insulin	insulin	NOUN
eshr-6129	99	69	receptors	receptor	NOUN
eshr-6129	99	70	on	on	ADP
eshr-6129	99	71	the	the	DET
eshr-6129	99	72	cells	cell	NOUN
eshr-6129	99	73	to	to	PART
eshr-6129	99	74	decrease	decrease	VERB
eshr-6129	99	75	the	the	DET
eshr-6129	99	76	insulin	insulin	NOUN
eshr-6129	99	77	resistance	resistance	NOUN
eshr-6129	99	78	in	in	ADP
eshr-6129	99	79	the	the	DET
eshr-6129	99	80	body	body	NOUN
eshr-6129	99	81	which	which	PRON
eshr-6129	99	82	would	would	AUX
eshr-6129	99	83	eventually	eventually	ADV
eshr-6129	99	84	help	help	VERB
eshr-6129	99	85	in	in	ADP
eshr-6129	99	86	controlling	control	VERB
eshr-6129	99	87	the	the	DET
eshr-6129	99	88	blood	blood	NOUN
eshr-6129	99	89	glucose	glucose	NOUN
eshr-6129	99	90	levels.24	levels.24	NOUN
eshr-6129	99	91	these	these	DET
eshr-6129	99	92	patients	patient	NOUN
eshr-6129	99	93	must	must	AUX
eshr-6129	99	94	be	be	AUX
eshr-6129	99	95	explained	explain	VERB
eshr-6129	99	96	about	about	ADP
eshr-6129	99	97	the	the	DET
eshr-6129	99	98	medical	medical	ADJ
eshr-6129	99	99	complications	complication	NOUN
eshr-6129	99	100	associated	associate	VERB
eshr-6129	99	101	with	with	ADP
eshr-6129	99	102	diabetes	diabetes	NOUN
eshr-6129	99	103	mellitus	mellitus	NOUN
eshr-6129	99	104	that	that	SCONJ
eshr-6129	99	105	they	they	PRON
eshr-6129	99	106	are	be	AUX
eshr-6129	99	107	likely	likely	ADJ
eshr-6129	99	108	to	to	PART
eshr-6129	99	109	develop	develop	VERB
eshr-6129	99	110	in	in	ADP
eshr-6129	99	111	the	the	DET
eshr-6129	99	112	future	future	NOUN
eshr-6129	99	113	.	.	PUNCT
eshr-6129	100	1	besides	besides	SCONJ
eshr-6129	100	2	this	this	PRON
eshr-6129	100	3	,	,	PUNCT
eshr-6129	100	4	the	the	DET
eshr-6129	100	5	patients	patient	NOUN
eshr-6129	100	6	should	should	AUX
eshr-6129	100	7	be	be	AUX
eshr-6129	100	8	advised	advise	VERB
eshr-6129	100	9	to	to	PART
eshr-6129	100	10	consume	consume	VERB
eshr-6129	100	11	a	a	DET
eshr-6129	100	12	smaller	small	ADJ
eshr-6129	100	13	number	number	NOUN
eshr-6129	100	14	of	of	ADP
eshr-6129	100	15	meats	meat	NOUN
eshr-6129	100	16	,	,	PUNCT
eshr-6129	100	17	eggs	egg	NOUN
eshr-6129	100	18	,	,	PUNCT
eshr-6129	100	19	and	and	CCONJ
eshr-6129	100	20	oily	oily	ADJ
eshr-6129	100	21	foods	food	NOUN
eshr-6129	100	22	to	to	PART
eshr-6129	100	23	improve	improve	VERB
eshr-6129	100	24	their	their	PRON
eshr-6129	100	25	lipid	lipid	NOUN
eshr-6129	100	26	profile	profile	NOUN
eshr-6129	100	27	further	far	ADV
eshr-6129	100	28	and	and	CCONJ
eshr-6129	100	29	that	that	SCONJ
eshr-6129	100	30	they	they	PRON
eshr-6129	100	31	should	should	AUX
eshr-6129	100	32	avoid	avoid	VERB
eshr-6129	100	33	eating	eat	VERB
eshr-6129	100	34	foods	food	NOUN
eshr-6129	100	35	with	with	ADP
eshr-6129	100	36	high	high	ADJ
eshr-6129	100	37	glycemic	glycemic	ADJ
eshr-6129	100	38	index	index	NOUN
eshr-6129	100	39	and	and	CCONJ
eshr-6129	100	40	must	must	AUX
eshr-6129	100	41	include	include	VERB
eshr-6129	100	42	complex	complex	ADJ
eshr-6129	100	43	carbohydrate	carbohydrate	NOUN
eshr-6129	100	44	-	-	PUNCT
eshr-6129	100	45	rich	rich	ADJ
eshr-6129	100	46	foods	food	NOUN
eshr-6129	100	47	and	and	CCONJ
eshr-6129	100	48	dietary	dietary	ADJ
eshr-6129	100	49	fibers	fiber	NOUN
eshr-6129	100	50	(	(	PUNCT
eshr-6129	100	51	salads	salad	NOUN
eshr-6129	100	52	)	)	PUNCT
eshr-6129	100	53	in	in	ADP
eshr-6129	100	54	their	their	PRON
eshr-6129	100	55	meals	meal	NOUN
eshr-6129	100	56	which	which	PRON
eshr-6129	100	57	would	would	AUX
eshr-6129	100	58	further	far	ADV
eshr-6129	100	59	decrease	decrease	VERB
eshr-6129	100	60	the	the	DET
eshr-6129	100	61	absorption	absorption	NOUN
eshr-6129	100	62	of	of	ADP
eshr-6129	100	63	cholesterol	cholesterol	NOUN
eshr-6129	100	64	from	from	ADP
eshr-6129	100	65	intestine	intestine	NOUN
eshr-6129	100	66	into	into	ADP
eshr-6129	100	67	the	the	DET
eshr-6129	100	68	blood	blood	NOUN
eshr-6129	100	69	.	.	PUNCT
eshr-6129	101	1	the	the	DET
eshr-6129	101	2	patients	patient	NOUN
eshr-6129	101	3	of	of	ADP
eshr-6129	101	4	t2	t2	NOUN
eshr-6129	101	5	dm	dm	NUM
eshr-6129	101	6	must	must	AUX
eshr-6129	101	7	also	also	ADV
eshr-6129	101	8	be	be	AUX
eshr-6129	101	9	motivated	motivate	VERB
eshr-6129	101	10	to	to	PART
eshr-6129	101	11	keep	keep	VERB
eshr-6129	101	12	their	their	PRON
eshr-6129	101	13	body	body	NOUN
eshr-6129	101	14	weight	weight	NOUN
eshr-6129	101	15	in	in	ADP
eshr-6129	101	16	control	control	NOUN
eshr-6129	101	17	and	and	CCONJ
eshr-6129	101	18	self	self	NOUN
eshr-6129	101	19	-	-	PUNCT
eshr-6129	101	20	monitor	monitor	VERB
eshr-6129	101	21	their	their	PRON
eshr-6129	101	22	blood	blood	NOUN
eshr-6129	101	23	pressure	pressure	NOUN
eshr-6129	101	24	and	and	CCONJ
eshr-6129	101	25	blood	blood	NOUN
eshr-6129	101	26	glucose	glucose	NOUN
eshr-6129	101	27	levels	level	NOUN
eshr-6129	101	28	continuously	continuously	ADV
eshr-6129	101	29	by	by	ADP
eshr-6129	101	30	using	use	VERB
eshr-6129	101	31	user	user	NOUN
eshr-6129	101	32	-	-	PUNCT
eshr-6129	101	33	friendly	friendly	ADJ
eshr-6129	101	34	point	point	NOUN
eshr-6129	101	35	-	-	PUNCT
eshr-6129	101	36	of	of	ADP
eshr-6129	101	37	-	-	PUNCT
eshr-6129	101	38	care	care	NOUN
eshr-6129	101	39	testing	testing	NOUN
eshr-6129	101	40	devices	device	NOUN
eshr-6129	101	41	such	such	ADJ
eshr-6129	101	42	as	as	ADP
eshr-6129	101	43	digital	digital	ADJ
eshr-6129	101	44	bp	bp	PROPN
eshr-6129	101	45	apparatus	apparatus	NOUN
eshr-6129	101	46	and	and	CCONJ
eshr-6129	101	47	glucometers.25	glucometers.25	VERB
eshr-6129	101	48	since	since	SCONJ
eshr-6129	101	49	studies	study	NOUN
eshr-6129	101	50	conducted	conduct	VERB
eshr-6129	101	51	at	at	ADP
eshr-6129	101	52	a	a	DET
eshr-6129	101	53	primary	primary	ADJ
eshr-6129	101	54	health	health	NOUN
eshr-6129	101	55	care	care	NOUN
eshr-6129	101	56	center	center	NOUN
eshr-6129	101	57	in	in	ADP
eshr-6129	101	58	saudi	saudi	PROPN
eshr-6129	101	59	arabia	arabia	PROPN
eshr-6129	101	60	are	be	AUX
eshr-6129	101	61	minimal	minimal	ADJ
eshr-6129	101	62	,	,	PUNCT
eshr-6129	101	63	our	our	PRON
eshr-6129	101	64	research	research	NOUN
eshr-6129	101	65	data	datum	NOUN
eshr-6129	101	66	has	have	VERB
eshr-6129	101	67	substantial	substantial	ADJ
eshr-6129	101	68	value	value	NOUN
eshr-6129	101	69	in	in	ADP
eshr-6129	101	70	formulating	formulate	VERB
eshr-6129	101	71	health	health	NOUN
eshr-6129	101	72	policies	policy	NOUN
eshr-6129	101	73	for	for	ADP
eshr-6129	101	74	the	the	DET
eshr-6129	101	75	local	local	ADJ
eshr-6129	101	76	population	population	NOUN
eshr-6129	101	77	to	to	PART
eshr-6129	101	78	ensure	ensure	VERB
eshr-6129	101	79	reasonable	reasonable	ADJ
eshr-6129	101	80	control	control	NOUN
eshr-6129	101	81	over	over	ADP
eshr-6129	101	82	diabetes	diabetes	NOUN
eshr-6129	101	83	mellitus	mellitus	NOUN
eshr-6129	101	84	.	.	PUNCT
eshr-6129	102	1	conclusion	conclusion	NOUN
eshr-6129	102	2	type	type	NOUN
eshr-6129	102	3	2	2	NUM
eshr-6129	102	4	diabetes	diabetes	NOUN
eshr-6129	102	5	mellitus	mellitus	NOUN
eshr-6129	102	6	patients	patient	NOUN
eshr-6129	102	7	presenting	present	VERB
eshr-6129	102	8	at	at	ADP
eshr-6129	102	9	the	the	DET
eshr-6129	102	10	primary	primary	ADJ
eshr-6129	102	11	health	health	NOUN
eshr-6129	102	12	care	care	NOUN
eshr-6129	102	13	center	center	NOUN
eshr-6129	102	14	of	of	ADP
eshr-6129	102	15	the	the	DET
eshr-6129	102	16	aseer	aseer	PROPN
eshr-6129	102	17	region	region	NOUN
eshr-6129	102	18	were	be	AUX
eshr-6129	102	19	found	find	VERB
eshr-6129	102	20	to	to	PART
eshr-6129	102	21	be	be	AUX
eshr-6129	102	22	obese	obese	ADJ
eshr-6129	102	23	,	,	PUNCT
eshr-6129	102	24	with	with	ADP
eshr-6129	102	25	52	52	NUM
eshr-6129	102	26	%	%	NOUN
eshr-6129	102	27	of	of	ADP
eshr-6129	102	28	cases	case	NOUN
eshr-6129	102	29	having	have	VERB
eshr-6129	102	30	concomitant	concomitant	ADJ
eshr-6129	102	31	hypertension	hypertension	NOUN
eshr-6129	102	32	.	.	PUNCT
eshr-6129	103	1	despite	despite	SCONJ
eshr-6129	103	2	taking	take	VERB
eshr-6129	103	3	oral	oral	ADJ
eshr-6129	103	4	hypoglycemic	hypoglycemic	ADJ
eshr-6129	103	5	drugs	drug	NOUN
eshr-6129	103	6	and	and	CCONJ
eshr-6129	103	7	insulin	insulin	NOUN
eshr-6129	103	8	,	,	PUNCT
eshr-6129	103	9	these	these	DET
eshr-6129	103	10	patients	patient	NOUN
eshr-6129	103	11	showed	show	VERB
eshr-6129	103	12	a	a	DET
eshr-6129	103	13	deranged	deranged	ADJ
eshr-6129	103	14	glycemic	glycemic	ADJ
eshr-6129	103	15	and	and	CCONJ
eshr-6129	103	16	lipid	lipid	NOUN
eshr-6129	103	17	profile	profile	NOUN
eshr-6129	103	18	.	.	PUNCT
eshr-6129	104	1	patients	patient	NOUN
eshr-6129	104	2	of	of	ADP
eshr-6129	104	3	t2	t2	NOUN
eshr-6129	104	4	dm	dm	NOUN
eshr-6129	104	5	in	in	ADP
eshr-6129	104	6	the	the	DET
eshr-6129	104	7	aseer	aseer	PROPN
eshr-6129	104	8	region	region	NOUN
eshr-6129	104	9	of	of	ADP
eshr-6129	104	10	saudi	saudi	PROPN
eshr-6129	104	11	arabia	arabia	PROPN
eshr-6129	104	12	must	must	AUX
eshr-6129	104	13	be	be	AUX
eshr-6129	104	14	regularly	regularly	ADV
eshr-6129	104	15	followed	follow	VERB
eshr-6129	104	16	up	up	ADP
eshr-6129	104	17	to	to	PART
eshr-6129	104	18	review	review	VERB
eshr-6129	104	19	the	the	DET
eshr-6129	104	20	ongoing	ongoing	ADJ
eshr-6129	104	21	drug	drug	NOUN
eshr-6129	104	22	therapy	therapy	NOUN
eshr-6129	104	23	and	and	CCONJ
eshr-6129	104	24	its	its	PRON
eshr-6129	104	25	compliance	compliance	NOUN
eshr-6129	104	26	so	so	SCONJ
eshr-6129	104	27	that	that	SCONJ
eshr-6129	104	28	glycemic	glycemic	ADJ
eshr-6129	104	29	and	and	CCONJ
eshr-6129	104	30	lipid	lipid	NOUN
eshr-6129	104	31	profiles	profile	NOUN
eshr-6129	104	32	can	can	AUX
eshr-6129	104	33	be	be	AUX
eshr-6129	104	34	adequately	adequately	ADV
eshr-6129	104	35	controlled	control	VERB
eshr-6129	104	36	,	,	PUNCT
eshr-6129	104	37	given	give	VERB
eshr-6129	104	38	the	the	DET
eshr-6129	104	39	impending	impending	ADJ
eshr-6129	104	40	risk	risk	NOUN
eshr-6129	104	41	of	of	ADP
eshr-6129	104	42	complications	complication	NOUN
eshr-6129	104	43	associated	associate	VERB
eshr-6129	104	44	with	with	ADP
eshr-6129	104	45	riaz	riaz	PROPN
eshr-6129	104	46	(	(	PUNCT
eshr-6129	104	47	correlation	correlation	NOUN
eshr-6129	104	48	between	between	ADP
eshr-6129	104	49	hba1c	hba1c	PROPN
eshr-6129	104	50	and	and	CCONJ
eshr-6129	104	51	lipid	lipid	NOUN
eshr-6129	104	52	profile	profile	NOUN
eshr-6129	104	53	in	in	ADP
eshr-6129	104	54	diabetes	diabetes	NOUN
eshr-6129	104	55	:	:	PUNCT
eshr-6129	104	56	a	a	DET
eshr-6129	104	57	health	health	NOUN
eshr-6129	104	58	concern	concern	NOUN
eshr-6129	104	59	in	in	ADP
eshr-6129	104	60	aseer	aseer	PROPN
eshr-6129	104	61	,	,	PUNCT
eshr-6129	104	62	saudi	saudi	PROPN
eshr-6129	104	63	arabia	arabia	PROPN
eshr-6129	104	64	)	)	PUNCT
eshr-6129	104	65	vol	vol	NOUN
eshr-6129	104	66	.	.	PROPN
eshr-6129	105	1	5	5	NUM
eshr-6129	105	2	,	,	PUNCT
eshr-6129	105	3	no	no	INTJ
eshr-6129	105	4	.	.	NOUN
eshr-6129	105	5	2	2	NUM
eshr-6129	105	6	,	,	PUNCT
eshr-6129	105	7	2023	2023	NUM
eshr-6129	105	8	,	,	PUNCT
eshr-6129	105	9	pp	pp	ADJ
eshr-6129	105	10	.	.	PUNCT
eshr-6129	106	1	60	60	NUM
eshr-6129	106	2	-	-	SYM
eshr-6129	106	3	68	68	NUM
eshr-6129	106	4	67	67	NUM
eshr-6129	106	5	10.26555	10.26555	NUM
eshr-6129	106	6	/	/	SYM
eshr-6129	106	7	eshr.v5i2.6129	eshr.v5i2.6129	PROPN
eshr-6129	106	8	t2	t2	NOUN
eshr-6129	106	9	dm	dm	PROPN
eshr-6129	106	10	.	.	PUNCT
eshr-6129	107	1	the	the	DET
eshr-6129	107	2	authors	author	NOUN
eshr-6129	107	3	also	also	ADV
eshr-6129	107	4	recommend	recommend	VERB
eshr-6129	107	5	that	that	DET
eshr-6129	107	6	thorough	thorough	ADJ
eshr-6129	107	7	counseling	counseling	NOUN
eshr-6129	107	8	of	of	ADP
eshr-6129	107	9	these	these	DET
eshr-6129	107	10	patients	patient	NOUN
eshr-6129	107	11	regarding	regard	VERB
eshr-6129	107	12	lifestyle	lifestyle	NOUN
eshr-6129	107	13	management	management	NOUN
eshr-6129	107	14	measures	measure	NOUN
eshr-6129	107	15	might	might	AUX
eshr-6129	107	16	be	be	AUX
eshr-6129	107	17	helpful	helpful	ADJ
eshr-6129	107	18	.	.	PUNCT
eshr-6129	108	1	acknowledgment	acknowledgment	NOUN
eshr-6129	108	2	the	the	DET
eshr-6129	108	3	authors	author	NOUN
eshr-6129	108	4	thank	thank	VERB
eshr-6129	108	5	the	the	DET
eshr-6129	108	6	nursing	nursing	NOUN
eshr-6129	108	7	staff	staff	NOUN
eshr-6129	108	8	working	work	VERB
eshr-6129	108	9	at	at	ADP
eshr-6129	108	10	a	a	DET
eshr-6129	108	11	primary	primary	ADJ
eshr-6129	108	12	health	health	NOUN
eshr-6129	108	13	care	care	NOUN
eshr-6129	108	14	center	center	NOUN
eshr-6129	108	15	for	for	ADP
eshr-6129	108	16	assisting	assist	VERB
eshr-6129	108	17	in	in	ADP
eshr-6129	108	18	data	datum	NOUN
eshr-6129	108	19	collection	collection	NOUN
eshr-6129	108	20	for	for	ADP
eshr-6129	108	21	this	this	DET
eshr-6129	108	22	study	study	NOUN
eshr-6129	108	23	.	.	PUNCT
eshr-6129	109	1	declarations	declaration	NOUN
eshr-6129	109	2	authors	author	NOUN
eshr-6129	109	3	'	'	PART
eshr-6129	109	4	contribution	contribution	NOUN
eshr-6129	109	5	fr	fr	PROPN
eshr-6129	109	6	designed	design	VERB
eshr-6129	109	7	the	the	DET
eshr-6129	109	8	study	study	NOUN
eshr-6129	109	9	,	,	PUNCT
eshr-6129	109	10	collected	collect	VERB
eshr-6129	109	11	the	the	DET
eshr-6129	109	12	data	datum	NOUN
eshr-6129	109	13	,	,	PUNCT
eshr-6129	109	14	and	and	CCONJ
eshr-6129	109	15	reviewed	review	VERB
eshr-6129	109	16	and	and	CCONJ
eshr-6129	109	17	edited	edit	VERB
eshr-6129	109	18	the	the	DET
eshr-6129	109	19	manuscript	manuscript	NOUN
eshr-6129	109	20	.	.	PUNCT
eshr-6129	110	1	an	an	DET
eshr-6129	110	2	statistically	statistically	ADV
eshr-6129	110	3	analyzed	analyze	VERB
eshr-6129	110	4	the	the	DET
eshr-6129	110	5	data	datum	NOUN
eshr-6129	110	6	,	,	PUNCT
eshr-6129	110	7	prepared	prepare	VERB
eshr-6129	110	8	the	the	DET
eshr-6129	110	9	result	result	NOUN
eshr-6129	110	10	,	,	PUNCT
eshr-6129	110	11	and	and	CCONJ
eshr-6129	110	12	wrote	write	VERB
eshr-6129	110	13	the	the	DET
eshr-6129	110	14	manuscript	manuscript	NOUN
eshr-6129	110	15	.	.	PUNCT
eshr-6129	111	1	funding	funding	NOUN
eshr-6129	111	2	statement	statement	NOUN
eshr-6129	111	3	this	this	DET
eshr-6129	111	4	research	research	NOUN
eshr-6129	111	5	has	have	AUX
eshr-6129	111	6	not	not	PART
eshr-6129	111	7	received	receive	VERB
eshr-6129	111	8	external	external	ADJ
eshr-6129	111	9	funding	funding	NOUN
eshr-6129	111	10	.	.	PUNCT
eshr-6129	112	1	conflict	conflict	NOUN
eshr-6129	112	2	of	of	ADP
eshr-6129	112	3	interest	interest	NOUN
eshr-6129	112	4	there	there	PRON
eshr-6129	112	5	is	be	VERB
eshr-6129	112	6	no	no	DET
eshr-6129	112	7	conflict	conflict	NOUN
eshr-6129	112	8	of	of	ADP
eshr-6129	112	9	interest	interest	NOUN
eshr-6129	112	10	in	in	ADP
eshr-6129	112	11	this	this	DET
eshr-6129	112	12	research	research	NOUN
eshr-6129	112	13	.	.	PUNCT
eshr-6129	113	1	references	reference	NOUN
eshr-6129	113	2	1	1	NUM
eshr-6129	113	3	.	.	PUNCT
eshr-6129	113	4	international	international	ADJ
eshr-6129	113	5	diabetes	diabetes	PROPN
eshr-6129	113	6	federation	federation	PROPN
eshr-6129	113	7	.	.	PUNCT
eshr-6129	114	1	idf	idf	PROPN
eshr-6129	114	2	diabetes	diabetes	PROPN
eshr-6129	114	3	atlas	atlas	PROPN
eshr-6129	114	4	,	,	PUNCT
eshr-6129	114	5	10th	10th	ADJ
eshr-6129	114	6	edition	edition	NOUN
eshr-6129	114	7	.	.	PUNCT
eshr-6129	114	8	2021	2021	NUM
eshr-6129	114	9	.	.	PUNCT
eshr-6129	115	1	2	2	X
eshr-6129	115	2	.	.	X
eshr-6129	115	3	meo	meo	PROPN
eshr-6129	115	4	sa	sa	PROPN
eshr-6129	115	5	,	,	PUNCT
eshr-6129	115	6	usmani	usmani	PROPN
eshr-6129	115	7	am	be	AUX
eshr-6129	115	8	,	,	PUNCT
eshr-6129	115	9	qalbani	qalbani	PROPN
eshr-6129	115	10	e.	e.	PROPN
eshr-6129	115	11	prevalence	prevalence	NOUN
eshr-6129	115	12	of	of	ADP
eshr-6129	115	13	type	type	NOUN
eshr-6129	115	14	2	2	NUM
eshr-6129	115	15	diabetes	diabetes	NOUN
eshr-6129	115	16	in	in	ADP
eshr-6129	115	17	the	the	DET
eshr-6129	115	18	arab	arab	ADJ
eshr-6129	115	19	world	world	NOUN
eshr-6129	115	20	:	:	PUNCT
eshr-6129	115	21	impact	impact	NOUN
eshr-6129	115	22	of	of	ADP
eshr-6129	115	23	gdp	gdp	NOUN
eshr-6129	115	24	and	and	CCONJ
eshr-6129	115	25	energy	energy	NOUN
eshr-6129	115	26	consumption	consumption	NOUN
eshr-6129	115	27	.	.	PUNCT
eshr-6129	116	1	eur	eur	PROPN
eshr-6129	116	2	rev	rev	PROPN
eshr-6129	116	3	med	med	PROPN
eshr-6129	116	4	pharmacol	pharmacol	PROPN
eshr-6129	116	5	sci	sci	PROPN
eshr-6129	116	6	.	.	PROPN
eshr-6129	116	7	2017;21(6):1303–12	2017;21(6):1303–12	NOUN
eshr-6129	116	8	.	.	PUNCT
eshr-6129	117	1	3	3	X
eshr-6129	117	2	.	.	X
eshr-6129	117	3	al	al	PROPN
eshr-6129	117	4	dawish	dawish	PROPN
eshr-6129	117	5	m	m	PROPN
eshr-6129	117	6	,	,	PUNCT
eshr-6129	117	7	robert	robert	PROPN
eshr-6129	117	8	a	a	PROPN
eshr-6129	117	9	,	,	PUNCT
eshr-6129	117	10	braham	braham	PROPN
eshr-6129	117	11	r	r	PROPN
eshr-6129	117	12	,	,	PUNCT
eshr-6129	117	13	al	al	PROPN
eshr-6129	117	14	hayek	hayek	PROPN
eshr-6129	117	15	a	a	PROPN
eshr-6129	117	16	,	,	PUNCT
eshr-6129	117	17	al	al	PROPN
eshr-6129	117	18	saeed	saeed	PROPN
eshr-6129	117	19	a	a	PROPN
eshr-6129	117	20	,	,	PUNCT
eshr-6129	117	21	ahmed	ahmed	PROPN
eshr-6129	117	22	r	r	PROPN
eshr-6129	117	23	,	,	PUNCT
eshr-6129	117	24	et	et	PROPN
eshr-6129	117	25	al	al	PROPN
eshr-6129	117	26	.	.	PROPN
eshr-6129	118	1	diabetes	diabete	VERB
eshr-6129	118	2	mellitus	mellitus	NOUN
eshr-6129	118	3	in	in	ADP
eshr-6129	118	4	saudi	saudi	PROPN
eshr-6129	118	5	arabia	arabia	PROPN
eshr-6129	118	6	:	:	PUNCT
eshr-6129	118	7	a	a	DET
eshr-6129	118	8	review	review	NOUN
eshr-6129	118	9	of	of	ADP
eshr-6129	118	10	the	the	DET
eshr-6129	118	11	recent	recent	ADJ
eshr-6129	118	12	literature	literature	NOUN
eshr-6129	118	13	.	.	PUNCT
eshr-6129	119	1	curr	curr	PROPN
eshr-6129	119	2	diabetes	diabetes	PROPN
eshr-6129	119	3	rev	rev	VERB
eshr-6129	119	4	.	.	PUNCT
eshr-6129	120	1	2016;12(4):359–68	2016;12(4):359–68	NUM
eshr-6129	120	2	.	.	NOUN
eshr-6129	120	3	4	4	NUM
eshr-6129	120	4	.	.	AUX
eshr-6129	120	5	faselis	faselis	PROPN
eshr-6129	120	6	c	c	PROPN
eshr-6129	120	7	,	,	PUNCT
eshr-6129	120	8	katsimardou	katsimardou	ADV
eshr-6129	120	9	a	a	X
eshr-6129	120	10	,	,	PUNCT
eshr-6129	120	11	imprialos	imprialos	X
eshr-6129	120	12	k	k	PROPN
eshr-6129	120	13	,	,	PUNCT
eshr-6129	120	14	deligkaris	deligkaris	VERB
eshr-6129	120	15	p	p	PRON
eshr-6129	120	16	,	,	PUNCT
eshr-6129	120	17	kallistratos	kallistratos	PROPN
eshr-6129	120	18	m	m	PROPN
eshr-6129	120	19	,	,	PUNCT
eshr-6129	120	20	dimitriadis	dimitriadis	VERB
eshr-6129	120	21	k.	k.	NOUN
eshr-6129	120	22	microvascular	microvascular	PROPN
eshr-6129	120	23	complications	complication	NOUN
eshr-6129	120	24	of	of	ADP
eshr-6129	120	25	type	type	NOUN
eshr-6129	120	26	2	2	NUM
eshr-6129	120	27	diabetes	diabetes	NOUN
eshr-6129	120	28	mellitus	mellitus	NOUN
eshr-6129	120	29	.	.	PUNCT
eshr-6129	121	1	curr	curr	PROPN
eshr-6129	121	2	vasc	vasc	PROPN
eshr-6129	121	3	pharmacol	pharmacol	PROPN
eshr-6129	121	4	.	.	PUNCT
eshr-6129	122	1	2020;18(2):117–24	2020;18(2):117–24	NUM
eshr-6129	122	2	.	.	PUNCT
eshr-6129	123	1	5	5	NUM
eshr-6129	123	2	.	.	PUNCT
eshr-6129	123	3	wang	wang	PROPN
eshr-6129	123	4	y	y	PROPN
eshr-6129	123	5	,	,	PUNCT
eshr-6129	123	6	beydoun	beydoun	PROPN
eshr-6129	123	7	m.	m.	NOUN
eshr-6129	123	8	meat	meat	NOUN
eshr-6129	123	9	consumption	consumption	NOUN
eshr-6129	123	10	is	be	AUX
eshr-6129	123	11	associated	associate	VERB
eshr-6129	123	12	with	with	ADP
eshr-6129	123	13	obesity	obesity	NOUN
eshr-6129	123	14	and	and	CCONJ
eshr-6129	123	15	central	central	ADJ
eshr-6129	123	16	obesity	obesity	NOUN
eshr-6129	123	17	among	among	ADP
eshr-6129	123	18	us	us	PROPN
eshr-6129	123	19	adults	adult	NOUN
eshr-6129	123	20	.	.	PUNCT
eshr-6129	124	1	int	int	NOUN
eshr-6129	124	2	j	j	PROPN
eshr-6129	124	3	obes	obes	PROPN
eshr-6129	124	4	.	.	PUNCT
eshr-6129	125	1	2009;33(6):621–8	2009;33(6):621–8	NUM
eshr-6129	125	2	.	.	PUNCT
eshr-6129	126	1	6	6	NUM
eshr-6129	126	2	.	.	X
eshr-6129	126	3	bays	bay	NOUN
eshr-6129	126	4	he	he	PRON
eshr-6129	126	5	,	,	PUNCT
eshr-6129	126	6	toth	toth	PROPN
eshr-6129	126	7	pp	pp	PROPN
eshr-6129	126	8	,	,	PUNCT
eshr-6129	126	9	kris	kris	PROPN
eshr-6129	126	10	-	-	PUNCT
eshr-6129	126	11	etherton	etherton	PROPN
eshr-6129	126	12	pm	pm	NOUN
eshr-6129	126	13	,	,	PUNCT
eshr-6129	126	14	abate	abate	VERB
eshr-6129	126	15	n	n	PRON
eshr-6129	126	16	,	,	PUNCT
eshr-6129	126	17	aronne	aronne	PROPN
eshr-6129	126	18	lj	lj	PROPN
eshr-6129	126	19	,	,	PUNCT
eshr-6129	126	20	brown	brown	PROPN
eshr-6129	126	21	wv	wv	PROPN
eshr-6129	126	22	,	,	PUNCT
eshr-6129	126	23	et	et	PROPN
eshr-6129	126	24	al	al	PROPN
eshr-6129	126	25	.	.	PUNCT
eshr-6129	127	1	obesity	obesity	NOUN
eshr-6129	127	2	,	,	PUNCT
eshr-6129	127	3	adiposity	adiposity	NOUN
eshr-6129	127	4	,	,	PUNCT
eshr-6129	127	5	and	and	CCONJ
eshr-6129	127	6	dyslipidemia	dyslipidemia	VERB
eshr-6129	127	7	:	:	PUNCT
eshr-6129	127	8	a	a	DET
eshr-6129	127	9	consensus	consensus	NOUN
eshr-6129	127	10	statement	statement	NOUN
eshr-6129	127	11	from	from	ADP
eshr-6129	127	12	the	the	DET
eshr-6129	127	13	national	national	PROPN
eshr-6129	127	14	lipid	lipid	PROPN
eshr-6129	127	15	association	association	PROPN
eshr-6129	127	16	.	.	PUNCT
eshr-6129	128	1	j	j	PROPN
eshr-6129	128	2	clin	clin	PROPN
eshr-6129	128	3	lipidol	lipidol	VERB
eshr-6129	128	4	.	.	PUNCT
eshr-6129	129	1	2013;7(4):304–83	2013;7(4):304–83	NUM
eshr-6129	129	2	.	.	NOUN
eshr-6129	129	3	7	7	X
eshr-6129	129	4	.	.	PUNCT
eshr-6129	129	5	cercato	cercato	PROPN
eshr-6129	129	6	c	c	PROPN
eshr-6129	129	7	,	,	PUNCT
eshr-6129	129	8	fonseca	fonseca	PROPN
eshr-6129	129	9	fa	fa	PROPN
eshr-6129	129	10	.	.	PUNCT
eshr-6129	129	11	cardiovascular	cardiovascular	ADJ
eshr-6129	129	12	risk	risk	NOUN
eshr-6129	129	13	and	and	CCONJ
eshr-6129	129	14	obesity	obesity	NOUN
eshr-6129	129	15	.	.	PUNCT
eshr-6129	130	1	diabetol	diabetol	VERB
eshr-6129	130	2	metab	metab	ADJ
eshr-6129	130	3	syndr	syndr	NOUN
eshr-6129	130	4	.	.	PUNCT
eshr-6129	131	1	2019;11(1):1–15	2019;11(1):1–15	NUM
eshr-6129	131	2	.	.	NOUN
eshr-6129	132	1	8	8	NUM
eshr-6129	132	2	.	.	PUNCT
eshr-6129	133	1	fuchs	fuchs	PROPN
eshr-6129	133	2	fd	fd	PROPN
eshr-6129	133	3	,	,	PUNCT
eshr-6129	133	4	whelton	whelton	PROPN
eshr-6129	133	5	pk	pk	PROPN
eshr-6129	133	6	.	.	PROPN
eshr-6129	133	7	high	high	ADJ
eshr-6129	133	8	blood	blood	NOUN
eshr-6129	133	9	pressure	pressure	NOUN
eshr-6129	133	10	and	and	CCONJ
eshr-6129	133	11	cardiovascular	cardiovascular	ADJ
eshr-6129	133	12	disease	disease	NOUN
eshr-6129	133	13	.	.	PUNCT
eshr-6129	134	1	hypertension	hypertension	NOUN
eshr-6129	134	2	.	.	PUNCT
eshr-6129	135	1	2020;(cvd):285–92	2020;(cvd):285–92	X
eshr-6129	135	2	.	.	PUNCT
eshr-6129	136	1	9	9	X
eshr-6129	136	2	.	.	X
eshr-6129	136	3	pedersen	pedersen	PROPN
eshr-6129	136	4	t	t	PROPN
eshr-6129	136	5	,	,	PUNCT
eshr-6129	136	6	kjekshus	kjekshus	PROPN
eshr-6129	136	7	j	j	PROPN
eshr-6129	136	8	,	,	PUNCT
eshr-6129	136	9	berg	berg	PROPN
eshr-6129	136	10	k	k	PROPN
eshr-6129	136	11	,	,	PUNCT
eshr-6129	136	12	haghfelt	haghfelt	VERB
eshr-6129	136	13	t	t	PROPN
eshr-6129	136	14	,	,	PUNCT
eshr-6129	136	15	faergeman	faergeman	NOUN
eshr-6129	136	16	o	o	NOUN
eshr-6129	136	17	,	,	PUNCT
eshr-6129	136	18	faergeman	faergeman	NOUN
eshr-6129	136	19	g	g	PROPN
eshr-6129	136	20	,	,	PUNCT
eshr-6129	136	21	et	et	PROPN
eshr-6129	136	22	al	al	PROPN
eshr-6129	136	23	.	.	PUNCT
eshr-6129	137	1	scandinavian	scandinavian	ADJ
eshr-6129	137	2	simvastatin	simvastatin	PROPN
eshr-6129	137	3	survival	survival	PROPN
eshr-6129	137	4	study	study	PROPN
eshr-6129	137	5	group	group	NOUN
eshr-6129	137	6	.	.	PUNCT
eshr-6129	138	1	randomised	randomise	VERB
eshr-6129	138	2	trial	trial	NOUN
eshr-6129	138	3	of	of	ADP
eshr-6129	138	4	cholesterol	cholesterol	NOUN
eshr-6129	138	5	lowering	lower	VERB
eshr-6129	138	6	in	in	ADP
eshr-6129	138	7	4444	4444	NUM
eshr-6129	138	8	patients	patient	NOUN
eshr-6129	138	9	with	with	ADP
eshr-6129	138	10	coronary	coronary	ADJ
eshr-6129	138	11	heart	heart	NOUN
eshr-6129	138	12	disease	disease	NOUN
eshr-6129	138	13	:	:	PUNCT
eshr-6129	138	14	the	the	DET
eshr-6129	138	15	scandinavian	scandinavian	ADJ
eshr-6129	138	16	simvastatin	simvastatin	PROPN
eshr-6129	138	17	survival	survival	PROPN
eshr-6129	138	18	study	study	PROPN
eshr-6129	138	19	(	(	PUNCT
eshr-6129	138	20	4s	4s	NUM
eshr-6129	138	21	)	)	PUNCT
eshr-6129	138	22	.	.	PUNCT
eshr-6129	139	1	j	j	PROPN
eshr-6129	139	2	atheroscler	atheroscler	PROPN
eshr-6129	139	3	.	.	PUNCT
eshr-6129	140	1	1994;5(3):81–7	1994;5(3):81–7	NUM
eshr-6129	140	2	.	.	PUNCT
eshr-6129	141	1	10	10	NUM
eshr-6129	141	2	.	.	X
eshr-6129	142	1	wong	wong	PROPN
eshr-6129	142	2	nd	nd	PROPN
eshr-6129	142	3	.	.	PROPN
eshr-6129	142	4	epidemiological	epidemiological	ADJ
eshr-6129	142	5	studies	study	NOUN
eshr-6129	142	6	of	of	ADP
eshr-6129	142	7	chd	chd	PROPN
eshr-6129	142	8	and	and	CCONJ
eshr-6129	142	9	the	the	DET
eshr-6129	142	10	evolution	evolution	NOUN
eshr-6129	142	11	of	of	ADP
eshr-6129	142	12	preventive	preventive	ADJ
eshr-6129	142	13	cardiology	cardiology	NOUN
eshr-6129	142	14	.	.	PUNCT
eshr-6129	143	1	nat	nat	PROPN
eshr-6129	143	2	rev	rev	PROPN
eshr-6129	143	3	cardiol	cardiol	NOUN
eshr-6129	143	4	.	.	PUNCT
eshr-6129	144	1	2014;11(5):276–89	2014;11(5):276–89	X
eshr-6129	144	2	.	.	NOUN
eshr-6129	144	3	11	11	NUM
eshr-6129	144	4	.	.	PUNCT
eshr-6129	144	5	berliner	berliner	PROPN
eshr-6129	144	6	j	j	PROPN
eshr-6129	144	7	,	,	PUNCT
eshr-6129	144	8	navab	navab	PROPN
eshr-6129	144	9	m	m	PROPN
eshr-6129	144	10	,	,	PUNCT
eshr-6129	144	11	fogelman	fogelman	NOUN
eshr-6129	144	12	a	a	PRON
eshr-6129	144	13	,	,	PUNCT
eshr-6129	144	14	frank	frank	PROPN
eshr-6129	144	15	j	j	PROPN
eshr-6129	144	16	,	,	PUNCT
eshr-6129	144	17	demer	demer	PROPN
eshr-6129	144	18	l	l	PROPN
eshr-6129	144	19	,	,	PUNCT
eshr-6129	144	20	edwards	edwards	PROPN
eshr-6129	144	21	p	p	PROPN
eshr-6129	144	22	,	,	PUNCT
eshr-6129	144	23	et	et	PROPN
eshr-6129	144	24	al	al	PROPN
eshr-6129	144	25	.	.	PUNCT
eshr-6129	144	26	atherosclerosis	atherosclerosis	NOUN
eshr-6129	144	27	:	:	PUNCT
eshr-6129	144	28	basic	basic	ADJ
eshr-6129	144	29	mechanisms	mechanism	NOUN
eshr-6129	144	30	oxidation	oxidation	NOUN
eshr-6129	144	31	,	,	PUNCT
eshr-6129	144	32	inflammation	inflammation	NOUN
eshr-6129	144	33	,	,	PUNCT
eshr-6129	144	34	and	and	CCONJ
eshr-6129	144	35	genetics	genetic	NOUN
eshr-6129	144	36	.	.	PUNCT
eshr-6129	145	1	circulation	circulation	NOUN
eshr-6129	145	2	.	.	PUNCT
eshr-6129	146	1	1995;91(9):2488	1995;91(9):2488	NUM
eshr-6129	146	2	–	–	PUNCT
eshr-6129	146	3	96	96	NUM
eshr-6129	146	4	.	.	PUNCT
eshr-6129	147	1	riaz	riaz	PROPN
eshr-6129	147	2	(	(	PUNCT
eshr-6129	147	3	correlation	correlation	NOUN
eshr-6129	147	4	between	between	ADP
eshr-6129	147	5	hba1c	hba1c	PROPN
eshr-6129	147	6	and	and	CCONJ
eshr-6129	147	7	lipid	lipid	NOUN
eshr-6129	147	8	profile	profile	NOUN
eshr-6129	147	9	in	in	ADP
eshr-6129	147	10	diabetes	diabetes	NOUN
eshr-6129	147	11	:	:	PUNCT
eshr-6129	147	12	a	a	DET
eshr-6129	147	13	health	health	NOUN
eshr-6129	147	14	concern	concern	NOUN
eshr-6129	147	15	in	in	ADP
eshr-6129	147	16	aseer	aseer	PROPN
eshr-6129	147	17	,	,	PUNCT
eshr-6129	147	18	saudi	saudi	PROPN
eshr-6129	147	19	arabia	arabia	PROPN
eshr-6129	147	20	)	)	PUNCT
eshr-6129	147	21	vol	vol	NOUN
eshr-6129	147	22	.	.	PROPN
eshr-6129	147	23	5	5	NUM
eshr-6129	147	24	,	,	PUNCT
eshr-6129	147	25	no	no	INTJ
eshr-6129	147	26	.	.	NOUN
eshr-6129	147	27	2	2	NUM
eshr-6129	147	28	,	,	PUNCT
eshr-6129	147	29	2023	2023	NUM
eshr-6129	147	30	,	,	PUNCT
eshr-6129	147	31	pp	pp	ADJ
eshr-6129	147	32	.	.	PUNCT
eshr-6129	148	1	60	60	NUM
eshr-6129	148	2	-	-	SYM
eshr-6129	148	3	68	68	NUM
eshr-6129	148	4	68	68	NUM
eshr-6129	148	5	10.26555	10.26555	NUM
eshr-6129	148	6	/	/	SYM
eshr-6129	148	7	eshr.v5i2.6129	eshr.v5i2.6129	PROPN
eshr-6129	148	8	12	12	NUM
eshr-6129	148	9	.	.	PUNCT
eshr-6129	149	1	gordon	gordon	PROPN
eshr-6129	149	2	t	t	PROPN
eshr-6129	149	3	,	,	PUNCT
eshr-6129	149	4	castelli	castelli	PROPN
eshr-6129	149	5	w	w	PROPN
eshr-6129	149	6	,	,	PUNCT
eshr-6129	149	7	hjortland	hjortland	PROPN
eshr-6129	149	8	m	m	PROPN
eshr-6129	149	9	,	,	PUNCT
eshr-6129	149	10	kannel	kannel	PROPN
eshr-6129	149	11	w	w	PROPN
eshr-6129	149	12	,	,	PUNCT
eshr-6129	149	13	dawber	dawber	PROPN
eshr-6129	149	14	t.	t.	PROPN
eshr-6129	149	15	high	high	ADJ
eshr-6129	149	16	density	density	NOUN
eshr-6129	149	17	lipoprotein	lipoprotein	ADJ
eshr-6129	149	18	as	as	ADP
eshr-6129	149	19	a	a	DET
eshr-6129	149	20	protective	protective	ADJ
eshr-6129	149	21	factor	factor	NOUN
eshr-6129	149	22	against	against	ADP
eshr-6129	149	23	coronary	coronary	ADJ
eshr-6129	149	24	heart	heart	NOUN
eshr-6129	149	25	disease	disease	NOUN
eshr-6129	149	26	.	.	PUNCT
eshr-6129	150	1	the	the	DET
eshr-6129	150	2	framingham	framingham	PROPN
eshr-6129	150	3	study	study	PROPN
eshr-6129	150	4	.	.	PUNCT
eshr-6129	151	1	am	be	AUX
eshr-6129	151	2	j	j	PROPN
eshr-6129	151	3	med	med	PROPN
eshr-6129	151	4	.	.	PUNCT
eshr-6129	152	1	1977;62(5):707–14	1977;62(5):707–14	NUM
eshr-6129	152	2	.	.	NOUN
eshr-6129	152	3	13	13	NUM
eshr-6129	152	4	.	.	PUNCT
eshr-6129	153	1	ference	ference	PROPN
eshr-6129	153	2	ba	ba	PROPN
eshr-6129	153	3	,	,	PUNCT
eshr-6129	153	4	ginsberg	ginsberg	PROPN
eshr-6129	153	5	hn	hn	PROPN
eshr-6129	153	6	,	,	PUNCT
eshr-6129	153	7	graham	graham	PROPN
eshr-6129	153	8	i	i	PROPN
eshr-6129	153	9	,	,	PUNCT
eshr-6129	153	10	ray	ray	PROPN
eshr-6129	153	11	kk	kk	PROPN
eshr-6129	153	12	,	,	PUNCT
eshr-6129	153	13	packard	packard	PROPN
eshr-6129	153	14	cj	cj	PROPN
eshr-6129	153	15	,	,	PUNCT
eshr-6129	153	16	bruckert	bruckert	PROPN
eshr-6129	153	17	e	e	PROPN
eshr-6129	153	18	,	,	PUNCT
eshr-6129	153	19	et	et	PROPN
eshr-6129	153	20	al	al	PROPN
eshr-6129	153	21	.	.	PUNCT
eshr-6129	153	22	low	low	ADJ
eshr-6129	153	23	-	-	PUNCT
eshr-6129	153	24	density	density	NOUN
eshr-6129	153	25	lipoproteins	lipoprotein	NOUN
eshr-6129	153	26	cause	cause	VERB
eshr-6129	153	27	atherosclerotic	atherosclerotic	ADJ
eshr-6129	153	28	cardiovascular	cardiovascular	ADJ
eshr-6129	153	29	disease	disease	NOUN
eshr-6129	153	30	.	.	PUNCT
eshr-6129	154	1	1	1	X
eshr-6129	154	2	.	.	X
eshr-6129	154	3	evidence	evidence	NOUN
eshr-6129	154	4	from	from	ADP
eshr-6129	154	5	genetic	genetic	ADJ
eshr-6129	154	6	,	,	PUNCT
eshr-6129	154	7	epidemiologic	epidemiologic	ADJ
eshr-6129	154	8	,	,	PUNCT
eshr-6129	154	9	and	and	CCONJ
eshr-6129	154	10	clinical	clinical	ADJ
eshr-6129	154	11	studies	study	NOUN
eshr-6129	154	12	.	.	PUNCT
eshr-6129	155	1	a	a	DET
eshr-6129	155	2	consensus	consensus	NOUN
eshr-6129	155	3	statement	statement	NOUN
eshr-6129	155	4	fromthe	fromthe	ADJ
eshr-6129	155	5	european	european	ADJ
eshr-6129	155	6	atherosclerosis	atherosclerosis	NOUN
eshr-6129	155	7	society	society	NOUN
eshr-6129	155	8	consensus	consensus	NOUN
eshr-6129	155	9	panel	panel	NOUN
eshr-6129	155	10	.	.	PUNCT
eshr-6129	156	1	eur	eur	PROPN
eshr-6129	156	2	heart	heart	NOUN
eshr-6129	156	3	j.	j.	PROPN
eshr-6129	156	4	2017;38(32):2459–72	2017;38(32):2459–72	PROPN
eshr-6129	156	5	.	.	PUNCT
eshr-6129	156	6	14	14	NUM
eshr-6129	156	7	.	.	PUNCT
eshr-6129	157	1	yaghi	yaghi	PROPN
eshr-6129	157	2	s	s	PROPN
eshr-6129	157	3	,	,	PUNCT
eshr-6129	157	4	elkind	elkind	PROPN
eshr-6129	157	5	msv	msv	PROPN
eshr-6129	157	6	.	.	PUNCT
eshr-6129	157	7	lipids	lipids	PROPN
eshr-6129	157	8	and	and	CCONJ
eshr-6129	157	9	cerebrovascular	cerebrovascular	ADJ
eshr-6129	157	10	disease	disease	NOUN
eshr-6129	157	11	:	:	PUNCT
eshr-6129	157	12	research	research	NOUN
eshr-6129	157	13	and	and	CCONJ
eshr-6129	157	14	practice	practice	NOUN
eshr-6129	157	15	.	.	PUNCT
eshr-6129	158	1	stroke	stroke	NOUN
eshr-6129	158	2	.	.	PUNCT
eshr-6129	159	1	2015;46(11):3322–8	2015;46(11):3322–8	NUM
eshr-6129	159	2	.	.	PUNCT
eshr-6129	160	1	15	15	NUM
eshr-6129	160	2	.	.	PUNCT
eshr-6129	161	1	tasneem	tasneem	PROPN
eshr-6129	161	2	a	a	PRON
eshr-6129	161	3	,	,	PUNCT
eshr-6129	161	4	vemuri	vemuri	PROPN
eshr-6129	161	5	h	h	NOUN
eshr-6129	161	6	,	,	PUNCT
eshr-6129	161	7	shaik	shaik	PROPN
eshr-6129	161	8	m	m	PROPN
eshr-6129	161	9	,	,	PUNCT
eshr-6129	161	10	khan	khan	PROPN
eshr-6129	161	11	m.	m.	NOUN
eshr-6129	161	12	correlation	correlation	NOUN
eshr-6129	161	13	between	between	ADP
eshr-6129	161	14	glycosylated	glycosylated	ADJ
eshr-6129	161	15	haemoglobin	haemoglobin	NOUN
eshr-6129	161	16	and	and	CCONJ
eshr-6129	161	17	dyslipidaemia	dyslipidaemia	VERB
eshr-6129	161	18	in	in	ADP
eshr-6129	161	19	patients	patient	NOUN
eshr-6129	161	20	with	with	ADP
eshr-6129	161	21	type	type	NOUN
eshr-6129	161	22	2	2	NUM
eshr-6129	161	23	diabetes	diabetes	NOUN
eshr-6129	161	24	mellitus	mellitus	NOUN
eshr-6129	161	25	.	.	PUNCT
eshr-6129	162	1	int	int	PROPN
eshr-6129	162	2	j	j	PROPN
eshr-6129	162	3	health	health	PROPN
eshr-6129	162	4	sci	sci	PROPN
eshr-6129	162	5	(	(	PUNCT
eshr-6129	162	6	qassim	qassim	NOUN
eshr-6129	162	7	)	)	PUNCT
eshr-6129	162	8	.	.	PUNCT
eshr-6129	163	1	2021;4(24):1–3	2021;4(24):1–3	NOUN
eshr-6129	163	2	.	.	PUNCT
eshr-6129	164	1	16	16	NUM
eshr-6129	164	2	.	.	PUNCT
eshr-6129	165	1	anderson	anderson	PROPN
eshr-6129	165	2	km	km	PROPN
eshr-6129	165	3	.	.	PUNCT
eshr-6129	166	1	cholesterol	cholesterol	NOUN
eshr-6129	166	2	and	and	CCONJ
eshr-6129	166	3	mortality	mortality	NOUN
eshr-6129	166	4	.	.	PUNCT
eshr-6129	167	1	30	30	NUM
eshr-6129	167	2	years	year	NOUN
eshr-6129	167	3	of	of	ADP
eshr-6129	167	4	follow	follow	NOUN
eshr-6129	167	5	-	-	PUNCT
eshr-6129	167	6	up	up	NOUN
eshr-6129	167	7	from	from	ADP
eshr-6129	167	8	the	the	DET
eshr-6129	167	9	framingham	framingham	PROPN
eshr-6129	167	10	study	study	PROPN
eshr-6129	167	11	.	.	PUNCT
eshr-6129	168	1	jama	jama	PROPN
eshr-6129	168	2	j	j	PROPN
eshr-6129	168	3	am	be	AUX
eshr-6129	168	4	med	med	ADJ
eshr-6129	168	5	assoc	assoc	NOUN
eshr-6129	168	6	.	.	PUNCT
eshr-6129	169	1	1987;257(16):2176–80	1987;257(16):2176–80	NUM
eshr-6129	169	2	.	.	PROPN
eshr-6129	169	3	17	17	NUM
eshr-6129	169	4	.	.	PUNCT
eshr-6129	169	5	nickenig	nickenig	PROPN
eshr-6129	169	6	g.	g.	PROPN
eshr-6129	169	7	central	central	ADJ
eshr-6129	169	8	role	role	NOUN
eshr-6129	169	9	of	of	ADP
eshr-6129	169	10	the	the	DET
eshr-6129	169	11	at(1)-receptor	at(1)-receptor	NOUN
eshr-6129	169	12	in	in	ADP
eshr-6129	169	13	atherosclerosis	atherosclerosis	NOUN
eshr-6129	169	14	.	.	PUNCT
eshr-6129	170	1	j	j	PROPN
eshr-6129	170	2	hum	hum	PROPN
eshr-6129	170	3	hypertens	hyperten	NOUN
eshr-6129	170	4	.	.	PUNCT
eshr-6129	171	1	2002;16:26–33	2002;16:26–33	NUM
eshr-6129	171	2	.	.	X
eshr-6129	172	1	18	18	NUM
eshr-6129	172	2	.	.	PUNCT
eshr-6129	173	1	nickenig	nickenig	PROPN
eshr-6129	173	2	g	g	PROPN
eshr-6129	173	3	,	,	PUNCT
eshr-6129	173	4	harrison	harrison	PROPN
eshr-6129	173	5	d.	d.	PROPN
eshr-6129	173	6	current	current	PROPN
eshr-6129	173	7	perspective	perspective	PROPN
eshr-6129	173	8	the	the	DET
eshr-6129	173	9	at1	at1	PROPN
eshr-6129	173	10	-type	-type	PROPN
eshr-6129	173	11	angiotensin	angiotensin	NOUN
eshr-6129	173	12	receptor	receptor	NOUN
eshr-6129	173	13	in	in	ADP
eshr-6129	173	14	oxidative	oxidative	ADJ
eshr-6129	173	15	stress	stress	NOUN
eshr-6129	173	16	and	and	CCONJ
eshr-6129	173	17	atherogenesis	atherogenesis	VERB
eshr-6129	173	18	part	part	PROPN
eshr-6129	173	19	ii	ii	PROPN
eshr-6129	173	20	:	:	PUNCT
eshr-6129	173	21	at1	at1	PROPN
eshr-6129	173	22	receptor	receptor	NOUN
eshr-6129	173	23	regulation	regulation	NOUN
eshr-6129	173	24	.	.	PUNCT
eshr-6129	174	1	circulation	circulation	NOUN
eshr-6129	174	2	.	.	PUNCT
eshr-6129	175	1	2002;530–6	2002;530–6	NUM
eshr-6129	175	2	.	.	NOUN
eshr-6129	176	1	19	19	NUM
eshr-6129	176	2	.	.	PUNCT
eshr-6129	176	3	nickenig	nickenig	PROPN
eshr-6129	176	4	g	g	PROPN
eshr-6129	176	5	,	,	PUNCT
eshr-6129	176	6	harrison	harrison	PROPN
eshr-6129	176	7	d.	d.	PROPN
eshr-6129	176	8	current	current	PROPN
eshr-6129	176	9	perspective	perspective	PROPN
eshr-6129	176	10	current	current	ADJ
eshr-6129	176	11	perspective	perspective	NOUN
eshr-6129	176	12	the	the	DET
eshr-6129	176	13	at1	at1	PROPN
eshr-6129	176	14	-type	-type	PROPN
eshr-6129	176	15	angiotensin	angiotensin	NOUN
eshr-6129	176	16	receptor	receptor	NOUN
eshr-6129	176	17	in	in	ADP
eshr-6129	176	18	oxidative	oxidative	ADJ
eshr-6129	176	19	stress	stress	NOUN
eshr-6129	176	20	and	and	CCONJ
eshr-6129	176	21	atherogenesis	atherogenesis	VERB
eshr-6129	176	22	part	part	NOUN
eshr-6129	176	23	i	i	NOUN
eshr-6129	176	24	:	:	PUNCT
eshr-6129	176	25	oxidative	oxidative	ADJ
eshr-6129	176	26	stress	stress	NOUN
eshr-6129	176	27	and	and	CCONJ
eshr-6129	176	28	atherogenesis	atherogenesis	NOUN
eshr-6129	176	29	.	.	PUNCT
eshr-6129	177	1	circulation	circulation	NOUN
eshr-6129	177	2	.	.	PUNCT
eshr-6129	178	1	2002;393–6	2002;393–6	ADJ
eshr-6129	178	2	.	.	PUNCT
eshr-6129	179	1	20	20	NUM
eshr-6129	179	2	.	.	PUNCT
eshr-6129	180	1	khavandi	khavandi	PROPN
eshr-6129	180	2	m	m	PROPN
eshr-6129	180	3	,	,	PUNCT
eshr-6129	180	4	duarte	duarte	PROPN
eshr-6129	180	5	f	f	PROPN
eshr-6129	180	6	,	,	PUNCT
eshr-6129	180	7	ginsberg	ginsberg	PROPN
eshr-6129	180	8	hn	hn	PROPN
eshr-6129	180	9	,	,	PUNCT
eshr-6129	180	10	reyes	reyes	NOUN
eshr-6129	180	11	-	-	PUNCT
eshr-6129	180	12	soffer	soffer	NOUN
eshr-6129	180	13	g.	g.	NOUN
eshr-6129	180	14	treatment	treatment	NOUN
eshr-6129	180	15	of	of	ADP
eshr-6129	180	16	dyslipidemias	dyslipidemia	NOUN
eshr-6129	180	17	to	to	PART
eshr-6129	180	18	prevent	prevent	VERB
eshr-6129	180	19	cardiovascular	cardiovascular	ADJ
eshr-6129	180	20	disease	disease	NOUN
eshr-6129	180	21	in	in	ADP
eshr-6129	180	22	patients	patient	NOUN
eshr-6129	180	23	with	with	ADP
eshr-6129	180	24	type	type	NOUN
eshr-6129	180	25	2	2	NUM
eshr-6129	180	26	diabetes	diabetes	NOUN
eshr-6129	180	27	.	.	PUNCT
eshr-6129	181	1	curr	curr	PROPN
eshr-6129	181	2	cardiol	cardiol	PROPN
eshr-6129	181	3	rep	rep	PROPN
eshr-6129	181	4	.	.	PROPN
eshr-6129	181	5	2017;19(1):1–16	2017;19(1):1–16	NUM
eshr-6129	181	6	.	.	PROPN
eshr-6129	181	7	21	21	NUM
eshr-6129	181	8	.	.	PUNCT
eshr-6129	182	1	dolzhenko	dolzhenko	PROPN
eshr-6129	182	2	m	m	PROPN
eshr-6129	182	3	,	,	PUNCT
eshr-6129	182	4	barnett	barnett	PROPN
eshr-6129	182	5	o	o	PROPN
eshr-6129	182	6	,	,	PUNCT
eshr-6129	182	7	grassos	grassos	PROPN
eshr-6129	182	8	c	c	NOUN
eshr-6129	182	9	,	,	PUNCT
eshr-6129	182	10	dragomiretska	dragomiretska	NOUN
eshr-6129	182	11	n	n	CCONJ
eshr-6129	182	12	,	,	PUNCT
eshr-6129	182	13	goloborodko	goloborodko	PROPN
eshr-6129	182	14	b	b	PROPN
eshr-6129	182	15	,	,	PUNCT
eshr-6129	182	16	ilashchuk	ilashchuk	PROPN
eshr-6129	182	17	t	t	PROPN
eshr-6129	182	18	,	,	PUNCT
eshr-6129	182	19	et	et	PROPN
eshr-6129	182	20	al	al	PROPN
eshr-6129	182	21	.	.	PUNCT
eshr-6129	182	22	management	management	NOUN
eshr-6129	182	23	of	of	ADP
eshr-6129	182	24	dyslipidemia	dyslipidemia	NOUN
eshr-6129	182	25	in	in	ADP
eshr-6129	182	26	individuals	individual	NOUN
eshr-6129	182	27	with	with	ADP
eshr-6129	182	28	low	low	ADJ
eshr-6129	182	29	-	-	PUNCT
eshr-6129	182	30	to	to	ADP
eshr-6129	182	31	-	-	PUNCT
eshr-6129	182	32	moderate	moderate	ADJ
eshr-6129	182	33	cardiovascular	cardiovascular	ADJ
eshr-6129	182	34	risk	risk	NOUN
eshr-6129	182	35	:	:	PUNCT
eshr-6129	182	36	role	role	NOUN
eshr-6129	182	37	of	of	ADP
eshr-6129	182	38	nutraceuticals	nutraceutical	NOUN
eshr-6129	182	39	.	.	PUNCT
eshr-6129	183	1	adv	adv	INTJ
eshr-6129	183	2	ther	ther	ADV
eshr-6129	183	3	.	.	PUNCT
eshr-6129	184	1	2020;37(11):4549–67	2020;37(11):4549–67	NUM
eshr-6129	184	2	.	.	X
eshr-6129	185	1	22	22	NUM
eshr-6129	185	2	.	.	PUNCT
eshr-6129	186	1	papatheodorou	papatheodorou	PROPN
eshr-6129	186	2	k	k	PROPN
eshr-6129	186	3	,	,	PUNCT
eshr-6129	186	4	banach	banach	NOUN
eshr-6129	186	5	m	m	PROPN
eshr-6129	186	6	,	,	PUNCT
eshr-6129	186	7	bekiari	bekiari	PROPN
eshr-6129	186	8	e	e	PROPN
eshr-6129	186	9	,	,	PUNCT
eshr-6129	186	10	rizzo	rizzo	PROPN
eshr-6129	186	11	m	m	PROPN
eshr-6129	186	12	,	,	PUNCT
eshr-6129	186	13	edmonds	edmond	NOUN
eshr-6129	186	14	m.	m.	NOUN
eshr-6129	186	15	complications	complication	NOUN
eshr-6129	186	16	of	of	ADP
eshr-6129	186	17	diabetes	diabetes	NOUN
eshr-6129	186	18	2017	2017	NUM
eshr-6129	186	19	konstantinos	konstantino	NOUN
eshr-6129	186	20	.	.	PUNCT
eshr-6129	187	1	j	j	PROPN
eshr-6129	187	2	diabetes	diabetes	NOUN
eshr-6129	187	3	res	re	NOUN
eshr-6129	187	4	.	.	PROPN
eshr-6129	188	1	2018;2018	2018;2018	NUM
eshr-6129	188	2	,	,	PUNCT
eshr-6129	188	3	arti:4	arti:4	PROPN
eshr-6129	188	4	.	.	PROPN
eshr-6129	188	5	23	23	NUM
eshr-6129	188	6	.	.	PUNCT
eshr-6129	189	1	khaltaev	khaltaev	PROPN
eshr-6129	189	2	n	n	PROPN
eshr-6129	189	3	,	,	PUNCT
eshr-6129	189	4	axelrod	axelrod	PROPN
eshr-6129	189	5	s.	s.	PROPN
eshr-6129	189	6	global	global	ADJ
eshr-6129	189	7	trends	trend	NOUN
eshr-6129	189	8	in	in	ADP
eshr-6129	189	9	diabetes	diabetes	NOUN
eshr-6129	189	10	-	-	PUNCT
eshr-6129	189	11	related	relate	VERB
eshr-6129	189	12	mortality	mortality	NOUN
eshr-6129	189	13	with	with	ADP
eshr-6129	189	14	regard	regard	NOUN
eshr-6129	189	15	to	to	ADP
eshr-6129	189	16	lifestyle	lifestyle	NOUN
eshr-6129	189	17	modifications	modification	NOUN
eshr-6129	189	18	,	,	PUNCT
eshr-6129	189	19	risk	risk	NOUN
eshr-6129	189	20	factors	factor	NOUN
eshr-6129	189	21	,	,	PUNCT
eshr-6129	189	22	and	and	CCONJ
eshr-6129	189	23	affordable	affordable	ADJ
eshr-6129	189	24	management	management	NOUN
eshr-6129	189	25	:	:	PUNCT
eshr-6129	189	26	a	a	DET
eshr-6129	189	27	preliminary	preliminary	ADJ
eshr-6129	189	28	analysis	analysis	NOUN
eshr-6129	189	29	.	.	PUNCT
eshr-6129	190	1	chronic	chronic	ADJ
eshr-6129	190	2	dis	dis	PROPN
eshr-6129	190	3	transl	transl	PROPN
eshr-6129	190	4	med	med	PROPN
eshr-6129	190	5	.	.	PUNCT
eshr-6129	191	1	2021;7(3):182–9	2021;7(3):182–9	X
eshr-6129	191	2	.	.	PROPN
eshr-6129	191	3	24	24	NUM
eshr-6129	191	4	.	.	PUNCT
eshr-6129	192	1	bird	bird	PROPN
eshr-6129	192	2	s	s	PROPN
eshr-6129	192	3	,	,	PUNCT
eshr-6129	192	4	hawley	hawley	PROPN
eshr-6129	192	5	j.	j.	PROPN
eshr-6129	192	6	update	update	PROPN
eshr-6129	192	7	on	on	ADP
eshr-6129	192	8	the	the	DET
eshr-6129	192	9	effects	effect	NOUN
eshr-6129	192	10	of	of	ADP
eshr-6129	192	11	physical	physical	ADJ
eshr-6129	192	12	activity	activity	NOUN
eshr-6129	192	13	on	on	ADP
eshr-6129	192	14	insulin	insulin	NOUN
eshr-6129	192	15	sensitivity	sensitivity	NOUN
eshr-6129	192	16	in	in	ADP
eshr-6129	192	17	humans	human	NOUN
eshr-6129	192	18	.	.	PUNCT
eshr-6129	193	1	bmj	bmj	PROPN
eshr-6129	193	2	open	open	ADJ
eshr-6129	193	3	sport	sport	NOUN
eshr-6129	193	4	exerc	exerc	PROPN
eshr-6129	193	5	med	med	PROPN
eshr-6129	193	6	.	.	PUNCT
eshr-6129	193	7	2017;2(1):1–26	2017;2(1):1–26	NUM
eshr-6129	193	8	.	.	X
eshr-6129	194	1	25	25	NUM
eshr-6129	194	2	.	.	PUNCT
eshr-6129	194	3	mellergård	mellergård	PROPN
eshr-6129	194	4	e	e	PROPN
eshr-6129	194	5	,	,	PUNCT
eshr-6129	194	6	johnsson	johnsson	PROPN
eshr-6129	194	7	p	p	PROPN
eshr-6129	194	8	,	,	PUNCT
eshr-6129	194	9	eek	eek	AUX
eshr-6129	194	10	f.	f.	PROPN
eshr-6129	194	11	developing	develop	VERB
eshr-6129	194	12	a	a	DET
eshr-6129	194	13	web	web	NOUN
eshr-6129	194	14	-	-	PUNCT
eshr-6129	194	15	based	base	VERB
eshr-6129	194	16	support	support	NOUN
eshr-6129	194	17	using	use	VERB
eshr-6129	194	18	self	self	NOUN
eshr-6129	194	19	-	-	PUNCT
eshr-6129	194	20	affirmation	affirmation	NOUN
eshr-6129	194	21	to	to	PART
eshr-6129	194	22	motivate	motivate	VERB
eshr-6129	194	23	lifestyle	lifestyle	NOUN
eshr-6129	194	24	changes	change	NOUN
eshr-6129	194	25	in	in	ADP
eshr-6129	194	26	type	type	NOUN
eshr-6129	194	27	2	2	NUM
eshr-6129	194	28	diabetes	diabetes	NOUN
eshr-6129	194	29	:	:	PUNCT
eshr-6129	194	30	a	a	DET
eshr-6129	194	31	qualitative	qualitative	ADJ
eshr-6129	194	32	study	study	NOUN
eshr-6129	194	33	assessing	assess	VERB
eshr-6129	194	34	patient	patient	ADJ
eshr-6129	194	35	perspectives	perspective	NOUN
eshr-6129	194	36	on	on	ADP
eshr-6129	194	37	self	self	NOUN
eshr-6129	194	38	-	-	PUNCT
eshr-6129	194	39	management	management	NOUN
eshr-6129	194	40	and	and	CCONJ
eshr-6129	194	41	views	view	NOUN
eshr-6129	194	42	on	on	ADP
eshr-6129	194	43	a	a	DET
eshr-6129	194	44	digital	digital	ADJ
eshr-6129	194	45	lifestyle	lifestyle	NOUN
eshr-6129	194	46	intervention	intervention	NOUN
eshr-6129	194	47	.	.	PUNCT
eshr-6129	195	1	internet	internet	NOUN
eshr-6129	195	2	interv	interv	NOUN
eshr-6129	195	3	.	.	PUNCT
eshr-6129	196	1	2021;24(march):100384	2021;24(march):100384	X
eshr-6129	196	2	.	.	PUNCT